<!DOCTYPE html>
<html>
<head>
  <meta charset="utf-8">
  
  <meta name="renderer" content="webkit">
  <meta http-equiv="X-UA-Compatible" content="IE=edge" >
  <link rel="dns-prefetch" href="http://molinzai.github.io">
  <title>ADC-New Linker | Molinzai&#39;s Blog</title>
  <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">
  <meta name="description" content="Title: Antibody-Exatecan Conjugates with a Novel Self-immolative Moiety Overcome Resistance in Colon and Lung Cancer IF: 6.8">
<meta property="og:type" content="article">
<meta property="og:title" content="ADC-New Linker">
<meta property="og:url" content="http://molinzai.github.io/2025/08/02/36693125/index.html">
<meta property="og:site_name" content="Molinzai&#39;s Blog">
<meta property="og:description" content="Title: Antibody-Exatecan Conjugates with a Novel Self-immolative Moiety Overcome Resistance in Colon and Lung Cancer IF: 6.8">
<meta property="og:locale">
<meta property="og:image" content="http://molinzai.github.io/2025/08/02/36693125/Fig.1.png">
<meta property="og:image" content="http://molinzai.github.io/2025/08/02/36693125/Fig.S1.png">
<meta property="og:image" content="http://molinzai.github.io/2025/08/02/36693125/Fig.S12.png">
<meta property="og:image" content="http://molinzai.github.io/2025/08/02/36693125/Fig.S3.png">
<meta property="og:image" content="http://molinzai.github.io/2025/08/02/36693125/Fig.S4.png">
<meta property="og:image" content="http://molinzai.github.io/2025/08/02/36693125/Fig.2-1.png">
<meta property="og:image" content="http://molinzai.github.io/2025/08/02/36693125/Fig.2-2.png">
<meta property="og:image" content="http://molinzai.github.io/2025/08/02/36693125/Fig.S6.png">
<meta property="og:image" content="http://molinzai.github.io/2025/08/02/36693125/Fig.S7.png">
<meta property="og:image" content="http://molinzai.github.io/2025/08/02/36693125/Fig.S18.png">
<meta property="og:image" content="http://molinzai.github.io/2025/08/02/36693125/Fig.S9.png">
<meta property="og:image" content="http://molinzai.github.io/2025/08/02/36693125/Fig.3-1.png">
<meta property="og:image" content="http://molinzai.github.io/2025/08/02/36693125/Fig.3-2.png">
<meta property="og:image" content="http://molinzai.github.io/2025/08/02/36693125/Fig.4.png">
<meta property="og:image" content="http://molinzai.github.io/2025/08/02/36693125/Fig.S10.png">
<meta property="og:image" content="http://molinzai.github.io/2025/08/02/36693125/Fig.S11.png">
<meta property="og:image" content="http://molinzai.github.io/2025/08/02/36693125/Fig.S12.png">
<meta property="og:image" content="http://molinzai.github.io/2025/08/02/36693125/Fig.S13.png">
<meta property="og:image" content="http://molinzai.github.io/2025/08/02/36693125/Fig.5-1.png">
<meta property="og:image" content="http://molinzai.github.io/2025/08/02/36693125/Fig.5-2.png">
<meta property="og:image" content="http://molinzai.github.io/2025/08/02/36693125/Fig.6-1.png">
<meta property="og:image" content="http://molinzai.github.io/2025/08/02/36693125/Fig.6-2.png">
<meta property="og:image" content="http://molinzai.github.io/2025/08/02/36693125/Fig.S5.png">
<meta property="og:image" content="http://molinzai.github.io/2025/08/02/36693125/Fig.S14.png">
<meta property="og:image" content="http://molinzai.github.io/2025/08/02/36693125/Fig.S15.png">
<meta property="og:image" content="http://molinzai.github.io/2025/08/02/36693125/Fig.S16.png">
<meta property="og:image" content="http://molinzai.github.io/2025/08/02/36693125/Fig.S18.png">
<meta property="og:image" content="http://molinzai.github.io/2025/08/02/36693125/Fig.S17.png">
<meta property="og:image" content="http://molinzai.github.io/2025/08/02/36693125/Fig.S19.png">
<meta property="article:published_time" content="2025-08-02T05:05:46.617Z">
<meta property="article:modified_time" content="2025-08-02T05:05:15.980Z">
<meta property="article:author" content="Molinzai">
<meta property="article:tag" content="ADC">
<meta name="twitter:card" content="summary">
<meta name="twitter:image" content="http://molinzai.github.io/2025/08/02/36693125/Fig.1.png">
  
    <link rel="alternative" href="/atom.xml" title="Molinzai&#39;s Blog" type="application/atom+xml">
  
  
    <link rel="icon" href="/favicon.png">
  
  <link rel="stylesheet" type="text/css" href="/./main.0cf68a.css">
  <style type="text/css">
  
    #container.show {
      background: linear-gradient(200deg,#a0cfe4,#e8c37e);
    }
  </style>
  

  

<meta name="generator" content="Hexo 5.4.2"></head>

<body>
  <div id="container" q-class="show:isCtnShow">
    <canvas id="anm-canvas" class="anm-canvas"></canvas>
    <div class="left-col" q-class="show:isShow">
      
<div class="overlay" style="background: #4d4d4d"></div>
<div class="intrude-less">
	<header id="header" class="inner">
		<a href="/" class="profilepic">
			<img src="/img/head.jpg" class="js-avatar">
		</a>
		<hgroup>
		  <h1 class="header-author"><a href="/">磨叽歪</a></h1>
		</hgroup>
		
		<p class="header-subtitle">一隅偏安</p>
		

		<nav class="header-menu">
			<ul>
			
				<li><a href="/">主页</a></li>
	        
				<li><a href="/archives/index.html">归档</a></li>
	        
			</ul>
		</nav>
		<nav class="header-smart-menu">
    		
    			
    			<a q-on="click: openSlider(e, 'innerArchive')" href="javascript:void(0)">所有文章</a>
    			
            
    			
    			<a q-on="click: openSlider(e, 'aboutme')" href="javascript:void(0)">关于我</a>
    			
            
		</nav>
		<nav class="header-nav">
			<div class="social">
				
					<a class="github" target="_blank" href="https://github.com/molinzai" title="github"><i class="icon-github"></i></a>
		        
					<a class="weibo" target="_blank" href="https://weibo.com/molinzai" title="weibo"><i class="icon-weibo"></i></a>
		        
			</div>
		</nav>
	</header>		
</div>

    </div>
    <div class="mid-col" q-class="show:isShow,hide:isShow|isFalse">
      
<nav id="mobile-nav">
  	<div class="overlay js-overlay" style="background: #4d4d4d"></div>
	<div class="btnctn js-mobile-btnctn">
  		<div class="slider-trigger list" q-on="click: openSlider(e)"><i class="icon icon-sort"></i></div>
	</div>
	<div class="intrude-less">
		<header id="header" class="inner">
			<div class="profilepic">
				<img src="/img/head.jpg" class="js-avatar">
			</div>
			<hgroup>
			  <h1 class="header-author js-header-author">磨叽歪</h1>
			</hgroup>
			
			<p class="header-subtitle"><i class="icon icon-quo-left"></i>一隅偏安<i class="icon icon-quo-right"></i></p>
			
			
			
				
			
				
			
			
			
			<nav class="header-nav">
				<div class="social">
					
						<a class="github" target="_blank" href="https://github.com/molinzai" title="github"><i class="icon-github"></i></a>
			        
						<a class="weibo" target="_blank" href="https://weibo.com/molinzai" title="weibo"><i class="icon-weibo"></i></a>
			        
				</div>
			</nav>

			<nav class="header-menu js-header-menu">
				<ul style="width: 50%">
				
				
					<li style="width: 50%"><a href="/">主页</a></li>
		        
					<li style="width: 50%"><a href="/archives/index.html">归档</a></li>
		        
				</ul>
			</nav>
		</header>				
	</div>
	<div class="mobile-mask" style="display:none" q-show="isShow"></div>
</nav>

      <div id="wrapper" class="body-wrap">
        <div class="menu-l">
          <div class="canvas-wrap">
            <canvas data-colors="#eaeaea" data-sectionHeight="100" data-contentId="js-content" id="myCanvas1" class="anm-canvas"></canvas>
          </div>
          <div id="js-content" class="content-ll">
            <article id="post-36693125"
  class="article article-type-post " itemscope itemprop="blogPost">
  <div class="article-inner">
    
      <header class="article-header">
        
  
    <h1 class="article-title" itemprop="name">
      ADC-New Linker
    </h1>
  

          
            <a href="/2025/08/02/36693125/" class="archive-article-date">
  	<time datetime="2025-08-02T05:05:46.617Z" itemprop="datePublished"><i class="icon-calendar icon"></i>2025-08-02</time>
</a>
              <!-- 需要添加的位置 -->
              <!-- 开始添加字数统计-->
              
                <div style="margin-top:10px;">
    <span class="post-time">
      <span class="post-meta-item-icon">
        <i class="fa fa-keyboard-o"></i>
        <span class="post-meta-item-text">  字数统计: </span>
        <span class="post-count">17.3k字</span>
      </span>
    </span>

    <span class="post-time">
      &nbsp; | &nbsp;
      <span class="post-meta-item-icon">
        <i class="fa fa-hourglass-half"></i>
        <span class="post-meta-item-text">  阅读时长: </span>
        <span class="post-count">69分</span>
      </span>
    </span>
</div>
                  
                    <!-- 添加完成 -->
                    
      </header>
      
        <div class="article-entry" itemprop="articleBody">
          
                    <blockquote>
<p>Title: Antibody-Exatecan Conjugates with a Novel Self-immolative Moiety Overcome Resistance in Colon and Lung Cancer</p>
<p>IF: 6.8</p>
</blockquote>
<span id="more"></span>
<blockquote>
<p>Publication Type: Cancer Discovery</p>
<p>PMID: 36693125</p>
</blockquote>
<h3 id="〇、文献背景"><a href="#〇、文献背景" class="headerlink" title="〇、文献背景"></a>〇、文献背景</h3><h3 id="一、题目要素"><a href="#一、题目要素" class="headerlink" title="一、题目要素"></a>一、题目要素</h3><h3 id="二、假设逻辑"><a href="#二、假设逻辑" class="headerlink" title="二、假设逻辑"></a>二、假设逻辑</h3><p>Exatecan疏水性极强。DXd来源于exatecan。</p>
<p>第一步：比较Exatecan/DXd/SN-38三个小分子体内体外的毒性。</p>
<p>第二步：T部分的优化</p>
<p>第三步：Tras-GGFG-DXd和DS-8201a（商品化）性能研究对比。</p>
<p>第四步：MTX-1000（ADC）的分析及体内外实验及优越性（与Tras-GGFG-DXd和DS-8201a比较）。</p>
<p>第五步：LP(T1000-Exatecan)延伸到其它ADC</p>
<h3 id="三、数据泛读"><a href="#三、数据泛读" class="headerlink" title="三、数据泛读"></a>三、数据泛读</h3><h4 id="3-1-比较Exatecan-DXd-SN-38三个小分子体内体外的毒性。"><a href="#3-1-比较Exatecan-DXd-SN-38三个小分子体内体外的毒性。" class="headerlink" title="3.1 比较Exatecan/DXd/SN-38三个小分子体内体外的毒性。"></a>3.1 比较Exatecan/DXd/SN-38三个小分子体内体外的毒性。</h4><h5 id="3-1-0-Exatecan效力，MDR敏感性和毒性。"><a href="#3-1-0-Exatecan效力，MDR敏感性和毒性。" class="headerlink" title="3.1.0 Exatecan效力，MDR敏感性和毒性。"></a>3.1.0 Exatecan效力，MDR敏感性和毒性。</h5><p>A. 检测Exatecan、DXd 和 SN-38 诱导的 DNA 捕获型 TOP1。左图：用指定浓度的药物处理 COLO205 细胞 30 分钟，通过 RADAR 实验分离 TOP1-DNA 共价复合物（TOP1ccs）。右图：单次实验中根据左图曝光图像对 TOP1ccs 进行定量。用 ImageJ 软件分析 TOP1 的强度，并以 DNA 上样量进行归一化。</p>
<blockquote>
<p>“TOP1ccs were isolated by RADAR assay” 这句话的核心含义是：<strong>通过RADAR分析法检测并定量了拓扑异构酶I共价复合物（TOP1ccs）</strong>。 </p>
<p>关键术语解析： 1. <strong>TOP1ccs</strong>     全称 <strong>Topoisomerase I covalent complexes</strong>（拓扑异构酶I共价复合物），是拓扑异构酶I（TOP1）在催化DNA解旋过程中形成的瞬时中间产物。TOP1ccs通常会被细胞快速修复，但在药物（如喜树碱类化疗药物）作用下会被稳定，导致DNA断裂并引发细胞死亡。 2. <strong>RADAR assay</strong>     全称 <strong>Rapid Approach to DNA Adduct Recovery</strong>（DNA加合物快速回收法），是一种<strong>定量检测DNA-蛋白质共价复合物（DPCCs）的技术</strong>。其核心原理是通过变性条件（如超声处理、高盐缓冲液）裂解细胞，使共价结合的DNA-蛋白质复合物与游离蛋白分离，再通过免疫检测（如抗体结合）定量目标复合物。 </p>
<p>实验流程与逻辑： 1. <strong>样本处理</strong>     细胞经药物处理（如TOP1抑制剂）后，裂解并释放DNA-蛋白质复合物。RADAR assay通过<strong>超声破碎</strong>和<strong>乙醇沉淀</strong>等步骤，选择性保留与DNA共价结合的TOP1（即TOP1ccs），同时去除游离蛋白。 2. <strong>检测与定量</strong>     利用抗TOP1抗体通过免疫印迹（Western blot）或化学发光法检测沉淀中的TOP1ccs，结合DNA含量标准化后，计算TOP1ccs的相对水平。例如，在摘要1的研究中，RADAR assay被用于比较不同TOP1抑制剂（如exatecan与拓扑替康）诱导TOP1ccs的能力，结果显示exatecan显著增加了TOP1ccs的积累。 3. <strong>“Isolated”的实际含义</strong>     此处的”isolated”并非指物理纯化TOP1ccs，而是指通过RADAR assay的<strong>选择性富集和检测</strong>，从复杂的细胞裂解物中<strong>特异性识别并定量TOP1ccs</strong>。这一过程类似于免疫沉淀（IP），但更强调对共价复合物的高效捕获。 ### 科学意义与应用场景： - <strong>药物研发</strong>：评估TOP1抑制剂的药效（如药物诱导TOP1ccs的能力），优化药物设计。 - <strong>机制研究</strong>：解析TOP1ccs的形成、修复及与疾病（如癌症）的关联。 - <strong>生物标志物发现</strong>：例如，通过RADAR assay验证SLFN11基因表达与TOP1ccs积累的关系，为个性化治疗提供依据。 </p>
<p>总结： “TOP1ccs were isolated by RADAR assay” 表明研究者采用RADAR技术，从细胞样本中<strong>特异性检测并定量了TOP1ccs</strong>，揭示了TOP1在DNA代谢或药物作用下的动态变化。这一方法凭借快速、灵敏的特点，已成为拓扑异构酶研究领域的重要工具。</p>
</blockquote>
<p>B，Exatecan诱导的TOP1降解。图中展示了实验方案。上图：COLO205细胞用指定的TOP1抑制剂孵育2小时。在没有抑制剂的情况下进行30分钟的TOP1逆转后，通过蛋白质印迹法测定TOP1水平。下图：细胞总TOP1条带的定量分析。使用ImageJ软件分析条带强度，并标准化为作为上样对照的微管蛋白（Tubulin）。</p>
<p>C、exatecan（黄色）和 DXd（浅灰色）与人 TOP1-DNA 结构（PDB：1T8I）结合的模型。Exatecan（PubChem：151115）和 DXd（PubChem：117888634）的结构坐标从 NCBI PubChem Compound 数据库（<a target="_blank" rel="noopener" href="http://www.ncbi.nlm.nih.gov/pccompound）以">http://www.ncbi.nlm.nih.gov/pccompound）以</a> 3D SDF 文件格式下载。使用 Schrödinger 软件进行Exatecan和 DXd 在 TOP1-DNA 结构中的叠加结构建模，并使用 PyMOL 软件进行图形展示。红色实心点表示Exatecan上的伯氨基（NH2），该氨基可与 + 1 位 DNA 碱基的氧原子（Base）和 TOP1 的 N352 残基形成两个额外的氢键（以虚线表示）。</p>
<p>D，在有 / 无抑制剂的情况下，exatecan / DXd/SN-38 在 Caco-2 细胞中的外排率。实验在 Transwell 板中进行，于 37°C 条件下孵育 2 小时，分别加入或不加入 P - 糖蛋白（P-gp）抑制剂维拉帕米、ABCG2 抑制剂新生霉素或双靶点抑制剂 GF120918（10μmol/L）。数值表示（B 到 A 方向的平均值）与（A 到 B 方向的平均值）的比值（3 次测量的平均值）。</p>
<p>E，NCI-H460 细胞与药物孵育 4 小时后，exatecan和 DXd 在细胞内积累的代表性荧光图像。上图：在明场（左图）观察到细胞的同一区域，未观察到 DXd 的荧光（中图）；exatecan的自发荧光（蓝色）在细胞中清晰可见（右图，无对应的明场细胞图像对照）。下图：ABCG2 抑制剂利血平增加了 DXd 在细胞内的积累（中图），但不影响Exatecan的积累（右图）。左图为与中图同一区域的明场图像。比例尺为 20μm。</p>
<blockquote>
<p>exatecan为啥会有自发荧光？</p>
</blockquote>
<p>F，在高 ABCG2（排除高 P-gp）/ 高 P-gp（排除高 ABCG2）及低 ABCG2/P-gp mRNA 表达的癌细胞中，DXd / exatecan的 IC50 比值。细胞毒性数据来自补充图 S1B，ABCG2/P-gp 表达数据来自补充图 S1D 和 S1E。ABCG2 高表达细胞系指 ABCG2 mRNA 表达＞2 且 P-gp mRNA＜2；P-gp 高表达细胞系指 P-gp mRNA 表达＞2 且 ABCG mRNA＜3。</p>
<p>G、ABCG2 和 P-gp 抑制剂可增强癌细胞对 DXd 和 SN-38 的敏感性，但对exatecan无此作用。比较在有 / 无 ABCG2 抑制剂 YHO-13177（用于 ASPC-1 和 H2170 细胞）或 P-gp 抑制剂 tariquidar（用于 COLO320DM 和 HCT-15 细胞）的情况下，exatecan、DXd 和 SN-38 的细胞毒性。SKOV3 和 COLO205 细胞中 ABCG2/P-gp 的表达水平较低。</p>
<p><img src="/2025/08/02/36693125/Fig.1.png" alt="Fig.1"></p>
<h5 id="3-1-1-Fig-S1-补充图S1-Exatecan的细胞毒性及对多药耐药基因的敏感性"><a href="#3-1-1-Fig-S1-补充图S1-Exatecan的细胞毒性及对多药耐药基因的敏感性" class="headerlink" title="3.1.1 Fig.S1 补充图S1. Exatecan的细胞毒性及对多药耐药基因的敏感性"></a>3.1.1 Fig.S1 补充图S1. Exatecan的细胞毒性及对多药耐药基因的敏感性</h5><p>A. Exatecan和DXd的结构。红色椭圆标注了Exatecan在NH₂（F环上）通过2-羟基乙酰基（CO-CH₂-OH）进行的结构修饰，使其成为亲水性更强的DXd。 </p>
<p>B. Exatecan与DXd的细胞毒性比较。将细胞与一系列浓度的Exatecan或DXd孵育5天，通过CCK8法测定细胞活力，并根据细胞活力-浓度曲线计算各细胞系的IC₅₀。</p>
<p>C. 检测Exatecan、DXd 和 SN-38 诱导的 DNA 捕获型 TOP1。DNA染色作为图1A-1B中RADAR测定的上样对照。 </p>
<p>D. 亲脂性配体效率（LLE）计算。使用Exatecan/SN-38/DXd的平均IC₅₀。LLE = pIC₅₀（平均值）- LogD₇.₀，其中LogD₇.₀值通过ChemAxon LogD预测工具（<a target="_blank" rel="noopener" href="https://disco.chemaxon.com/calculators/demo/plugins/logd/）预测。">https://disco.chemaxon.com/calculators/demo/plugins/logd/）预测。</a> </p>
<p>E. Exatecan与DXd/SN-38在Caco-2细胞中的外排测定。地高辛和红霉素雌酮3-硫酸盐钠盐的渗透率和外排比用作阳性对照。所用抑制剂列于表格中。</p>
<p>F. Exatecan和DXd的吸光度/发射光谱扫描。 </p>
<p>G. 通过流式细胞术测定的细胞系中ABCG2的表达水平（相对于同型IgG对照）。</p>
<p>H-J. 药物孵育细胞4小时后，Exatecan和DXd在HCI-H460细胞内积累的代表性荧光图像。 D. 在COLO205细胞中，Exatecan（右上）和DXd（左上）的积累情况相似，且不受ABCG2抑制剂利血平（下）的影响。 E. 在NCI-H460细胞中，DXd无积累（上中；左图为同一区域细胞的明场观察结果），且不受P-糖蛋白抑制剂维拉帕米的影响，Exatecan的积累也未受影响（右上）。ABCG2和P-糖蛋白的双重抑制（中下和左）与单独ABCG2抑制的效果相似（见图1C中下）。 F. NCI-H460细胞在单独使用利血平（右上）或维拉帕米（右下）时无荧光。同一区域细胞的明场图像作为对照。比例尺：20μM。</p>
<p><img src="/2025/08/02/36693125/Fig.S1.png" alt="Fig.S1"></p>
<h5 id="3-1-2-Fig-S2-Exatecan-DXd-SN-38对多药耐药基因的敏感性。"><a href="#3-1-2-Fig-S2-Exatecan-DXd-SN-38对多药耐药基因的敏感性。" class="headerlink" title="3.1.2 Fig.S2 Exatecan/DXd/SN-38对多药耐药基因的敏感性。"></a>3.1.2 Fig.S2 Exatecan/DXd/SN-38对多药耐药基因的敏感性。</h5><p>A-C. 来自癌细胞系百科全书（CCLE，网址：<a target="_blank" rel="noopener" href="https://sites.broadinstitute.org/ccle/）的P-糖蛋白（P-gp）和ABCG2的mRNA表达数据，以及通过流式细胞术获得的蛋白表达数据。A">https://sites.broadinstitute.org/ccle/）的P-糖蛋白（P-gp）和ABCG2的mRNA表达数据，以及通过流式细胞术获得的蛋白表达数据。A</a>. 在该数据库中，ABCG2/P-gp高表达和低表达细胞系分别定义为表达量位于前20-30%和后20-30%的细胞系（图表顶部列出具体信息）。B. ABCG2的mRNA表达与细胞表面蛋白表达的相关性。ABCG2蛋白表达通过鼠抗ABCG2抗体经流式细胞术检测。C. 两株P-gp mRNA和细胞表面蛋白均高表达的细胞系。除少数P-gp mRNA高表达的细胞系外，未发现P-gp的mRNA表达与细胞表面蛋白表达存在相关性。 </p>
<p>D、E. 基于图S1B和图S1F-S1H的数据，DXd/Exatecan的IC50比值与ABCG2（D）和P-gp（E）mRNA表达的关系。绿色标注的细胞系为ABCG2和P-gp均高表达的细胞系，在图1F的ABCG2高表达组和P-gp高表达组中未纳入这些细胞系；浅黄色标注的细胞系在图1F的低表达组绘图时未纳入。 </p>
<p>F、G. ABCG2和P-gp抑制剂可增强癌细胞系对DXd/SN-38的敏感性。比较H2710细胞（F，ABCG2高表达）在有/无2μM YHO-13177时，对Exatecan、DXd和SN-38的细胞毒性。对于高P-gp表达的HCT-15细胞（G），使用5μM tariquidar作为P-gp抑制剂。数据来自2次独立实验，IC50的变化情况见图1G。</p>
<p><img src="/2025/08/02/36693125/Fig.S12.png" alt="Fig.S2"></p>
<h5 id="3-1-3-Fig-S3-Exatecan对大鼠的毒性。"><a href="#3-1-3-Fig-S3-Exatecan对大鼠的毒性。" class="headerlink" title="3.1.3 Fig.S3 Exatecan对大鼠的毒性。"></a>3.1.3 Fig.S3 Exatecan对大鼠的毒性。</h5><p>大鼠毒性研究。6只大鼠在第1、8、15、22和29天给予甲磺酸埃克替康3、10、30mg/kg（在A中显示为红色箭头），恢复期为4周（6只动物中的3只）。</p>
<p>A.体重变化百分比。虚线表示起始体重。</p>
<p>B.白细胞计数。 </p>
<p>C.中性粒细胞计数。 </p>
<p>D-E.血液学结果显示输注5次（6只大鼠）和恢复4周（3只大鼠）。D.红细胞计数。E.淋巴细胞计数。 </p>
<p>F-G.血清化学。F.血清丙氨酸转氨酶水平。G.血清天冬氨酸转氨酶水平。</p>
<p><img src="/2025/08/02/36693125/Fig.S3.png" alt="Fig.S3"></p>
<h4 id="3-2-T部分的优化"><a href="#3-2-T部分的优化" class="headerlink" title="3.2 T部分的优化"></a>3.2 T部分的优化</h4><h5 id="3-2-0-Fig-S4-T部分的设计和优化。"><a href="#3-2-0-Fig-S4-T部分的设计和优化。" class="headerlink" title="3.2.0 Fig.S4 T部分的设计和优化。"></a>3.2.0 Fig.S4 T部分的设计和优化。</h5><p>A. T部分的筛选与优化过程。常用的肽连接子包含在S0中。在MC/连接子（称为M部分）或PAB（称为T部分）上的修饰位点如结构1（S1）所示。</p>
<p>首先使用PEG修饰MC或PAB，得到M900（S2）或T900（S3）。用甲基氨甲基或聚肌氨酸（pSAR）取代PEG，生成了额外的T部分T800和T1000（S4）。</p>
<p>用与甲基氨甲基类似的含亲水胺基的基团（丁胺）修饰肽连接子VA，得到VK（S5中的M800）。通过将曲妥珠单抗（Tras）与Exatecan通过每个M和T部分进行偶联，对HER2靶向ADC的理化特性进行比较，从而筛选出T1000（T800）作为抗体-Exatecan偶联物的最佳结构。</p>
<p>B. 通过尺寸排阻色谱（SEC）分析T部分-Exatecan抗体偶联物（ADCs）的结构-聚集性关系。所用抗体为靶向HER2的曲妥珠单抗（Tras）。</p>
<p>C. 源自对氨基苄氧羰基（PABC）修饰的T部分的亲水性评分。辛醇-水分配系数对数（CLogP）的计算方法如Buecheler JW、Winzer M、Tonillo J、Weber C、Gieseler H在《Payload Hydrophobicity on the Stability of Antibody-Drug Conjugates》（《载药疏水性对抗体偶联物稳定性的影响》，《分子药剂学》，第15卷，2656-2664页，2018年）中所述。</p>
<p><img src="/2025/08/02/36693125/Fig.S4.png" alt="Fig.S4"></p>
<h4 id="3-3-MTX-1000（ADC）的分析及体内外实验及优越性-效果与安全性）（与Tras-GGFG-DXd和DS-8201a比较）。"><a href="#3-3-MTX-1000（ADC）的分析及体内外实验及优越性-效果与安全性）（与Tras-GGFG-DXd和DS-8201a比较）。" class="headerlink" title="3.3 MTX-1000（ADC）的分析及体内外实验及优越性(效果与安全性）（与Tras-GGFG-DXd和DS-8201a比较）。"></a>3.3 MTX-1000（ADC）的分析及体内外实验及优越性(效果与安全性）（与Tras-GGFG-DXd和DS-8201a比较）。</h4><h5 id="3-3-1-mAb-T1000-exatecan具有优异的理化和药理学特性"><a href="#3-3-1-mAb-T1000-exatecan具有优异的理化和药理学特性" class="headerlink" title="3.3.1 mAb-T1000-exatecan具有优异的理化和药理学特性"></a>3.3.1 mAb-T1000-exatecan具有优异的理化和药理学特性</h5><div class="table-container">
<table>
<thead>
<tr>
<th>ADC</th>
<th>mAb</th>
<th>linker</th>
<th>payload</th>
</tr>
</thead>
<tbody>
<tr>
<td>Tras-GGFG-Dxd</td>
<td>Tras</td>
<td>GGFG</td>
<td>Dxd</td>
</tr>
<tr>
<td>MTX-1000</td>
<td>Tras</td>
<td>T1000</td>
<td>exatecan</td>
</tr>
<tr>
<td>DS-8201a</td>
<td></td>
<td>GGFG</td>
<td>Dxd</td>
</tr>
</tbody>
</table>
</div>
<p>A，mAb-T1000-exatecan。Exatecan连接到经X修饰的自降解对氨基苄基氨基甲酸酯（PABC）间隔臂（以红色剪刀标记）。T部分的修饰结构见方框内。图中标注了VA连接子和马来酰亚胺己酰基（MC）间隔臂。左侧为抗体示意图。</p>
<p>B，曲妥珠单抗（Tras）-T1000-Exatecan/MTX-1000在人血浆和猴血浆中的体外稳定性，通过毒素释放量测定，并与Tras-GGFG-DXd进行比较。</p>
<p>C，Tras-GGFG-DXd和MTX-1000在大鼠体内的药代动力学。以4 mg/kg剂量静脉注射给药（n = 5）。</p>
<p>D，Exatecan释放与靶标表达的相关性。通过流式细胞术测定各细胞系的HER2表达水平，用100 nmol/L的Tras-T1000-Exatecan处理24小时后，通过LC/MS-MS测定培养液中的Exatecan浓度（n = 3）。</p>
<p>E，MTX-1000和DS-8201a捕获DNA拓扑异构酶I（TOP1）的检测结果汇总。数据见补充图S9E。图1A中的有效载荷数据以虚线显示。</p>
<p>F，MTX-1000和DS-8201a诱导TOP1降解的结果汇总。数据见补充图S9F。</p>
<p>G，患者来源类器官（PDO）对MTX-1000和DS-8201a的响应。展示了两个独立类器官的明场（左）和死活细胞（右）代表性图像。结直肠癌PDO用50 μg/mL的MTX-1000或DS-8201a处理6天。活细胞用钙黄绿素AM（绿色）染色，死细胞用碘化丙啶（PI；红色）染色。比例尺：20 μm。</p>
<p>H，ADC处理第0天和第6天时类器官的大小变化。将不同浓度的DS-8201a或MTX-1000与类器官共孵育6天，测量存活类器官的大小（参见参考文献34）。数据为2次独立测量的平均值±标准误。</p>
<p>I，ADC在类器官中的渗透定量分析。MTX-1000与DS-8201a从类器官表面到核心的PI染色信号空间分布。分析方法见补充图S10F，使用ImageJ软件完成。</p>
<p>J，MTX-1000、T-DM1和Tras-GGFG-DXd在体外共培养条件下的旁观者杀伤效应。将HCC1954和MDA-MB-468细胞共培养，用10 nmol/L的ADC处理5天。收集贴壁细胞后，分别用细胞计数器和流式细胞仪测定HER2阳性和HER2阴性细胞的数量及比例。图示为HCC1954和MDA-MB-468活细胞数。</p>
<p>K，MTX-1000/DS-8201a/Trodelvy和Exatecan/DXd/SN-38的骨髓毒性潜力。采用CellTiter-Glo 3D（CTG-3D）检测法评估对CD34+人骨髓造血干细胞/祖细胞的浓度依赖性抑制作用。将细胞（250 μL/孔）接种于96孔板，用SFEMII基础培养基和髓系特异性细胞因子组合进行扩增和早期分化。第1天加入5-氟尿嘧啶（5-FU）和测试化合物，第9天将细胞转移至96孔白色平底板。加入等体积的CTG-3D试剂检测细胞活力，用发光仪测量发光强度并计算各谱系的IC50值。每个数据点代表平均值±标准差（n = 3）。左图为ADC数据，中图为有效载荷数据，右图为有效载荷与ADC的IC50比值。</p>
<p><img src="/2025/08/02/36693125/Fig.2-1.png" alt="Fig.2-1"></p>
<p><img src="/2025/08/02/36693125/Fig.2-2.png" alt="Fig.2-2"></p>
<h5 id="3-3-2-由T部分启用的抗体-exatecan缀合物的物理化学图谱。"><a href="#3-3-2-由T部分启用的抗体-exatecan缀合物的物理化学图谱。" class="headerlink" title="3.3.2 由T部分启用的抗体-exatecan缀合物的物理化学图谱。"></a>3.3.2 由T部分启用的抗体-exatecan缀合物的物理化学图谱。</h5><p>A. 通过酶联免疫吸附测定（ELISA）检测MTX-1000、曲妥珠单抗（Tras）及Tras-GGFG-DXd与抗原（重组HER2蛋白）的结合情况。</p>
<p>B. 采用流式细胞术检测MTX-1000、曲妥珠单抗（Tras）及Tras-GGFG-DXd与COLO205细胞的结合情况，并以同型对照抗体（IgG）作为参照。</p>
<p>C. 以曲妥珠单抗（Tras）为靶向HER2的T部分-Exatecan抗体偶联物（ADCs）的尺寸排阻色谱图（SEC）。其中包含Tras-GGFG-DXd。使用未修饰的对氨基苄氧羰基（PABC）直接与抗体偶联（即Tras-PABC-Exatecan）时，观察到严重的聚集现象。</p>
<p>D. T部分-Exatecan抗体偶联物（ADCs）与裸抗体（T）的疏水作用色谱图（HIC）。按亲水性从高到低对ADC进行标记：所有Exatecan-曲妥珠单抗ADC的亲水性均高于Tras-GGFG-DXd。</p>
<p>E. 通过反相色谱分析DAR（药物抗体比率）为8和4的Tras-T1000-Exatecan/MTX-1000。</p>
<p>F. ADC稳定性比较。在37℃（7天）条件下以及冻融条件（-80℃放置30分钟后室温解冻，重复3次）下，通过高效液相色谱（HPLC）对T部分-ExatecanADC、Tras-GGFG-DXd和曲妥珠单抗（Tras）的稳定性进行表征。</p>
<p>G、H. T部分ADC与DS-8201a的热稳定性和光稳定性。在55℃加热（G）或实验室光照（300-500勒克斯）（H）条件下放置72小时后，通过尺寸排阻色谱（SEC）分析ADC的聚集情况。</p>
<p><img src="/2025/08/02/36693125/Fig.S6.png" alt="Fig.S6"></p>
<h5 id="3-3-3-mAb-T1000-exatecan的HIC、DAR、SEC"><a href="#3-3-3-mAb-T1000-exatecan的HIC、DAR、SEC" class="headerlink" title="3.3.3 mAb-T1000-exatecan的HIC、DAR、SEC"></a>3.3.3 mAb-T1000-exatecan的HIC、DAR、SEC</h5><p>A-C. 针对HER3（A）、TROP2（B）和CDH6（C）的T部分-Exatecan偶联物。所使用的抗体为：HER3对应的帕妥珠单抗（Patritumab），TROP2对应的达妥昔单抗（Datopotamab）和hRS7（IMMU-132），以及CDH6对应的DS6000。图中展示了疏水作用色谱（HIC）和尺寸排阻色谱（SEC）数据。TROP2抗体偶联物（ADC）的药物抗体比率（DAR）为4，且本研究中hRS7-T1000-Exatecan也称为MTX-132。</p>
<p><img src="/2025/08/02/36693125/Fig.S7.png" alt="Fig.S7"></p>
<h5 id="3-3-4-MTX-1000的体外和体内稳定性。"><a href="#3-3-4-MTX-1000的体外和体内稳定性。" class="headerlink" title="3.3.4 MTX-1000的体外和体内稳定性。"></a>3.3.4 MTX-1000的体外和体内稳定性。</h5><p>A.与Tras-GGFG-DXd相比，Tras-T1000-exatecan/MTX-1000在血浆中的体外稳定性通过毒素释放测量。</p>
<p>B-C.与Tras-GGFG-DXd相比，MTX-1000的总抗体或ADC体外血浆稳定性。1mg/ml ADC在人、猴、小鼠和大鼠血浆中稀释并通过ELISA测量<br>（测定格式如下所示）。</p>
<p>D. LC-MS在指定时间点测量的大鼠ADC有效载荷释放的比较。</p>
<p>E.大鼠以4 mg/kg单次静脉注射ADC后总抗体和ADC的药代动力学参数（n=3，平均值±SD）。</p>
<p><img src="/2025/08/02/36693125/Fig.S18.png" alt="Fig.S8"></p>
<h5 id="3-3-5-MTX-1000的细胞动力学和机制。"><a href="#3-3-5-MTX-1000的细胞动力学和机制。" class="headerlink" title="3.3.5 MTX-1000的细胞动力学和机制。"></a>3.3.5 MTX-1000的细胞动力学和机制。</h5><p>A. 通过流式细胞术检测不同细胞系上HER2的表达情况。根据HER2抗体（T）相对于同型对照抗体（IgG）的平均荧光强度（MFI），将表达水平分为高、中、低三类：MFI＞100为高表达，20-100为中表达，＜20为低表达。 </p>
<p>B. 通过流式细胞术检测MTX-1000（T）和Tras-GGFG-DXd（D）在癌细胞系中的内化率。 </p>
<p>C. 通过流式细胞术检测ADC结合后8小时，MTX-1000和Tras-GGFG-DXd在癌细胞系中的内化率。 </p>
<p>D. DXd的释放与靶点表达无相关性。通过流式细胞术确定各细胞系上HER2的表达情况，并用液相色谱-质谱联用（LC/MS-MS）检测100 nM DS-8201a处理24小时后培养基中DXd的浓度（n=3）。 </p>
<p>E. DS-8201a在细胞培养基中的稳定性低于MTX-1000。将ADC与含10%胎牛血清（FBS）的细胞培养基共同孵育8小时和24小时，通过LC/MS-MS检测释放的载药（n=2）。上方图表显示DS-8201a/MTX-1000的释放载药浓度比，下方表格为浓度测量值。 </p>
<p>F. 检测MTX-1000和DS-8201a诱导的DNA捕获型TOP1。左图：用指定浓度的药物处理COLO205细胞30分钟，通过RADAR实验分离TOP1-DNA共价复合物（TOP1ccs）。用ImageJ软件分析TOP1的强度，并以DNA上样量进行归一化（右图）。数据用GraphPad Prism 8绘图。TOP1ccs的定量结果见图2E。 </p>
<p>G. Exatecan诱导的TOP1降解。将COLO205细胞与指定的TOP1抑制剂共同孵育2小时，随后在无抑制剂的条件下逆转TOP1作用30分钟，通过蛋白质印迹法（Western blotting）检测TOP1水平。D：重复实验中细胞总TOP1条带的定量结果。用ImageJ软件分析条带强度，并以GAPDH作为上样对照进行归一化。结果汇总见图2F。 </p>
<p>H. DNA损伤诱导与凋亡。用MTX-1000或对照处理HCC1954细胞长达72小时，通过蛋白质印迹法分析DNA损伤标志物（γH2AX、pKAP1和pChk1）和凋亡标志物（裂解的PARP）。</p>
<p><img src="/2025/08/02/36693125/Fig.S9.png" alt="Fig.S9"></p>
<h5 id="3-3-6-mAb-T1000-exatecan通过提高治疗指数和肿瘤内药效学响应克服治疗耐药性。"><a href="#3-3-6-mAb-T1000-exatecan通过提高治疗指数和肿瘤内药效学响应克服治疗耐药性。" class="headerlink" title="3.3.6  mAb-T1000-exatecan通过提高治疗指数和肿瘤内药效学响应克服治疗耐药性。"></a>3.3.6  mAb-T1000-exatecan通过提高治疗指数和肿瘤内药效学响应克服治疗耐药性。</h5><p>A，基于补充图S12D-S12H数据的治疗指数比较。在中高靶标表达肿瘤中，MTX-1000/MTX-132相比DS-8201a/Trodelvy显示出更高的治疗指数，这是因为其肿瘤退缩的最低有效剂量更低，而猴毒性研究中的无观察到有害作用剂量（HNSTD）相近。在对DS-8201a/Trodelvy耐药的低靶标表达肿瘤（或高多药耐药基因表达，见图4数据）中，MTX-1000/MTX-132仍有效。CR，完全缓解，肿瘤体积较基线变化达到-100%；PR，部分缓解，肿瘤体积较基线变化＜0。</p>
<p>B，靶向CDH6的DS-6000-T1000-Exatecan在对DS-6000-GGFG-DXd耐药的肾癌患者来源异种移植（PDX）模型中有效。未处理的小鼠肿瘤组织的免疫组化（IHC）图像显示CDH6低表达及H评分。比例尺：20 μm。当肿瘤大小平均达到150-200 mm³时（第0天），向PDX小鼠静脉注射指定ADC（10 mg/kg）。</p>
<p>C，靶向HER3的P-T1000-Exatecan在对P-GGFG-DXd耐药的肺鳞状细胞癌模型中引起肿瘤退缩。</p>
<p>D-F，T部分-ExatecanADC克服了DXd/SN-38 ADC的治疗耐药性。每个模型的实验设计和ADC给药方案如图所示。D，COLO025模型中DS-8201a与MTX-1000的对比。E，COLO205模型中MTX-132与Trodelvy的对比。F，H2170模型中P-T1000-Exatecan与P-GGFG-DXd的对比。</p>
<p>G，ADC在体内的组织分布。对经对照、DS-8201a和MTX-1000处理的COLO205异种移植肿瘤进行γH2AX的免疫组化分析。每个数值代表平均值（黑色条）和个体数据（3只小鼠，每只测量2次）。展示了第1天和第3天的代表性图像。</p>
<p>H和I，MTX-1000（H）或MTX-132（I）在大型原发肿瘤中的疗效。</p>
<p>J，MTX-1000与DS-8201a相比，肿瘤初始体积的最佳百分比变化总结。在所有体内研究中，向细胞系来源异种移植（CDX）小鼠静脉注射指定ADC（剂量为10 mg/kg或指定剂量），给药时间如箭头所示。</p>
<p><img src="/2025/08/02/36693125/Fig.3-1.png" alt="Fig.3-1"></p>
<p><img src="/2025/08/02/36693125/Fig.3-2.png" alt="Fig.3-2"></p>
<h5 id="3-3-7-mAb-T1000-exatecan或多药耐药（MDR）抑制剂与DXd-SN-38-ADC联合使用克服MDR耐药性。"><a href="#3-3-7-mAb-T1000-exatecan或多药耐药（MDR）抑制剂与DXd-SN-38-ADC联合使用克服MDR耐药性。" class="headerlink" title="3.3.7 mAb-T1000-exatecan或多药耐药（MDR）抑制剂与DXd/SN-38 ADC联合使用克服MDR耐药性。"></a>3.3.7 mAb-T1000-exatecan或多药耐药（MDR）抑制剂与DXd/SN-38 ADC联合使用克服MDR耐药性。</h5><div class="table-container">
<table>
<thead>
<tr>
<th>ADC</th>
<th>mAb</th>
<th>Linker</th>
<th>Payload</th>
</tr>
</thead>
<tbody>
<tr>
<td>MTX-1000</td>
<td>Tras</td>
<td>T1000</td>
<td>exatecan</td>
</tr>
<tr>
<td>DS-8201a</td>
<td></td>
<td>GGFG</td>
<td>Dxd</td>
</tr>
<tr>
<td>P-T1000-exatecan</td>
<td>HER3抗体Patritumab</td>
<td>T1000</td>
<td>exatecan</td>
</tr>
<tr>
<td>P-GGFG-Dxd</td>
<td>HER3抗体Patritumab</td>
<td>GGFG</td>
<td>Dxd</td>
</tr>
<tr>
<td>Dato-T1000-exatecan</td>
<td>TROP2抗体datopotamab</td>
<td>T1000</td>
<td>exatecan</td>
</tr>
<tr>
<td>Dato-GGFG-Dxd</td>
<td>TROP2抗体datopotamab</td>
<td>GGFG</td>
<td>Dxd</td>
</tr>
<tr>
<td></td>
<td></td>
<td></td>
</tr>
</tbody>
</table>
</div>
<p>A，在HCT-15细胞中，P-糖蛋白（P-gp）抑制剂对靶向HER2/HER3/TROP2的ADC体外细胞毒性的改善作用。图中显示IC50的倍数变化。</p>
<p>B和C，在HCT-15模型中，靶向TROP2的ADC联合或不联合P-gp抑制剂他利奎达（tariquidar）的体内疗效。B，肿瘤生长及抑制情况。n.s.，无显著性差异。C，来自B的肿瘤初始体积最佳百分比变化。每个ADC均标注其名称及所用的有效载荷。他利奎达单药在HCT-15中无效。</p>
<p>D-F，在HCT-15（P-gp表达）和ASPC-1（ABCG2表达）模型中，靶向HER2的ADC联合或不联合MDR抑制剂的效果。D和E，肿瘤生长及抑制情况。D中使用他利奎达，E中使用YHO-13351。F，来自D和E的肿瘤初始体积最佳百分比变化。YHO-13351单药在ASPC-1中无效。</p>
<p>G，在ASPC-1模型中，靶向HER3的ADC联合或不联合ABCG2抑制剂YHO-13351的效果。初始肿瘤体积约为900 mm³。左图，肿瘤生长及抑制情况。蓝色线代表使用T800-Exatecan而非T1000-Exatecan的ADC。t.i.w. × 2，每周3次，持续2周。右图，P-GGFG-DXd联合与不联合YHO-13351在第68天和第75天的肿瘤体积比较。n=3。</p>
<p>H，在高P-gp表达的患者来源异种移植（PDX）模型中，靶向TROP2的Dato-DXd联合或不联合他利奎达的效果。图中显示ABCG2和P-gp的mRNA水平。初始肿瘤体积为600 mm³。n=2。</p>
<blockquote>
<p>在所有体内研究中，对细胞系来源异种移植（CDX）/PDX小鼠静脉注射指定ADC（剂量为10 mg/kg或指定剂量），给药时间如箭头所示。每个数值代表平均值±标准误（n=5或另有说明）。非配对双侧t检验。<em>，P＜0.05；<strong>，P＜0.01；</strong></em>，P＜0.001。小分子抑制剂的剂量分别为：YHO-13351为50 mg/kg[口服，每日1次，每周期5天，共2个周期]；他利奎达为15 mg/kg（口服，每日1次，每周期5天，共3个周期）。</p>
</blockquote>
<p><img src="/2025/08/02/36693125/Fig.4.png" alt="Fig.4"></p>
<h5 id="3-3-8-结肠癌对ADC的类器官反应。"><a href="#3-3-8-结肠癌对ADC的类器官反应。" class="headerlink" title="3.3.8 结肠癌对ADC的类器官反应。"></a>3.3.8 结肠癌对ADC的类器官反应。</h5><p>A.用于衍生结肠癌类器官（P6）的患者样本中HER2表达的代表性IHC。</p>
<p>B.结肠癌类器官P6的代表性H&amp;E染色。显示全视图和放大的单个类器官。刻度条被标记。</p>
<p>C、D. 类器官P6在第0天（C，即给予指定ADC之前）和第6天（D，即药物处理之后）的活/死细胞代表性图像。左侧为96孔板的整体视图，右侧为特定区域的放大视图。结肠癌细胞患者来源类器官（PDO）的活细胞用钙黄绿素AM（绿色）染色，死细胞用碘化丙啶（PI，红色）染色。图中显示了比例尺。</p>
<p>E.（P6）类器官在药物处理6天后对ADC的剂量反应。存活类器官数据以两次独立实验的平均值±标准误（SE）表示。 F. ADC穿透类器官的测量示意图。将类器官人为划分为从表层到核心的4个圆形区域。计数每个圆形区域内的活细胞或死细胞，并用于绘制活/死细胞分布（补充图10F；图2I）。</p>
<p>G. 类器官中ADC穿透能力的定量分析。MTX-1000与DS-8201a的钙黄绿素AM（Calcein AM）染色信号从类器官表层到核心的空间分布。 H. 患者来源类器官（PDO）在处理6天后对MTX-1000和DS-8201a的反应。展示了类器官的代表性明场图像（左）和活/死细胞图像（右）。结肠癌细胞PDO经浓度为50μg/ml的MTX-1000或DS-8201a处理，活细胞用钙黄绿素AM（绿色）染色，死细胞用碘化丙啶（PI，红色）染色，图中显示了比例尺。</p>
<p><img src="/2025/08/02/36693125/Fig.S10.png" alt="Fig.S10"></p>
<h5 id="3-3-9-MTX-1000、T-DM1和Tras-GGFG-DXd在体外共培养条件下的旁观者杀伤效应。"><a href="#3-3-9-MTX-1000、T-DM1和Tras-GGFG-DXd在体外共培养条件下的旁观者杀伤效应。" class="headerlink" title="3.3.9 MTX-1000、T-DM1和Tras-GGFG-DXd在体外共培养条件下的旁观者杀伤效应。"></a>3.3.9 MTX-1000、T-DM1和Tras-GGFG-DXd在体外共培养条件下的旁观者杀伤效应。</h5><p>A，B. ADC对HCC1954（HER2+）和MDA-MB-468（HER2-）细胞的生长抑制活性。肿瘤细胞用ADC处理5天，计算细胞活力（%）。</p>
<p>C.流式细胞术分析数据。HCC1954和MDA-MB-468细胞共培养并用10 nM ADC处理5天。收集贴壁细胞后，细胞数量和人类比例<br>表皮生长因子受体2（HER2）阳性和HER2阴性细胞分别由细胞计数器和流式细胞仪测定。</p>
<p>D. HCC1954和MDA-MB-468活细胞的数量。</p>
<p><img src="/2025/08/02/36693125/Fig.S11.png" alt="Fig.S11"></p>
<h5 id="3-3-10-猴子体内MTX-1000的血液学和血清化学"><a href="#3-3-10-猴子体内MTX-1000的血液学和血清化学" class="headerlink" title="3.3.10 猴子体内MTX-1000的血液学和血清化学"></a>3.3.10 猴子体内MTX-1000的血液学和血清化学</h5><p>6只猴子在第1天、第22天、第43天（如箭头所示）给予10,30mg/kg甲氨蝶呤-1000，恢复期为1周。</p>
<p>A.体重变化。虚线表示起始体重。<br>B-G.血液学。白细胞计数。G.中性粒细胞计数。MTX-1000对食蟹猴（交叉反应物种）的毒性通过重复静脉给药进行<br>（每3周3次，剂量分别为10毫克/千克和30毫克/千克）研究。在指定的时间给予ADC。<br>H，I.血清化学。<br>J. MTX-1000与Tras-GGFG-DXd相比的主要毒性发现总结。</p>
<p><img src="/2025/08/02/36693125/Fig.S12.png" alt="Fig.S12"></p>
<h5 id="3-3-11-mAb-T1000-exatecan显示出强大的抗肿瘤疗效和改善的治疗指标"><a href="#3-3-11-mAb-T1000-exatecan显示出强大的抗肿瘤疗效和改善的治疗指标" class="headerlink" title="3.3.11 mAb-T1000-exatecan显示出强大的抗肿瘤疗效和改善的治疗指标"></a>3.3.11 mAb-T1000-exatecan显示出强大的抗肿瘤疗效和改善的治疗指标</h5><p>A-D. T部分exatecan ADC对癌细胞系的体外细胞毒性。在一系列浓度的ADC下处理细胞6天，计算每个细胞系的IC50。<br>非活性显示为IC50&gt;100 nM，如果无法准确确定准确的IC50，则标记为非活性。</p>
<p>A. HER2<br>表达（相对MFI）和MTX-1000和Tras-GGFG-DXd细胞毒性。</p>
<p>B. MTX-1000/Tras-GGFG-DXd细胞毒性与/不与ABCG2抑制剂利血平在H460中。流式细胞术<br>HER2相对于同种型对照IgG的表达显示在左侧。</p>
<p>C. TROP2靶向ADC细胞毒性。Datopotamab-T1000-exatecan和Datopotamab-GGFG-DXd<br>在低TROP2表达细胞LK-2中比较同种型对照IgG ADC。目标表达的流式细胞术显示在左侧。</p>
<p>D. HER3靶向ADC细胞毒性。Patritumab<br>在低HER3表达细胞COLO205中比较T1000-exatecan和Patritumab-GGFG-DXd各自同种型对照IgG ADC。流式细胞术和靶的IHC数据<br>表达式显示在左侧。</p>
<p>E. MTX-1000（蓝色）和Tras-GGFG-DXd（红色）在HER2高表达异种移植物（CDX）模型中的体内疗效。HER2表达在左侧显示为流式细胞仪（相对<br>未经处理的小鼠肿瘤组织上的MFI）和IHC图像和H评分。标尺条，50μm。CDX小鼠在第0天（肿瘤大小）静脉注射指示的ADC（10 mg/kg）<br>达到约200 mm3）和7（红色箭头）。每个值代表平均值和SEM（n=5）。每个动物组的体重变化显示在右侧。</p>
<p>F.TROP2靶向ADC的体内疗效。MTX-132（蓝色）和Trodelvy（紫色）和Dato-GGFG-DXd（红色）在TROP2高表达异种移植（CDX）模型中。</p>
<p>G. TROP2靶向ADC的体内功效。MTX-132（蓝色）和Trodelvy（红色）在TROP2培养基表达异种移植物（CDX）模型中。</p>
<p>H.基于猴子HNSTD和肿瘤消退最小有效剂量（MED）的治疗指数估计总结。数据基于已发表的结果<br>学习。<br>I.小鼠单次静脉注射10 mg/kg或3 mg/kg ADC后总抗体和ADC的药代动力学）。</p>
<p><img src="/2025/08/02/36693125/Fig.S13.png" alt="Fig.S13"></p>
<h4 id="3-4-LP-T1000-Exatecan-延伸到其它ADC"><a href="#3-4-LP-T1000-Exatecan-延伸到其它ADC" class="headerlink" title="3.4 LP(T1000-Exatecan)延伸到其它ADC"></a>3.4 LP(T1000-Exatecan)延伸到其它ADC</h4><h5 id="3-4-1-mAb-T1000-exatecan可克服耐药性，并在结肠癌细胞中与PARP-ATR抑制剂产生协同作用。"><a href="#3-4-1-mAb-T1000-exatecan可克服耐药性，并在结肠癌细胞中与PARP-ATR抑制剂产生协同作用。" class="headerlink" title="3.4.1 mAb-T1000-exatecan可克服耐药性，并在结肠癌细胞中与PARP/ATR抑制剂产生协同作用。"></a>3.4.1 mAb-T1000-exatecan可克服耐药性，并在结肠癌细胞中与PARP/ATR抑制剂产生协同作用。</h5><p>A，结肠癌患者来源异种移植（PDX）模型的相关信息。展示了TP53/KRAS/BRAF的突变状态以及微卫星不稳定性（MSI）状态。基于免疫组化（IHC）评分标注了靶标表达水平。WT，野生型。</p>
<p>B-E，T部分-ExatecanADC（蓝色）和GGFG-DXd ADC（红色）在结肠癌异种移植（CDX）和PDX模型中的体内疗效。标注了靶标及细胞系/PDX肿瘤类型。每个模型中的靶标表达通过流式细胞术（相对平均荧光强度）和/或未处理小鼠肿瘤组织的IHC图像及H评分展示。比例尺：20 μm。当肿瘤大小平均达到150-200 mm³时（第0天），向CDX/PDX小鼠静脉注射指定ADC（除非另有标注，剂量均为10 mg/kg），后续给药时间如红色箭头所示。每个数值代表平均值±标准误（n=4或5）。非配对双侧t检验。<em>，P＜0.05；<strong>，P＜0.01；</strong></em>，P＜0.001。n.s.，无显著性差异；T800-e，T800-Exatecan；T1000-e，T1000-Exatecan。各模型所用ADC：靶向HER3的P-T1000-Exatecan和P-GGFG-DXd（B）；靶向HER2的MTX-1000、MTX-800和曲妥珠单抗（Tras）-GGFG-DXd（C）；以及靶向TROP2的Dato-GGFG-DXd和使用hRS7（IMMU-132抗体）的MTX-132（D和E）。E，PDX 360837模型中Dato-GGFG-DXd和MTX-132的个体肿瘤体积蜘蛛图。</p>
<p>F和G，MTX-1000及Tras-GGFG-DXd与他拉唑帕尼（Tala）（F）或M4344（G）联合使用的联合指数（CI）。根据补充图S17G的细胞活力数据计算得出。与Tras-GGFG-DXd相比，MTX-1000在更宽的浓度范围内与他拉唑帕尼具有协同作用，且在更低浓度下与M4344具有协同作用。</p>
<p>H和I，在COLO205异种移植模型中，MTX-1000（蓝色）或Tras-GGFG-DXd（红色）联合他拉唑帕尼（H）或M4344（I）的体内疗效。当肿瘤大小达到约200 mm³时（第0天）及第7天，向小鼠静脉注射指定ADC（基于图3A的数据，Tras-GGFG-DXd剂量为10 mg/kg，MTX-1000剂量为3 mg/kg），给药时间如红色箭头所示。他拉唑帕尼每日口服给药，M4344每周口服给药（未在曲线上标注）。</p>
<p><img src="/2025/08/02/36693125/Fig.5-1.png" alt="Fig.5-1"></p>
<p><img src="/2025/08/02/36693125/Fig.5-2.png" alt="Fig.5-2"></p>
<h5 id="3-5-2-靶向肺癌耐药性的mAb-T1000-exatecan。"><a href="#3-5-2-靶向肺癌耐药性的mAb-T1000-exatecan。" class="headerlink" title="3.5.2 靶向肺癌耐药性的mAb-T1000-exatecan。"></a>3.5.2 靶向肺癌耐药性的mAb-T1000-exatecan。</h5><div class="table-container">
<table>
<thead>
<tr>
<th>ADC</th>
<th>mAb</th>
<th>linker</th>
<th>payload</th>
</tr>
</thead>
<tbody>
<tr>
<td>MTX-132</td>
<td>Trop2抗体hRS7</td>
<td>T1000</td>
<td>Exatecan</td>
</tr>
<tr>
<td>MTX-1000</td>
<td>HER2抗体</td>
<td>T1000</td>
<td>Exatecan</td>
</tr>
<tr>
<td>P-T1000-Exatecan</td>
<td>HER3抗体Patritumab</td>
<td>T1000</td>
<td>Exatecan</td>
</tr>
</tbody>
</table>
</div>
<p>A，肺癌患者来源异种移植（PDX）模型的相关信息。展示了EGFR的突变状态和扩增情况。</p>
<p>B-H，ADC[T1000-Exatecan（蓝色）和DXd（红色）]及其他药物在异种移植（CDX）和PDX模型中的体内疗效。标注了靶标和PDX肿瘤类型。每个模型中的靶标表达通过未处理小鼠肿瘤组织的免疫组化（IHC）图像及H评分展示。比例尺：20 μm。当肿瘤大小平均达到150-200 mm³时（第0天），向PDX小鼠静脉注射指定ADC（除非另有标注，剂量均为10 mg/kg）或其他药物（标注剂量），后续给药时间如红色箭头所示。</p>
<blockquote>
<p>各模型所用ADC/药物如下：<br>B和C，靶向TROP2的ADC在肺鳞状细胞癌PDX中的体外疗效。</p>
<p>D，MTX-1000和曲妥珠单抗（Tras）-GGFG-DXd，包括个体肿瘤大小的蜘蛛图。</p>
<p>E，P-T1000-Exatecan和P-GGFG-DXd。</p>
<p>F，第30天时MTX-1000、P-T1000-Exatecan（-e）与酪氨酸激酶抑制剂/西妥昔单抗的肿瘤体积比较。</p>
<p>G和H，P-T1000-Exatecan和P-GGFG-DXd。G中展示了个体肿瘤体积的蜘蛛图，H中进行了对比分析。</p>
</blockquote>
<p><img src="/2025/08/02/36693125/Fig.6-1.png" alt="Fig.6-1"></p>
<p><img src="/2025/08/02/36693125/Fig.6-2.png" alt="Fig.6-2"></p>
<h5 id="3-5-3-Tras-GGFG-DXd和DS-8201a的物理化学和功能等效性。"><a href="#3-5-3-Tras-GGFG-DXd和DS-8201a的物理化学和功能等效性。" class="headerlink" title="3.5.3 Tras-GGFG-DXd和DS-8201a的物理化学和功能等效性。"></a>3.5.3 Tras-GGFG-DXd和DS-8201a的物理化学和功能等效性。</h5><blockquote>
<p>DS-8201a的SEC/HIC（红色）和内部合成的Tras-GGFG-DXd（蓝色）。两个ADC显示相同的轮廓（红色和蓝色重叠）。<br>B. DS-8201a和Tras-GGFG-DXd的相同质谱检测。在LC-MS之前，所有ADC均用PNGaseF预消化以去除N-聚糖以产生去糖基化的ADC<br>轻链（LCs）和重链（HC）的LC-ESI-MS分析表明，分子量的变化与连接的有效载荷一致，并且高<br>所有ADC的同质性。<br>C-E. Tras-GGFG-DXd与DS-8201a的功能等效性在体内得到验证。当<br>肿瘤大小达到平均150-200 mm3<br>.每个值代表平均值和SEM（n=5）。Tras-GGFG-DXd（蓝色）和<br>DS-8201a（红色）。Tras-GGFG-DXd/DS-8201a在HCC1954（中到高HER2表达）中比在COLO205或JIMT-1（低HER2表达）中更有效。<br>F.小鼠（n=3，平均值±SD）单次静脉注射ADC 10 mg/kg或3 mg/kg后总抗体和ADC的药代动力学。总抗体和ADC通过描述的方法测量<br>补充图S8B，S8C。</p>
</blockquote>
<p><img src="/2025/08/02/36693125/Fig.S5.png" alt="Fig.S5"></p>
<h5 id="3-5-4-mAb-T1000-exatecan在PDX模型中显示出更高的抗肿瘤效力和更好的瘤内药效学反应。"><a href="#3-5-4-mAb-T1000-exatecan在PDX模型中显示出更高的抗肿瘤效力和更好的瘤内药效学反应。" class="headerlink" title="3.5.4 mAb-T1000-exatecan在PDX模型中显示出更高的抗肿瘤效力和更好的瘤内药效学反应。"></a>3.5.4 mAb-T1000-exatecan在PDX模型中显示出更高的抗肿瘤效力和更好的瘤内药效学反应。</h5><p>A-F. T部分-Exatecan偶联物（蓝色）与GGFG-DXd偶联物（红色）在PDX模型中的体内疗效。图中标注了靶点和PDX肿瘤类型。每个模型中的靶点表达情况以未处理的小鼠肿瘤组织的免疫组织化学（IHC）图像及H评分表示。当肿瘤大小平均达到150-200mm³时（第0天），通过静脉注射给予PDX模型小鼠指定的抗体偶联物（ADCs），剂量为10mg/kg，后续给药时间由红色箭头标注。各模型所用的ADCs如下：A、D和F中为靶向HER2的MTX-1000和/或MTX-800，以及Tras-GGFG-DXd；B、C和E中为靶向TROP2的Dato-GGFG-DXd和hRS7-T1000-Exatecan（MTX-132）。</p>
<p><img src="/2025/08/02/36693125/Fig.S14.png" alt="Fig.S14"></p>
<h5 id="3-5-5-mAb-T1000-exatecan通过改善治疗指数和肿瘤内药效学反应克服治疗耐药性。"><a href="#3-5-5-mAb-T1000-exatecan通过改善治疗指数和肿瘤内药效学反应克服治疗耐药性。" class="headerlink" title="3.5.5 mAb-T1000-exatecan通过改善治疗指数和肿瘤内药效学反应克服治疗耐药性。"></a>3.5.5 mAb-T1000-exatecan通过改善治疗指数和肿瘤内药效学反应克服治疗耐药性。</h5><p>A. 在HCT-15异种移植模型中，MTX-1000克服了对DS-8201a治疗耐药的肿瘤。图中展示了实验设计和ADC给药方案。 </p>
<p>B. 在COLO205异种移植模型中，MTX-132克服了对Trodelvy治疗耐药的肿瘤。从图3E中单独提取两个肿瘤大小组（800或1500 mm³）的数据进行绘图。与Trodelvy组中肿瘤持续生长相比，MTX-132使肿瘤缩小。图中标注了ADC剂量。 </p>
<p>C、D. 在H2170（C）和HCT-15（D）异种移植模型中，MTX-132克服了对Dato-DXd治疗耐药的肿瘤。每个模型均展示了实验设计和ADC给药方案。 </p>
<p>E. MTX-1000和DS-8201a的体内药效学。在COLO205模型中给予MTX-1000和DS-8201a，分别在24小时和72小时后获取肿瘤组织，用于γH2AX免疫组织化学（IHC）检测。</p>
<p>F. COLO205药效学研究中的肿瘤大小测量。左侧为平均肿瘤大小，右侧为第1天（上）和第3天（下）的个体肿瘤大小。n=3。 </p>
<p>G. γH2AX IHC的H评分。每组3只小鼠，每只进行两次测量。 </p>
<p>H. 靶向HER3的ADC在ASPC-1中的体内疗效。在所有体内研究中，对细胞系来源异种移植（CDX）小鼠按箭头所示时间点静脉注射指定ADC（剂量为10 mg/kg或指定剂量）。</p>
<p><img src="/2025/08/02/36693125/Fig.S15.png" alt="Fig.S15"></p>
<h5 id="3-5-6-mAb-T1000-exatecan或MDR抑制剂与DXd-SN-38-ADC的组合克服MDR耐药性。"><a href="#3-5-6-mAb-T1000-exatecan或MDR抑制剂与DXd-SN-38-ADC的组合克服MDR耐药性。" class="headerlink" title="3.5.6 mAb-T1000-exatecan或MDR抑制剂与DXd/SN-38 ADC的组合克服MDR耐药性。"></a>3.5.6 mAb-T1000-exatecan或MDR抑制剂与DXd/SN-38 ADC的组合克服MDR耐药性。</h5><p>A. 用于体内实验的细胞系的ABCG2/P-糖蛋白（P-gp）及靶点表达情况。ABCG2在H2170和ASPC1细胞中表达，而P-gp在HCT-15细胞中高表达（以浅绿色显示）。通过流式细胞术展示了HER2、HER3和TROP2的表达水平。 </p>
<p>B-D. 多药耐药（MDR）抑制对体外细胞毒性IC50的改善作用。数据显示了在有无MDR抑制剂的情况下的IC50（nM）：针对ABCG2的抑制剂YHO-13351（用于H2170和ASPC1细胞），以及针对P-gp的抑制剂 tariquidar（用于HCT-15细胞）。各靶点对应的ADC分别列出。 </p>
<p>E. 在HCT-15细胞中，有无P-gp抑制剂tariquidar时靶向HER3的ADC的作用。左侧为肿瘤生长及抑制情况，右侧为左侧实验中肿瘤体积相对于初始体积的最佳百分比变化。 </p>
<p>F. 在高P-gp表达的PDX模型中靶向TROP2的ADC的作用。展示了TROP2的表达（IHC）和MDR基因（mRNA表达）情况。MTX-132对肿瘤有抑制作用，而Dato-DXd无此效果。当Dato-DXd组中两只小鼠的肿瘤体积达到600 mm³时，用于测试与P-gp抑制剂tariquidar的联合治疗（图4H）。 </p>
<p>在所有体内研究中，对细胞系来源异种移植（CDX）/患者来源异种移植（PDX）小鼠按箭头所示时间点静脉注射指定ADC（剂量为10 mg/kg或指定剂量）。对于小分子抑制剂，YHO-13351的剂量为50 mg/kg（口服，每周5天，持续1周），tariquidar的剂量为15 mg/kg（口服，每周5天，持续3周）。</p>
<p><img src="/2025/08/02/36693125/Fig.S16.png" alt="Fig.S16"></p>
<h5 id="3-5-7-具有EGFR三突变的患者源性异种移植（PDX）模型。"><a href="#3-5-7-具有EGFR三突变的患者源性异种移植（PDX）模型。" class="headerlink" title="3.5.7 具有EGFR三突变的患者源性异种移植（PDX）模型。"></a>3.5.7 具有EGFR三突变的患者源性异种移植（PDX）模型。</h5><p>A.建立PDX的方案。</p>
<p>B.患者200717和PDX样本（P1和P5）中EGFR突变的总结。</p>
<p>C.患者肿瘤的苏木精和伊红（H&amp;E）的代表性图像（P0）和PDX通道3（P3）。20倍的图像。</p>
<p>D.在PDX 200717中，EGFR/ALK TKI抑制剂单独使用和与西妥昔单抗联合使用的体外疗效。实验细节见图6。</p>
<p>E.通过IHC和FISH检测PDX 200662. c-met扩增的患者特征。</p>
<p>F.2006年EGFR抑制剂的体内功效62。图6中的实验细节</p>
<p><img src="/2025/08/02/36693125/Fig.S18.png" alt="Fig.S18"></p>
<h4 id="3-5-治疗应用"><a href="#3-5-治疗应用" class="headerlink" title="3.5 治疗应用"></a>3.5 治疗应用</h4><h5 id="3-5-1-Exatecan-MTX-1000和PARP-ATR抑制剂在结肠癌细胞中协同作用。"><a href="#3-5-1-Exatecan-MTX-1000和PARP-ATR抑制剂在结肠癌细胞中协同作用。" class="headerlink" title="3.5.1 Exatecan/MTX-1000和PARP/ATR抑制剂在结肠癌细胞中协同作用。"></a>3.5.1 Exatecan/MTX-1000和PARP/ATR抑制剂在结肠癌细胞中协同作用。</h5><p>A-F. Exatecan和DXd在有/无Tala（A、C、E）及M4344（B、D、F）情况下对COLO205细胞的细胞毒性。将细胞与指定药物共同孵育5天，数据来自2次独立实验。每个细胞毒性曲线下方列出了IC50值。细胞活力曲线（A、B）；A和B中IC50的汇总表（C、D）；</p>
<p>E-F. Exatecan/DXd与Tala（E）及M4344（F）联合使用时IC50的改善情况汇总表。 G. 当与他拉唑帕尼（Talazoparib）和M4344联用时，Exatecan比DXd更有效。将COLO205细胞与一系列浓度的Exatecan/DXd分别联合600 nM他拉唑帕尼或25 nM M4344共同孵育4天（补充图S8A、8D）。计算Exatecan/DXd的IC50并以倍数变化表示。 </p>
<p>H-I. Exatecan（蓝线）或DXd（红线）与他拉唑帕尼（H）或M4344（I）在COLO205细胞中的联合指数（CI）。CI值＜1表明存在协同作用，使用CompuSyn软件（ComboSyn公司，美国帕拉姆斯）根据补充图S8A、8D的细胞活力数据进行分析。在比DXd更低的浓度下，Exatecan就与他拉唑帕尼和M4344表现出协同作用（蓝线位于红线左侧）。 </p>
<p>J. 在有/无他拉唑帕尼和M4344的情况下，MTX-1000或Tras-GGFG-DXd对COLO205细胞的细胞毒性。将细胞与指定药物共同孵育5天。</p>
<p><img src="/2025/08/02/36693125/Fig.S17.png" alt="Fig.S17"></p>
<h5 id="3-5-2-MTX-1000诱导免疫原性细胞死亡并增强抗PD-1的抗肿瘤免疫作用"><a href="#3-5-2-MTX-1000诱导免疫原性细胞死亡并增强抗PD-1的抗肿瘤免疫作用" class="headerlink" title="3.5.2 MTX-1000诱导免疫原性细胞死亡并增强抗PD-1的抗肿瘤免疫作用"></a>3.5.2 MTX-1000诱导免疫原性细胞死亡并增强抗PD-1的抗肿瘤免疫作用</h5><p>A、B. Exatecan和MTX-1000在体外诱导免疫原性细胞死亡。将HER2阳性COLO205细胞接种于96孔板，与指定浓度的Exatecan/DXd或ADC（MTX-1000/Tras-GGFG-DXd）共同孵育48小时。米托蒽醌用作免疫原性细胞死亡（ICD）的阳性对照。通过流式细胞术评估Exatecan和DXd（A）或MTX-1000和Tras-GGFG-DXd诱导的钙网蛋白（CRT）向细胞表面的转运。通过碘化丙啶（PI）染色设门以排除死细胞。A. CRT阳性细胞的百分比；B. CRT的平均荧光强度（MFI）。</p>
<p>C. 药物处理48小时后的细胞活力。通过细胞计数仪对细胞数量进行计数。 </p>
<p>D. 通过流式细胞术确认外源性导入的人HER2基因在小鼠CT26细胞中的表达。CT26-hHER2细胞上的HER2表达为中等水平（相对MFI为30-50）。 </p>
<p>E. MTX-1000/Tras-GGFG-DXd与抗PD-1阻断抗体的联合作用。在接种CT26-hHER2细胞的免疫健全小鼠模型中，比较MTX-1000/Tras-GGFG-DXd（10 mg/kg，每周1次，共2次，静脉注射）联合抗PD-1抗体（5 mg/kg，每周2次，共2个周期，静脉注射）与各单药的体内作用。在箭头所示时间点给药。 </p>
<p>F. MTX-1000/Tras-GGFG-DXd与抗PD-1阻断抗体联合治疗的肿瘤生长抑制作用。在接种CT26-hHER2细胞的免疫健全小鼠模型（n=8）中，比较MTX-1000/Tras-GGFG-DXd（10 mg/kg，每周1次，共2次，静脉注射）联合抗PD-1抗体（5 mg/kg，每周2次，共2个周期，静脉注射）与各单药的作用。将Tras-GGFG-DXd处理组与MTX-1000组、Tras-GGFG-DXd+PD-1组进行比较；将MTX-1000组与Tras-GGFG-DXd组、MTX-1000+PD-1组进行比较；将PD-1组与Tras-GGFG-DXd+PD-1组、MTX-1000+PD-1组进行比较。 </p>
<p>G. 图7D中各动物组的体重变化。</p>
<p><img src="/2025/08/02/36693125/Fig.S19.png" alt="Fig.S19"></p>
<h3 id="四、套路总结"><a href="#四、套路总结" class="headerlink" title="四、套路总结"></a>四、套路总结</h3><h4 id="4-1-疾病"><a href="#4-1-疾病" class="headerlink" title="4.1 疾病"></a>4.1 疾病</h4><h4 id="4-2-表型"><a href="#4-2-表型" class="headerlink" title="4.2 表型"></a>4.2 表型</h4><h4 id="4-3-方法"><a href="#4-3-方法" class="headerlink" title="4.3 方法"></a>4.3 方法</h4><h5 id="4-3-1-Synthesis-of-T-Moiety"><a href="#4-3-1-Synthesis-of-T-Moiety" class="headerlink" title="4.3.1 Synthesis of T Moiety"></a>4.3.1 Synthesis of T Moiety</h5><p>Synthesis of T moiety and all other chemical compounds is described in the Supplementary Note.</p>
<h5 id="4-3-2-Antibodies-and-ADCs-and-Compounds"><a href="#4-3-2-Antibodies-and-ADCs-and-Compounds" class="headerlink" title="4.3.2 Antibodies and ADCs, and Compounds"></a>4.3.2 Antibodies and ADCs, and Compounds</h5><div class="table-container">
<table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td>The anti-HER2 antibody (Tras)</td>
<td>Geneway Biotechnology Co., Ltd.</td>
<td>FX03DS1901</td>
</tr>
<tr>
<td>anti-CDH6 antibody (hG019)</td>
<td>generated in the CHO or 293F expression system and purified by Mabselect Sure Resin (GE Healthcare) in gravity column</td>
<td></td>
</tr>
<tr>
<td>anti-TROP2 antibodies (Dato and sacituzumab)</td>
<td>generated in the CHO or 293F expression system and purified by Mabselect Sure Resin (GE Healthcare) in gravity column</td>
<td></td>
</tr>
<tr>
<td>anti-HER3 antibody (patritumab)</td>
<td>generated in the CHO or 293F expression system and purified by Mabselect Sure Resin (GE Healthcare) in gravity column</td>
<td></td>
</tr>
<tr>
<td>T-DM1</td>
<td>F. Hoffmann-La Roche (Basel, Switzerland).</td>
<td></td>
</tr>
<tr>
<td>Control IgG1</td>
<td>Beijing Solarbio Science and Technology Co., Ltd.</td>
<td></td>
</tr>
<tr>
<td>Anti-mouse PD-1 antibody</td>
<td>ChemPartner (batch#: 201630002).</td>
<td></td>
</tr>
<tr>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>MC GGFG–DXd</td>
<td>MedChemExpress</td>
<td>HY-114233</td>
</tr>
<tr>
<td>Talazoparib</td>
<td>MedChemExpress</td>
<td>HY 108413</td>
</tr>
<tr>
<td>exatecan</td>
<td>MedChemExpress</td>
<td>HY-13631</td>
</tr>
<tr>
<td>DXd</td>
<td>MedChemExpress</td>
<td>HY-13631E</td>
</tr>
<tr>
<td>M4344</td>
<td>MedChemExpress</td>
<td>HY-136270</td>
</tr>
<tr>
<td></td>
<td></td>
</tr>
</tbody>
</table>
</div>
<p> The sequences of these antibodies were obtained from the corresponding patents and literature. </p>
<p>ADCs were synthesized as described above, and their DAR values were determined by reverse-phase chromatography. The drug distribution was analyzed by HIC and further characterized by reduced reverse-phase LC/MS (Supplementary Note).</p>
<p>T-DXd/DS-8201a was made in house with Tras (Batch#: FX03DS1901, Geneway Biotech) using linker–payload directly purchased from MedChemExpress: MC-GGFG–DXd (HY-114233, MedChemExpress). </p>
<h5 id="4-3-3-ADC-Preparation"><a href="#4-3-3-ADC-Preparation" class="headerlink" title="4.3.3 ADC Preparation"></a>4.3.3 ADC Preparation</h5><p>裸抗单克隆抗体溶液（10 mg/mL，溶于含 2 mmol/L EDTA 的 PBS（pH 7.0）中）用 7 摩尔当量的TCEP在 37°C 下处理 2 小时。随后，向完全还原的抗体中加入 14 摩尔当量的连接子药物（来自 10 mmol/L 的 DMA 储备液），同时保持残余 DMA 浓度低于 10%（v/v）。将混合物在室温下孵育 1 小时，然后通过 Zeba 离心脱盐柱（赛默飞世尔科技）进行纯化，以去除过量试剂。在此步骤中，所得抗体药物偶联物（ADC）也进行了缓冲液置换，转入制剂缓冲液（20 mmol/L 组氨酸、150 mmol/L NaCl，pH 5.5）中。此外，通过用活性炭处理产物（每 1 mL ADC 溶液加入 30 mg 活性炭），并在室温下涡旋 2 小时，可彻底去除过量的连接子药物。之后通过无菌过滤（0.2 μm PES 滤膜）去除活性炭，最终的 ADC 在 - 80°C 下储存。</p>
<blockquote>
<p>摩尔当量（Molar Equivalent） 是化学和生物化学实验中常用的概念，用于表示不同物质之间的化学计量关系，核心是通过 “摩尔数的比例” 来描述反应物之间的用量关系，而非直接使用质量或体积。</p>
<p>具体含义：<br>当说 “A 物质使用 X 摩尔当量的 B 物质” 时，指的是 B 物质的摩尔数 = X × A 物质的摩尔数。</p>
<p>这里的 “A 物质” 通常是反应中的 “基准物质”（如待修饰的分子、核心反应物等），而 “B 物质” 是相对于它的添加物（如试剂、反应物等）。</p>
<p>举例说明：<br>以你提供的实验为例：<br>“用 7 摩尔当量的 TCEP 处理裸抗单克隆抗体（mAb）”<br>假设抗体（mAb）的摩尔数为 n，则 TCEP 的摩尔数 = 7 × n。<br>后续 “加入 14 摩尔当量的连接子药物”，指连接子药物的摩尔数 = 14 × n（同样以抗体的摩尔数为基准）。</p>
<p>为什么用摩尔当量？<br>简化计量：不同物质的分子量不同，直接用质量或体积难以统一比例，而摩尔数能反映分子数量的比例，更贴合化学反应的本质（按分子数比例反应）。</p>
<p>灵活调整用量：根据反应需求，通过当量倍数调整试剂用量（如过量试剂促进反应完全）。例如，用 7 倍当量的 TCEP 可能是为了确保抗体完全还原（TCEP 作为还原剂，过量可保证反应彻底）。</p>
<p>与 “摩尔比” 的区别：<br>摩尔当量强调 “以某一物质为基准的倍数”（如 “7 当量” 即 7:1 的比例）。<br>摩尔比则直接表示两种物质的摩尔数之比（如 TCEP 与 mAb 的摩尔比为 7:1）。</p>
<p>两者本质一致，只是表述角度不同，摩尔当量更侧重 “以基准物质为参照” 的计量方式。</p>
<p>简言之，摩尔当量是通过分子数量比例来控制反应中试剂用量的实用概念，广泛用于合成、修饰（如 ADC 制备）等实验中。</p>
<p>在上述文本中，DMA 是指二甲基乙酰胺（Dimethylacetamide）。<br>二甲基乙酰胺是一种无色透明液体，能与水、醇、醚等有机溶剂混合，是一种极性溶剂。文中提到 “from a 10 mmol/L DMA stock solution”，结合其作为溶剂的性质，可知此处 DMA 是作为 linker-drug 的溶剂，用于后续与抗体的偶联反应</p>
</blockquote>
<h5 id="4-3-4-ADC-Concentration-DAR-and-Aggregation-Measurement"><a href="#4-3-4-ADC-Concentration-DAR-and-Aggregation-Measurement" class="headerlink" title="4.3.4 ADC Concentration, DAR, and Aggregation Measurement"></a>4.3.4 ADC Concentration, DAR, and Aggregation Measurement</h5><p>通过测量 ADC 水溶液在 280 nm 和 370 nm 两个波长下的紫外吸光度，可计算出 ADC 中单抗（mAb）和偶联药物的浓度，这是基于在任一给定波长下的总吸光度等于体系中所有吸光化学物质的吸光度之和（吸光度的加和性）。相关方程式如下：</p>
<blockquote>
<p>A₂₈₀ = Aₐ,₂₈₀ + A~ᵈ~,₂₈₀ = εₐ,₂₈₀×Cₐ + ε~ᵈ~,₂₈₀×C~ᵈ~ （1）</p>
<p>A₃₇₀ = Aₐ,₃₇₀ + A~ᵈ~,₃₇₀ = εₐ,₃₇₀×Cₐ + ε~ᵈ~,₃₇₀×C~ᵈ~ （2）</p>
<p>式中，εₐ,₂₈₀、εₐ,₃₇₀、εᵈ,₂₈₀和 εᵈ,₃₇₀的值，部分是根据抗体的氨基酸序列计算得出，部分是通过按照朗伯 - 比尔定律对化合物进行紫外测量获得。将上述数值代入联立方程（1）和（2）并求解，即可确定 Cₐ（抗体浓度）和 C~ᵈ~（药物浓度）。通过 C~ᵈ~除以 Cₐ，可得到每个抗体上平均偶联的药物分子数量。</p>
</blockquote>
<div class="table-container">
<table>
<thead>
<tr>
<th>SEC测聚集度</th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td>Agilent 1260 Infinity II HPLC system with UV detection at 280 nm.</td>
<td></td>
<td></td>
</tr>
<tr>
<td>The column was a TSKgel G3000SWXL column  (Tosoh Bioscience).</td>
<td></td>
<td></td>
</tr>
<tr>
<td>Samples were injected at a 50 μg load.</td>
<td></td>
<td></td>
</tr>
<tr>
<td>The flow rate was 0.75 mL/minute,</td>
<td></td>
<td></td>
</tr>
<tr>
<td>the column temperature was set at room temperature.</td>
<td></td>
<td></td>
</tr>
<tr>
<td>The mobile phase was 200 mmol/L sodium phosphate, 150 mmol/L sodium chloride (pH 7.0). and 15% (v/v) isopropanol</td>
<td></td>
<td></td>
</tr>
<tr>
<td></td>
<td></td>
</tr>
</tbody>
</table>
</div>
<div class="table-container">
<table>
<thead>
<tr>
<th>HIC测DAR</th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td>butyl HIC column (TSK-gel Butyl-NPR 4.6 × 35 mm  2.5 μm, Tosoh Bioscience)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>room temperature</td>
<td></td>
<td></td>
</tr>
<tr>
<td>Agilent 1260 Infinity II HPLC system with UV detection at 280 nm.</td>
<td></td>
<td></td>
</tr>
<tr>
<td>Mobile phase A was 1.5 mol/L (NH4)2SO4,  50 mmol/L K2HPO4, pH 7.0</td>
<td></td>
<td></td>
</tr>
<tr>
<td>mobile phase B was 21.3 mmol/L KH2PO4, 28.6 mmol/L K2HPO4, 25% (v/v) isopropanol, pH 7.0.</td>
<td></td>
<td></td>
</tr>
<tr>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>The gradient program was as follows:</td>
<td></td>
<td></td>
</tr>
<tr>
<td>B %: 0% to 25% (0–1 minutes,  0.8 mL/minute)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>25% (1–3 minutes, 0.6 mL/minute)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>25% to 80%(3–13 minutes 0.6 mL/minute)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>80% (13–17 minutes, 0.6 mL/minute)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>80% to 0% (17–17.10 minutes, 0.5 mL/minute)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>0% (17.10-25 minutes, 0.7 mL/minute)</td>
<td></td>
</tr>
</tbody>
</table>
</div>
<h5 id="4-3-5-Flow-Cytometry"><a href="#4-3-5-Flow-Cytometry" class="headerlink" title="4.3.5 Flow Cytometry"></a>4.3.5 Flow Cytometry</h5><div class="table-container">
<table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td>Alexa Fluor 488  goat anti-mouse IgG secondary antibodies</td>
<td>Jackson ImmunoRe search</td>
<td>no. 115-545-003</td>
</tr>
<tr>
<td>Alexa Fluor 594 goat anti-mouse IgG secondary antibodies</td>
<td>Jackson ImmunoRe search</td>
<td>no. 115-545-003</td>
</tr>
<tr>
<td>Hoechst 33258</td>
<td>Sigma</td>
<td>no. 94403</td>
</tr>
<tr>
<td>The LIVE/DEAD Fixable Near-IR  Dead Cell Stain Kit</td>
<td>Thermo Fisher Scientific</td>
</tr>
</tbody>
</table>
</div>
<blockquote>
<p>对于细胞表面蛋白，IF和FACS测定在缓冲液中没有清洁剂的非渗透条件下进行。使用Alexa Fluor 488和594山羊抗小鼠IgG二抗检测抗体结合信号（杰克逊免疫研究，编号115-545-003和编号115-585-003）。</p>
<p>简而言之，将附在盖玻片上（IF测定）的细胞首先固定在4%多聚甲醛（PFA）中10分钟。然后去除PFA，并用1×PBS冲洗细胞3次。细胞在4℃下在封闭缓冲液中封闭过夜（1×PBS含有10%正常山羊血清；加入0.1%Triton用于细胞内蛋白）。去除封闭缓冲液后，孵育细胞在室温下用一抗（在封闭缓冲液中以1:100稀释至1,000）3小时。细胞在1×PBS中冲洗6次，然后与fluorescence-labeled抗体（在封闭缓冲液中以1:100,000稀释比用1:10,000 Hoechst 33258稀释）1小时。最后，用1×PBS冲洗细胞3次。用尼康共聚焦系统A1Si记录IF图像。IF结果的3D重建在ImageJ（NCBI，NIH免费软件）中进行。</p>
<p>简而言之，悬浮在1×PBS中（FACS测定）的细胞首先固定在4%多聚甲醛（PFA）中10分钟。然后去除PFA，并用1×PBS冲洗细胞3次。细胞在4℃下在封闭缓冲液中封堵过夜（1×PBS含有10%正常山羊血清；加入0.1%Triton用于细胞内蛋白）。去除封闭缓冲液后，孵育细胞在室温下用一抗（在封闭缓冲液中以1:100稀释至1,000）3小时。细胞在1×PBS中冲洗6次，然后与fluorescence-labeled抗体（在封闭缓冲液中以1:100,000稀释）1小时。最后，用1×PBS冲洗细胞3次。使用 BD Accuri C6 Plus 系统收集流式细胞术（FACS）数据。实验中设置了两个对照样本：一个是未加一抗的对照样本，另一个是加入同型对照抗体的样本。通过 LIVE/DEAD Fixable Near-IR 死细胞染色试剂盒排除死细胞。</p>
</blockquote>
<h5 id="4-3-6-Cell-Lines-and-PDX-Models"><a href="#4-3-6-Cell-Lines-and-PDX-Models" class="headerlink" title="4.3.6 Cell Lines and PDX Models"></a>4.3.6 Cell Lines and PDX Models</h5><div class="table-container">
<table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td>COLO205 (RRID:CVCL_0218)</td>
<td>ATCC</td>
<td></td>
</tr>
<tr>
<td>HCT-15 (RRID:CVCL_0292)</td>
<td>ATCC</td>
<td></td>
</tr>
<tr>
<td>DLD-1 (RRID: CVCL_0248)</td>
<td>ATCC</td>
<td></td>
</tr>
<tr>
<td>HT-29 (RRID:CVCL_0320)</td>
<td>中科院</td>
<td></td>
</tr>
<tr>
<td>SK-MES-1 (RRID:CVCL_0630)</td>
<td>中科院</td>
<td></td>
</tr>
<tr>
<td>NCI-H292 (RRID:CVCL_0455)</td>
<td>中科院</td>
<td></td>
</tr>
<tr>
<td>MDA-MB-468 (RRID:CVCL_0419)</td>
<td>中科院</td>
<td></td>
</tr>
<tr>
<td>SK-OV-3 (RRID:CVCL_0532)</td>
<td>中科院</td>
<td></td>
</tr>
<tr>
<td>LoVo (RRID:CVCL_0399)</td>
<td>中科院</td>
<td></td>
</tr>
<tr>
<td>NCI-H460  (RRID:CVCL_0459)</td>
<td>中科院</td>
<td></td>
</tr>
<tr>
<td>BxPC-3 (RRID:CVCL_0186)</td>
<td>中科院</td>
<td></td>
</tr>
<tr>
<td>PC9 (RRID:CVCL_B260)</td>
<td>中科院</td>
<td></td>
</tr>
<tr>
<td>The mouse colon cancer cell line CT26 (RRID:CVCL_7254)</td>
<td>ATCC</td>
<td></td>
</tr>
<tr>
<td></td>
<td></td>
</tr>
</tbody>
</table>
</div>
<p>细胞维持在RPMI 1640培养基（COLO205、NCI-H292、HCT15、DLD-1、NCI-H460、BxPC-3和PC9）或DMEM（SK-MES-1和MDA-MB-468）或F-12K培养基（LoVo）或补充有10%热灭活FBS的McCoy’s 5A培养基（HT-29和SK-OV-3）中，并在37℃在5%CO2气氛中培养。当细胞生长到80%汇合时，用1×PBS和1 mmol/L EDTA处理10~20分钟使其从培养板上解离。不使用胰蛋白酶以避免对细胞表面蛋白的损伤。rMFI由抗靶向AbFITC的MFI/同种型对照-FITC的MFI的比率计算。</p>
<div class="table-container">
<table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td>An empty vector (pQCXIN)</td>
<td>Clontech</td>
<td></td>
</tr>
<tr>
<td>human HER2 gene (sequence based on NM_004448.3)</td>
<td></td>
<td></td>
</tr>
<tr>
<td></td>
<td></td>
</tr>
</tbody>
</table>
</div>
<p>将空载体（pQCXIN；Clontech）或人HER2基因（基于NM_004448.3的序列）逆转录导入CT26细胞（分别为CT26和CT26-hHER2）。将细胞培养在补充有10%热灭活FBS和250μg/mL遗传蛋白（Thermo Fisher Science）的RPMI 1640培养基中，在5%CO2气氛下于37℃下培养。通过流式细胞术确认人HER2表达。所有PDX模型（362014、361795、360837、200717、200662、200615和360961）均于2021年从Lidebiotech Co.， Ltd.获得。</p>
<h5 id="4-3-7-Cytotoxic-Assay"><a href="#4-3-7-Cytotoxic-Assay" class="headerlink" title="4.3.7 Cytotoxic Assay"></a>4.3.7 Cytotoxic Assay</h5><div class="table-container">
<table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td>MTT (5 mg/mL,  20 μL)</td>
<td>Sigma-Aldrich</td>
<td></td>
</tr>
<tr>
<td>Thermo Scientific Multiskan EX microplate reader</td>
<td>Thermo</td>
<td></td>
</tr>
<tr>
<td></td>
<td></td>
</tr>
</tbody>
</table>
</div>
<p>根据细胞系，以适当密度将细胞接种到96孔板中（通常在100微升合适的培养基中，每孔1000 - 3000个细胞）。过夜孵育后，加入一系列浓度的小分子或抗体药物偶联物（ADC）药物及对照。5或6天后评估细胞活力。向孔中加入MTT（5毫克/毫升，20微升，Sigma-Aldrich公司产品），在37℃下继续孵育2至4小时。然后去除培养基，用0.1N盐酸/异丙醇将孔内物质充分溶解。使用赛默飞世尔科技（Thermo Scientific）的Multiskan EX酶标仪在570纳米波长（参考波长690纳米）下测量吸光度值。通过抑制剂量 - 反应曲线拟合（GraphPad Prism 9软件）确定与未处理细胞或其他对照处理细胞相比的半数抑制浓度（IC50）值。</p>
<h5 id="4-3-8-Cell-Line-and-PDX-Studies"><a href="#4-3-8-Cell-Line-and-PDX-Studies" class="headerlink" title="4.3.8 Cell Line and PDX Studies"></a>4.3.8 Cell Line and PDX Studies</h5><p>将4至6周龄的雌性BALB/c裸鼠一起安置SPF条件下维持。将每个细胞悬液或肿瘤片段皮下接种到雌性裸鼠中。当肿瘤生长到适当的体积时，荷瘤小鼠根据肿瘤体积随机分为治疗组和对照组，并开始给药。向小鼠体内注入抗体和ADC。口服小分子药物。每周测量两次（3-4天）定义为1/2×长×宽2的肿瘤体积。TGI（%）计算如下：TGI (%) = [1-（评估日实验组肿瘤体积的平均值）/（评估日对照组肿瘤体积的平均值）]×100。当小鼠到达终点（肿瘤体积超过3,000 mm3，&gt;体重减少10%，或临床迹象表明小鼠出于伦理原因应被安乐死）时，用CO2气体进行安乐死。</p>
<h5 id="4-3-9-Syngeneic-Model"><a href="#4-3-9-Syngeneic-Model" class="headerlink" title="4.3.9 Syngeneic Model"></a>4.3.9 Syngeneic Model</h5><div class="table-container">
<table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td>Tumor Dissociation Kit</td>
<td>Miltenyi Biotec</td>
<td></td>
</tr>
<tr>
<td>gentleMACS Octo  Dissociator with Heaters</td>
<td>Miltenyi Biotec</td>
<td></td>
</tr>
<tr>
<td>Mouse BD Fc Block reagent</td>
<td>Becton Dickinson</td>
</tr>
</tbody>
</table>
</div>
<p>雌性BALB/c小鼠，体重约18~20 g，每个笼子5只小鼠。驯化9天后，在右侧皮下接种CT26-hHER2细胞（3×105细胞/0.1 mL/小鼠），用于肿瘤发育。接种后10天，将36只肿瘤大小在100~200 mm^3^（平均肿瘤大小178 mm^3^）的小鼠纳入疗效研究，随机分为六个治疗组，在随机化日（定义为D0）开始治疗。MTX-1000、DS-8201a（10 mg/kg）、抗PD-1抗体（5 mg/kg）静脉注射，体积为10 mL/kg给小鼠。作为对照，ABS缓冲液（10 mmol/L乙酸缓冲液，5%山梨醇，pH 5.5）以与药物相同的体积给药。MTX-1000和DS-8201a在第0天和第7天给药。抗PD-1抗体在第0、3、7和10天给药。</p>
<p>对于T细胞、树突状细胞和肿瘤细胞的流式细胞仪分析，当肿瘤的平均体积达到约250至400 mm3（肿瘤接种后8天）时，用载体或DS-8201a（10 mg/kg，一次，静脉注射；第0天）处理小鼠。小鼠在第8天用CO2窒息安乐死，肿瘤被切割成小块，并用带有加热器的GateleMACS Octo解离器与肿瘤解离试剂盒解离。用Mouse BD Fc Block试剂阻断所得单细胞，并用针对小鼠CD3、CD4、CD8、CD11c、CD45、CD86、颗粒酶B、MHC I类、MHC II类、PD-L1和人HER2的抗体染色。 </p>
<h5 id="4-3-10-Tissue-Multiplex-IHC"><a href="#4-3-10-Tissue-Multiplex-IHC" class="headerlink" title="4.3.10 Tissue Multiplex IHC"></a>4.3.10 Tissue Multiplex IHC</h5><p>根据制造商（珀金埃尔默公司）的方案，采用欧泊多重染色法对福尔马林固定、石蜡包埋的肿瘤组织蜡块切片进行DAPI、CD45、CD4和CD8染色。在Vectra 3.0仪器上进行玻片扫描。所有图像均使用HALOTM图像分析平台进行分析。对整个切片进行分析，排除大片坏死区域和间质区域。分别计数单阳性细胞。对图像进行光谱解混，评估染色强度和形态，基于组织标志物对组织进行分割，基于细胞核和细胞膜标志物对细胞进行分割，并进行表型评分。 </p>
<h5 id="4-3-11-PK-of-MTX-1000-DS-8201a-in-Rat-Mouse"><a href="#4-3-11-PK-of-MTX-1000-DS-8201a-in-Rat-Mouse" class="headerlink" title="4.3.11 PK of MTX-1000/DS-8201a in Rat/Mouse"></a>4.3.11 PK of MTX-1000/DS-8201a in Rat/Mouse</h5><p>采用经过验证的配体结合测定法测定血浆中ADC和总抗体的浓度，定量下限为0.02微克/毫升。简要来说，用包被缓冲液中的1微克/毫升人HER2蛋白（His标签，北京义翘神州科技股份有限公司）包被免疫板，并在4°C下放置过夜。洗涤后，封闭免疫板，将每个系列稀释的样品加入孔中。</p>
<p>①在37°C下孵育1至2小时后，洗涤免疫板，并与HRP-hIgG Fc孵育以<strong>测量总抗体</strong>；在37°C下反应1至2小时后，直接加入TMB溶液，用酶标仪测量每个孔的A450值。</p>
<p>②在37°C下孵育1至2小时后，洗涤免疫板，与生物素标记的抗Exatecan/DXd抗体孵育以测量ADC。在37°C下反应1至2小时后，与链霉亲和素蛋白-HRP在37°C下孵育40至60分钟后加入。用酶标仪测量每个孔的A450值。</p>
<p>采用经过验证的液相色谱-串联质谱（LC/MS-MS）方法测定血浆中有效载荷Exatecan/DXd的浓度，定量下限为0.05纳克/毫升。</p>
<p>以4.0毫克/千克的剂量对大鼠静脉注射MTX - 1000/DS - 8201a。给药后长达21天内测量血浆中ADC、总抗体和DXd的浓度。 </p>
<blockquote>
<p>在药代动力学（Pharmacokinetics，PK）研究中，血液样本的采集时间点设置需根据药物类型、给药途径、研究目的（如临床前/临床）及动物种属等因素综合确定，核心是完整反映药物的吸收、分布、代谢、排泄（ADME）过程，尤其是血药浓度 - 时间曲线的关键阶段（如达峰、消除相）。 以下是常见的血液样本采集时间点设计原则及示例：  </p>
<p><strong>1. 基本原则</strong> - <strong>覆盖完整曲线</strong>：需包含给药前（0时刻，基线）、给药后吸收相（如快速上升至峰浓度）、分布相、消除相（包括末端消除）的时间点。</p>
<p><strong>关键节点密集</strong>：在峰浓度（Cmax）前后、消除速率变化较大的阶段（如分布相到消除相的转折点）增加采样点，末端消除相至少保留3 - 5个点以准确计算消除半衰期（t1/2）。 </p>
<p><strong>避免过度采样</strong>：兼顾数据完整性与动物福利（如小鼠等小动物总采血量通常不超过总血量的15% - 20%）。  </p>
<p><strong>2. 不同给药途径的常见采样点示例</strong> </p>
<p><strong>（1）静脉注射（IV）</strong> - 特点：无吸收过程，血药浓度初始较高，快速进入分布相和消除相。 - 示例（以小鼠临床前研究为例，总采样点8 - 12个）：    0（给药前）、5 min、15 min、30 min、1 h、2 h、4 h、8 h、12 h、24 h、48 h、72 h（根据消除速率可延长至96 h或更久）。 </p>
<p><strong>（2）皮下注射（SC）或肌肉注射（IM）</strong> - 特点：存在吸收过程，需覆盖从给药后到吸收达峰、再到消除的阶段。 - 示例（总采样点10 - 14个）：    0、15 min、30 min、1 h、2 h、4 h、6 h、8 h、12 h、24 h、48 h、72 h、96 h、120 h。 </p>
<p><strong>（3）口服给药（PO）</strong> - 特点：吸收过程复杂（受胃肠道吸收速率影响），可能存在滞后时间。 - 示例（总采样点10 - 16个）：    0、15 min、30 min、1 h、2 h、3 h、4 h、6 h、8 h、12 h、24 h、36 h、48 h、72 h、96 h、120 h。  </p>
<p><strong>3. 临床研究与大动物的调整</strong> - <strong>临床研究</strong>：人体PK采样点通常更稀疏（减少对受试者的侵入性），但需覆盖关键阶段，例如：    0、0.5 h、1 h、2 h、4 h、8 h、12 h、24 h、48 h、72 h、7 d、14 d、21 d（根据药物半衰期调整，如长效药物可延长至数周）。</p>
<p><strong>大动物（如犬、猴）</strong>：因血容量较大，可适当增加采样点，例如静脉注射后可增加3 min、10 min等早期点，更精准捕捉初始分布相。  </p>
<p><strong>4. 特殊情况</strong> - <strong>长效药物（如抗体药物）</strong>：半衰期可能长达数天至数周，采样点可延长至给药后数周甚至数月（如每3 - 7天一次）。 </p>
<p><strong>代谢物研究</strong>：若需同时监测代谢物，采样点需同步覆盖代谢物的生成与消除过程，可能与原型药采样点一致或略作调整。  总之，具体采样点数量无固定标准，通常<strong>单次给药研究的采样点总数在8 - 16个</strong>（小动物可能略少，大动物/临床研究可适当增加），核心是通过这些点绘制完整的血药浓度 - 时间曲线，以计算PK参数（如Cmax、AUC、t1/2、CL等）。实际实验中需结合预实验结果（如初步估算的半衰期）进一步优化。</p>
</blockquote>
<div class="table-container">
<table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td>Human HER2 Protein,His Tag</td>
<td>(Acrobiosystems Inc.,  Beijing)</td>
<td></td>
</tr>
<tr>
<td>HRP-conjugated anti-human IgG  Fc secondary antibody</td>
<td>(Abcam Inc.)</td>
<td></td>
</tr>
<tr>
<td>biotin-labeled anti-exatecan/DXd antibody</td>
<td>(Abmart)</td>
<td></td>
</tr>
<tr>
<td>TMB solution</td>
<td>(KPL Inc.)</td>
<td></td>
</tr>
<tr>
<td>Streptavidin  Protein,HRP (Thermo Scientific)</td>
<td></td>
</tr>
</tbody>
</table>
</div>
<h5 id="4-3-12-In-Vitro-Stability-of-MTX-1000-DS-8201a-in-Plasma"><a href="#4-3-12-In-Vitro-Stability-of-MTX-1000-DS-8201a-in-Plasma" class="headerlink" title="4.3.12 In Vitro Stability of MTX-1000/DS-8201a in Plasma"></a>4.3.12 In Vitro Stability of MTX-1000/DS-8201a in Plasma</h5><blockquote>
<p>在小鼠、大鼠、猴子和人血浆中评估了MTX-1000/DS-8201a浓度为10 mg/mL、37℃至21天的xatecan/DXd的释放速率。 </p>
</blockquote>
<p>The release rate of exatecan/DXd from MTX-1000/DS-8201a at  the concentration of 10 mg/mL at 37°C up to 21 days was evaluated  in mouse, rat, monkey, and human plasma. </p>
<h5 id="4-3-13-ELISA"><a href="#4-3-13-ELISA" class="headerlink" title="4.3.13 ELISA"></a>4.3.13 ELISA</h5><div class="table-container">
<table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td>His-tagged HER2-ECD protein</td>
<td>Sino Biological</td>
<td></td>
</tr>
<tr>
<td>PathScan Phospho-Akt1 (Ser473)  Sandwich ELISA Kit and</td>
<td>Cell Signaling Technology</td>
<td></td>
</tr>
<tr>
<td>PathScan Total-Akt1 Sandwich ELISA  Kit</td>
<td>Cell Signaling Technology</td>
</tr>
</tbody>
</table>
</div>
<p>对于结合测定，免疫板在包衣缓冲液中涂覆2.5 mg/mL Heis-tag标记的HER2-ED蛋白并在4°C下保持过夜。洗涤后，将板堵塞，将每种串联稀释的物质加入孔中。在37°C下孵育1.5小时后，将板洗涤并在37°C下与HRP结合的抗人IgG二抗孵育1小时。洗涤后，加入TMB溶液并用微孔板阅读器测量每个孔中的A450。</p>
<p>对于磷酸化Akt（pAkt）的检测，SK-BR-3细胞在96孔板中预孵育4天，然后与每种物质孵育24小时。孵育后，根据制造商的说明，裂解细胞并使用PathScan Phospho-Akt1（Ser473）Sandwich ELISA Kit和PathScan Total-Akt1 Sandwich ELISA Kit检测细胞间pAkt和总Akt。通过将处理过的归一化pAkt值除以未处理过的归一化pAkt值来计算每个样品孔的相对pAkt。 </p>
<h5 id="4-3-14-Immunoblotting"><a href="#4-3-14-Immunoblotting" class="headerlink" title="4.3.14 Immunoblotting"></a>4.3.14 Immunoblotting</h5><div class="table-container">
<table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td>M-PER lysis  buffer containing Halt Protease and Phosphatase Inhibitor Cock tail</td>
<td>Thermo Fisher Scientific</td>
<td></td>
</tr>
<tr>
<td>anti–phospho-Chk1 (Ser345; 133D3) rabbit mAb</td>
<td>Cell Signaling Technology</td>
<td></td>
</tr>
<tr>
<td>anti-Chk1  (2G1D5) mouse mAb</td>
<td>Cell Signaling Technology</td>
<td></td>
</tr>
<tr>
<td>anti–cleaved PARP (Asp214) antibody</td>
<td>Cell Signaling Technology</td>
<td></td>
</tr>
<tr>
<td>anti–β-actin (8H10D10) mouse mAb</td>
<td>Cell Signaling Technology</td>
<td></td>
</tr>
<tr>
<td>anti–phospho-Histone H2A.X (Ser139) antibody</td>
<td>Millipore</td>
<td></td>
</tr>
<tr>
<td>anti–Histone H2A.X antibody</td>
<td>Abcam</td>
</tr>
</tbody>
</table>
</div>
<p>用每种物质处理KPL - 4细胞。在24、48或72小时后，收集细胞，裂解细胞，将样品上样，SDS - PAGE进行分离，并转移至聚偏二氟乙烯膜上。将膜封闭，在4℃下用一抗孵育过夜。然后，洗涤膜，使用SNAP皮内给药系统（密理博公司）与荧光标记的二抗孵育10分钟。使用奥德赛成像系统（LI - COR公司）检测荧光信号。 </p>
<h5 id="4-3-15-Detection-of-Cellular-TOP1ccs"><a href="#4-3-15-Detection-of-Cellular-TOP1ccs" class="headerlink" title="4.3.15 Detection of Cellular TOP1ccs"></a>4.3.15 Detection of Cellular TOP1ccs</h5><div class="table-container">
<table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td>DNAzol</td>
<td>Invitrogen</td>
<td></td>
</tr>
<tr>
<td>抗TOP1抗体</td>
<td>BD Biosciences #556597</td>
<td></td>
</tr>
<tr>
<td>抗dsDNA抗体</td>
<td>Abcam #3519</td>
</tr>
</tbody>
</table>
</div>
<p><strong>实验流程概述</strong> </p>
<ol>
<li><strong>细胞处理与裂解</strong>     <ul>
<li>将COLO205细胞（1–3×10⁶个/样本）用TOP1抑制剂处理后，用PBS洗涤。   </li>
<li>加入600 μL DNAzol裂解细胞，DNAzol中的高盐成分可选择性沉淀DNA-蛋白质复合物（如TOP1ccs）。 </li>
</ul>
</li>
<li><strong>核酸沉淀与清洗</strong>     <ul>
<li>加入300 μL无水乙醇，14,000 rpm离心沉淀核酸（含DNA结合的TOP1）。   </li>
<li>用75%乙醇洗涤沉淀，去除杂质，再溶于200 μL TE缓冲液。 </li>
</ul>
</li>
<li><strong>DNA剪切与变性</strong>     <ul>
<li><strong>加热变性</strong>：65°C孵育15分钟，破坏非共价结合的蛋白质-DNA相互作用，仅保留共价交联的TOP1ccs。   </li>
<li><strong>超声剪切</strong>：用超声波破碎仪（40%输出功率）进行4轮脉冲处理（10秒脉冲+10秒间隔），将DNA打断为约500 bp片段，便于后续检测。 </li>
</ul>
</li>
<li><strong>样本分离与定量</strong>     <ul>
<li>4°C下15,000 rpm离心5分钟，取上清（含剪切后的DNA-TOP1复合物）。   </li>
<li>取1 μL样本用NanoDrop测定260 nm吸光度，定量DNA浓度，确保后续上样量一致。 </li>
</ul>
</li>
<li><strong>免疫印迹检测</strong>     <ul>
<li><strong>Slot Blot</strong>：将2 mg样本（基于DNA浓度归一化）点样到硝酸纤维素膜上，通过真空抽滤使DNA-TOP1复合物固定在膜上。   </li>
<li><strong>抗体杂交</strong>：     <ul>
<li>用抗TOP1抗体检测DNA结合的TOP1。     </li>
<li>用抗dsDNA抗体作为上样量对照，确保各样本DNA总量一致。   </li>
</ul>
</li>
<li><strong>密度分析</strong>：用ImageJ软件定量条带强度，计算TOP1信号与DNA信号的比值，反映TOP1ccs的相对水平。  </li>
</ul>
</li>
</ol>
<p><strong>技术关键点</strong> </p>
<ol>
<li><strong>DNAzol的作用</strong>     - DNAzol中的胍盐可裂解细胞并选择性沉淀DNA及与之共价结合的蛋白质（如TOP1ccs），而游离蛋白质保留在溶液中被去除。 </li>
<li><strong>超声剪切的意义</strong>     - 将DNA剪切成小片段可增加抗原表位的暴露，提高抗体结合效率，同时避免大分子量DNA在膜上的聚集导致信号不均。 </li>
<li><strong>Slot Blot vs. Western Blot</strong>     <ul>
<li><strong>Slot Blot</strong>：直接将样本点样到膜上，适合批量定量分析，但无法分离蛋白质分子量。   </li>
<li><strong>Western Blot</strong>：需先通过SDS-PAGE分离蛋白质，再转膜检测，可区分不同分子量的蛋白质条带。此处选择Slot Blot是为了快速定量DNA结合的TOP1总量。 </li>
</ul>
</li>
<li><strong>对照设置</strong>  用抗dsDNA抗体作为内参，校正不同样本间DNA上样量的差异，确保TOP1信号的变化真实反映TOP1ccs的丰度变化。  </li>
</ol>
<p><strong>应用与意义</strong> </p>
<p>该方法通过改良RADAR技术，实现了对DNA捕获的TOP1（即TOP1ccs）的定量检测，可用于： </p>
<ul>
<li>评估TOP1抑制剂（如喜树碱类药物）的疗效，通过检测药物诱导TOP1ccs积累的能力。</li>
<li>研究TOP1ccs修复机制或相关蛋白（如SLFN11）的功能。 </li>
<li>比较不同细胞系或处理条件下TOP1ccs的水平差异（如摘要3中比较敏感与耐药细胞）。 通过标准化的实验流程和严格的定量分析，该方法为拓扑异构酶I靶向药物的研发和作用机制研究提供了关键技术支持。 </li>
</ul>
<h5 id="4-3-16-Toxicity-Studies-in-Rats-and-Monkeys"><a href="#4-3-16-Toxicity-Studies-in-Rats-and-Monkeys" class="headerlink" title="4.3.16 Toxicity Studies in Rats and Monkeys"></a>4.3.16 Toxicity Studies in Rats and Monkeys</h5><p>MTX-1000 was intravenously administered intermittently at  3-week intervals over a 6-week period to cynomolgus monkeys  (Table 1). Clinical signs, body weight, food consumption, and clinical pathology were monitored throughout the study. A necropsy was  conducted on the day after the last administration. The reversibility  of the toxic changes was assessed in a subsequent 6-week recovery  period in cynomolgus monkeys. </p>
<blockquote>
<p>对食蟹猴（表1）在6周时间内，以3周为间隔，间歇性静脉注射MTX - 1000。在整个研究过程中，监测临床体征、体重、食物摄入量和临床病理情况。在最后一次给药后的次日进行尸检。在随后6周的恢复期内，评估食蟹猴毒性变化的可逆性。 </p>
</blockquote>
<h5 id="4-3-17-Organoids-Preparation-for-Drug-Tests"><a href="#4-3-17-Organoids-Preparation-for-Drug-Tests" class="headerlink" title="4.3.17 Organoids Preparation for Drug Tests"></a>4.3.17 Organoids Preparation for Drug Tests</h5><div class="table-container">
<table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td>96-well cell culture plate</td>
<td>Corning</td>
<td>3799</td>
</tr>
<tr>
<td>Matrigel</td>
<td>Corning</td>
<td>356231</td>
</tr>
</tbody>
</table>
</div>
<p>收获类器官，当类器官生长到直径50μm时，接种在96孔细胞培养板中（Corning，3799）。采用夹心法进行药物试验。接种前，将50μL 50%矩阵胶（Corning，356231，Matrigle与PBS 1:1混合）滴在培养板底作为底层。然后，将10μL 10%矩阵胶（Matrigle与PBS 1:9混合）滴在底层作为中间层。在每个孔中加入类器官培养基（200μL）作为上层。药物试验将在培养1天后开始。</p>
<h5 id="4-3-18-Colon-Cancer-Organoids-Drug-Test-Assays"><a href="#4-3-18-Colon-Cancer-Organoids-Drug-Test-Assays" class="headerlink" title="4.3.18 Colon Cancer Organoids Drug Test Assays"></a>4.3.18 Colon Cancer Organoids Drug Test Assays</h5><p>对于药物试验，钙黄绿素AM用于活细胞染色，在第RCO培养基被移除并用含200μL药物的培养基代替，3天后再次刷新含药物的培养基，然后，钙黄绿素AM/PI用于第6天的活/死细胞染色，使用Z堆栈成像技术用于第0天和第6天的类器官的拍照（尼康，Ti2-E），使用NIS-Elements AR软件（尼康）测量活类器官的大小。统计分析除毒性研究外的所有统计分析均使用SAS System Release9.1.3和9.2（SAS Institute Inc.）进行。毒性研究中的Sta tistical分析使用MUSCOT（YukmsCo.， Ltd.）进行。所有IC50和ED50值均通过Sig moid Emax模型确定，并通过Spear man秩相关系数假设检验评估剂量依赖性。统计和数据检验确定显著性在相关图例中有详细说明。简而言之，t检验或单向方差分析用于确定治疗条件的统计显著性，双向方差分析用于区分剂量和转化的贡献。</p>
<h4 id="4-4-模型"><a href="#4-4-模型" class="headerlink" title="4.4 模型"></a>4.4 模型</h4><h4 id="4-5-标志物"><a href="#4-5-标志物" class="headerlink" title="4.5 标志物"></a>4.5 标志物</h4>
                      

                        
        </div>
        <div class="article-info article-info-index">
          
              
	<div class="article-tag tagcloud">
		<i class="icon-price-tags icon"></i>
		<ul class="article-tag-list">
			 
        		<li class="article-tag-list-item">
        			<a href="javascript:void(0)" class="js-tag article-tag-list-link color4">ADC</a>
        		</li>
      		
		</ul>
	</div>

                

                  

                      
                        
<div class="share-btn share-icons tooltip-left">
  <div class="tooltip tooltip-east">
    <span class="tooltip-item">
      <a href="javascript:;" class="share-sns share-outer">
        <i class="icon icon-share"></i>
      </a>
    </span>
    <span class="tooltip-content">
      <div class="share-wrap">
        <div class="share-icons">
          <a class="weibo share-sns" href="javascript:;" data-type="weibo">
            <i class="icon icon-weibo"></i>
          </a>
          <a class="weixin share-sns wxFab" href="javascript:;" data-type="weixin">
            <i class="icon icon-weixin"></i>
          </a>
          <a class="qq share-sns" href="javascript:;" data-type="qq">
            <i class="icon icon-qq"></i>
          </a>
          <a class="douban share-sns" href="javascript:;" data-type="douban">
            <i class="icon icon-douban"></i>
          </a>
          <a class="qzone share-sns" href="javascript:;" data-type="qzone">
            <i class="icon icon-qzone"></i>
          </a>
          <a class="facebook share-sns" href="javascript:;" data-type="facebook">
            <i class="icon icon-facebook"></i>
          </a>
          <a class="twitter share-sns" href="javascript:;" data-type="twitter">
            <i class="icon icon-twitter"></i>
          </a>
          <a class="google share-sns" href="javascript:;" data-type="google">
            <i class="icon icon-google"></i>
          </a>
        </div>
      </div>
    </span>
  </div>
</div>

<div class="page-modal wx-share js-wx-box">
    <a class="close js-modal-close" href="javascript:;"><i class="icon icon-close"></i></a>
    <p>扫一扫，分享到微信</p>
    <div class="wx-qrcode">
      <img src="//pan.baidu.com/share/qrcode?url=http://molinzai.github.io/2025/08/02/36693125/" alt="微信分享二维码">
    </div>
</div>

<div class="mask js-mask"></div>
                          
                            <div class="clearfix"></div>
        </div>
  </div>
</article>

  
<nav id="article-nav">
  
  
    <a href="/2025/06/22/FZ-AD005/" id="article-nav-older" class="article-nav-link-wrap">
      <div class="article-nav-title">FZ-AD005</div>
      <i class="icon-circle-right"></i>
    </a>
  
</nav>

    
      <aside class="wrap-side-operation">
    <div class="mod-side-operation">
        
        <div class="jump-container" id="js-jump-container" style="display:none;">
            <a href="javascript:void(0)" class="mod-side-operation__jump-to-top">
                <i class="icon-font icon-back"></i>
            </a>
            <div id="js-jump-plan-container" class="jump-plan-container" style="top: -11px;">
                <i class="icon-font icon-plane jump-plane"></i>
            </div>
        </div>
        
        
        <div class="toc-container tooltip-left">
            <i class="icon-font icon-category"></i>
            <div class="tooltip tooltip-east">
                <span class="tooltip-item">
                </span>
                <span class="tooltip-content">
                    <div class="toc-article">
                    <ol class="toc"><li class="toc-item toc-level-3"><a class="toc-link" href="#%E3%80%87%E3%80%81%E6%96%87%E7%8C%AE%E8%83%8C%E6%99%AF"><span class="toc-number">1.</span> <span class="toc-text">〇、文献背景</span></a></li><li class="toc-item toc-level-3"><a class="toc-link" href="#%E4%B8%80%E3%80%81%E9%A2%98%E7%9B%AE%E8%A6%81%E7%B4%A0"><span class="toc-number">2.</span> <span class="toc-text">一、题目要素</span></a></li><li class="toc-item toc-level-3"><a class="toc-link" href="#%E4%BA%8C%E3%80%81%E5%81%87%E8%AE%BE%E9%80%BB%E8%BE%91"><span class="toc-number">3.</span> <span class="toc-text">二、假设逻辑</span></a></li><li class="toc-item toc-level-3"><a class="toc-link" href="#%E4%B8%89%E3%80%81%E6%95%B0%E6%8D%AE%E6%B3%9B%E8%AF%BB"><span class="toc-number">4.</span> <span class="toc-text">三、数据泛读</span></a><ol class="toc-child"><li class="toc-item toc-level-4"><a class="toc-link" href="#3-1-%E6%AF%94%E8%BE%83Exatecan-DXd-SN-38%E4%B8%89%E4%B8%AA%E5%B0%8F%E5%88%86%E5%AD%90%E4%BD%93%E5%86%85%E4%BD%93%E5%A4%96%E7%9A%84%E6%AF%92%E6%80%A7%E3%80%82"><span class="toc-number">4.1.</span> <span class="toc-text">3.1 比较Exatecan&#x2F;DXd&#x2F;SN-38三个小分子体内体外的毒性。</span></a><ol class="toc-child"><li class="toc-item toc-level-5"><a class="toc-link" href="#3-1-0-Exatecan%E6%95%88%E5%8A%9B%EF%BC%8CMDR%E6%95%8F%E6%84%9F%E6%80%A7%E5%92%8C%E6%AF%92%E6%80%A7%E3%80%82"><span class="toc-number">4.1.1.</span> <span class="toc-text">3.1.0 Exatecan效力，MDR敏感性和毒性。</span></a></li><li class="toc-item toc-level-5"><a class="toc-link" href="#3-1-1-Fig-S1-%E8%A1%A5%E5%85%85%E5%9B%BES1-Exatecan%E7%9A%84%E7%BB%86%E8%83%9E%E6%AF%92%E6%80%A7%E5%8F%8A%E5%AF%B9%E5%A4%9A%E8%8D%AF%E8%80%90%E8%8D%AF%E5%9F%BA%E5%9B%A0%E7%9A%84%E6%95%8F%E6%84%9F%E6%80%A7"><span class="toc-number">4.1.2.</span> <span class="toc-text">3.1.1 Fig.S1 补充图S1. Exatecan的细胞毒性及对多药耐药基因的敏感性</span></a></li><li class="toc-item toc-level-5"><a class="toc-link" href="#3-1-2-Fig-S2-Exatecan-DXd-SN-38%E5%AF%B9%E5%A4%9A%E8%8D%AF%E8%80%90%E8%8D%AF%E5%9F%BA%E5%9B%A0%E7%9A%84%E6%95%8F%E6%84%9F%E6%80%A7%E3%80%82"><span class="toc-number">4.1.3.</span> <span class="toc-text">3.1.2 Fig.S2 Exatecan&#x2F;DXd&#x2F;SN-38对多药耐药基因的敏感性。</span></a></li><li class="toc-item toc-level-5"><a class="toc-link" href="#3-1-3-Fig-S3-Exatecan%E5%AF%B9%E5%A4%A7%E9%BC%A0%E7%9A%84%E6%AF%92%E6%80%A7%E3%80%82"><span class="toc-number">4.1.4.</span> <span class="toc-text">3.1.3 Fig.S3 Exatecan对大鼠的毒性。</span></a></li></ol></li><li class="toc-item toc-level-4"><a class="toc-link" href="#3-2-T%E9%83%A8%E5%88%86%E7%9A%84%E4%BC%98%E5%8C%96"><span class="toc-number">4.2.</span> <span class="toc-text">3.2 T部分的优化</span></a><ol class="toc-child"><li class="toc-item toc-level-5"><a class="toc-link" href="#3-2-0-Fig-S4-T%E9%83%A8%E5%88%86%E7%9A%84%E8%AE%BE%E8%AE%A1%E5%92%8C%E4%BC%98%E5%8C%96%E3%80%82"><span class="toc-number">4.2.1.</span> <span class="toc-text">3.2.0 Fig.S4 T部分的设计和优化。</span></a></li></ol></li><li class="toc-item toc-level-4"><a class="toc-link" href="#3-3-MTX-1000%EF%BC%88ADC%EF%BC%89%E7%9A%84%E5%88%86%E6%9E%90%E5%8F%8A%E4%BD%93%E5%86%85%E5%A4%96%E5%AE%9E%E9%AA%8C%E5%8F%8A%E4%BC%98%E8%B6%8A%E6%80%A7-%E6%95%88%E6%9E%9C%E4%B8%8E%E5%AE%89%E5%85%A8%E6%80%A7%EF%BC%89%EF%BC%88%E4%B8%8ETras-GGFG-DXd%E5%92%8CDS-8201a%E6%AF%94%E8%BE%83%EF%BC%89%E3%80%82"><span class="toc-number">4.3.</span> <span class="toc-text">3.3 MTX-1000（ADC）的分析及体内外实验及优越性(效果与安全性）（与Tras-GGFG-DXd和DS-8201a比较）。</span></a><ol class="toc-child"><li class="toc-item toc-level-5"><a class="toc-link" href="#3-3-1-mAb-T1000-exatecan%E5%85%B7%E6%9C%89%E4%BC%98%E5%BC%82%E7%9A%84%E7%90%86%E5%8C%96%E5%92%8C%E8%8D%AF%E7%90%86%E5%AD%A6%E7%89%B9%E6%80%A7"><span class="toc-number">4.3.1.</span> <span class="toc-text">3.3.1 mAb-T1000-exatecan具有优异的理化和药理学特性</span></a></li><li class="toc-item toc-level-5"><a class="toc-link" href="#3-3-2-%E7%94%B1T%E9%83%A8%E5%88%86%E5%90%AF%E7%94%A8%E7%9A%84%E6%8A%97%E4%BD%93-exatecan%E7%BC%80%E5%90%88%E7%89%A9%E7%9A%84%E7%89%A9%E7%90%86%E5%8C%96%E5%AD%A6%E5%9B%BE%E8%B0%B1%E3%80%82"><span class="toc-number">4.3.2.</span> <span class="toc-text">3.3.2 由T部分启用的抗体-exatecan缀合物的物理化学图谱。</span></a></li><li class="toc-item toc-level-5"><a class="toc-link" href="#3-3-3-mAb-T1000-exatecan%E7%9A%84HIC%E3%80%81DAR%E3%80%81SEC"><span class="toc-number">4.3.3.</span> <span class="toc-text">3.3.3 mAb-T1000-exatecan的HIC、DAR、SEC</span></a></li><li class="toc-item toc-level-5"><a class="toc-link" href="#3-3-4-MTX-1000%E7%9A%84%E4%BD%93%E5%A4%96%E5%92%8C%E4%BD%93%E5%86%85%E7%A8%B3%E5%AE%9A%E6%80%A7%E3%80%82"><span class="toc-number">4.3.4.</span> <span class="toc-text">3.3.4 MTX-1000的体外和体内稳定性。</span></a></li><li class="toc-item toc-level-5"><a class="toc-link" href="#3-3-5-MTX-1000%E7%9A%84%E7%BB%86%E8%83%9E%E5%8A%A8%E5%8A%9B%E5%AD%A6%E5%92%8C%E6%9C%BA%E5%88%B6%E3%80%82"><span class="toc-number">4.3.5.</span> <span class="toc-text">3.3.5 MTX-1000的细胞动力学和机制。</span></a></li><li class="toc-item toc-level-5"><a class="toc-link" href="#3-3-6-mAb-T1000-exatecan%E9%80%9A%E8%BF%87%E6%8F%90%E9%AB%98%E6%B2%BB%E7%96%97%E6%8C%87%E6%95%B0%E5%92%8C%E8%82%BF%E7%98%A4%E5%86%85%E8%8D%AF%E6%95%88%E5%AD%A6%E5%93%8D%E5%BA%94%E5%85%8B%E6%9C%8D%E6%B2%BB%E7%96%97%E8%80%90%E8%8D%AF%E6%80%A7%E3%80%82"><span class="toc-number">4.3.6.</span> <span class="toc-text">3.3.6  mAb-T1000-exatecan通过提高治疗指数和肿瘤内药效学响应克服治疗耐药性。</span></a></li><li class="toc-item toc-level-5"><a class="toc-link" href="#3-3-7-mAb-T1000-exatecan%E6%88%96%E5%A4%9A%E8%8D%AF%E8%80%90%E8%8D%AF%EF%BC%88MDR%EF%BC%89%E6%8A%91%E5%88%B6%E5%89%82%E4%B8%8EDXd-SN-38-ADC%E8%81%94%E5%90%88%E4%BD%BF%E7%94%A8%E5%85%8B%E6%9C%8DMDR%E8%80%90%E8%8D%AF%E6%80%A7%E3%80%82"><span class="toc-number">4.3.7.</span> <span class="toc-text">3.3.7 mAb-T1000-exatecan或多药耐药（MDR）抑制剂与DXd&#x2F;SN-38 ADC联合使用克服MDR耐药性。</span></a></li><li class="toc-item toc-level-5"><a class="toc-link" href="#3-3-8-%E7%BB%93%E8%82%A0%E7%99%8C%E5%AF%B9ADC%E7%9A%84%E7%B1%BB%E5%99%A8%E5%AE%98%E5%8F%8D%E5%BA%94%E3%80%82"><span class="toc-number">4.3.8.</span> <span class="toc-text">3.3.8 结肠癌对ADC的类器官反应。</span></a></li><li class="toc-item toc-level-5"><a class="toc-link" href="#3-3-9-MTX-1000%E3%80%81T-DM1%E5%92%8CTras-GGFG-DXd%E5%9C%A8%E4%BD%93%E5%A4%96%E5%85%B1%E5%9F%B9%E5%85%BB%E6%9D%A1%E4%BB%B6%E4%B8%8B%E7%9A%84%E6%97%81%E8%A7%82%E8%80%85%E6%9D%80%E4%BC%A4%E6%95%88%E5%BA%94%E3%80%82"><span class="toc-number">4.3.9.</span> <span class="toc-text">3.3.9 MTX-1000、T-DM1和Tras-GGFG-DXd在体外共培养条件下的旁观者杀伤效应。</span></a></li><li class="toc-item toc-level-5"><a class="toc-link" href="#3-3-10-%E7%8C%B4%E5%AD%90%E4%BD%93%E5%86%85MTX-1000%E7%9A%84%E8%A1%80%E6%B6%B2%E5%AD%A6%E5%92%8C%E8%A1%80%E6%B8%85%E5%8C%96%E5%AD%A6"><span class="toc-number">4.3.10.</span> <span class="toc-text">3.3.10 猴子体内MTX-1000的血液学和血清化学</span></a></li><li class="toc-item toc-level-5"><a class="toc-link" href="#3-3-11-mAb-T1000-exatecan%E6%98%BE%E7%A4%BA%E5%87%BA%E5%BC%BA%E5%A4%A7%E7%9A%84%E6%8A%97%E8%82%BF%E7%98%A4%E7%96%97%E6%95%88%E5%92%8C%E6%94%B9%E5%96%84%E7%9A%84%E6%B2%BB%E7%96%97%E6%8C%87%E6%A0%87"><span class="toc-number">4.3.11.</span> <span class="toc-text">3.3.11 mAb-T1000-exatecan显示出强大的抗肿瘤疗效和改善的治疗指标</span></a></li></ol></li><li class="toc-item toc-level-4"><a class="toc-link" href="#3-4-LP-T1000-Exatecan-%E5%BB%B6%E4%BC%B8%E5%88%B0%E5%85%B6%E5%AE%83ADC"><span class="toc-number">4.4.</span> <span class="toc-text">3.4 LP(T1000-Exatecan)延伸到其它ADC</span></a><ol class="toc-child"><li class="toc-item toc-level-5"><a class="toc-link" href="#3-4-1-mAb-T1000-exatecan%E5%8F%AF%E5%85%8B%E6%9C%8D%E8%80%90%E8%8D%AF%E6%80%A7%EF%BC%8C%E5%B9%B6%E5%9C%A8%E7%BB%93%E8%82%A0%E7%99%8C%E7%BB%86%E8%83%9E%E4%B8%AD%E4%B8%8EPARP-ATR%E6%8A%91%E5%88%B6%E5%89%82%E4%BA%A7%E7%94%9F%E5%8D%8F%E5%90%8C%E4%BD%9C%E7%94%A8%E3%80%82"><span class="toc-number">4.4.1.</span> <span class="toc-text">3.4.1 mAb-T1000-exatecan可克服耐药性，并在结肠癌细胞中与PARP&#x2F;ATR抑制剂产生协同作用。</span></a></li><li class="toc-item toc-level-5"><a class="toc-link" href="#3-5-2-%E9%9D%B6%E5%90%91%E8%82%BA%E7%99%8C%E8%80%90%E8%8D%AF%E6%80%A7%E7%9A%84mAb-T1000-exatecan%E3%80%82"><span class="toc-number">4.4.2.</span> <span class="toc-text">3.5.2 靶向肺癌耐药性的mAb-T1000-exatecan。</span></a></li><li class="toc-item toc-level-5"><a class="toc-link" href="#3-5-3-Tras-GGFG-DXd%E5%92%8CDS-8201a%E7%9A%84%E7%89%A9%E7%90%86%E5%8C%96%E5%AD%A6%E5%92%8C%E5%8A%9F%E8%83%BD%E7%AD%89%E6%95%88%E6%80%A7%E3%80%82"><span class="toc-number">4.4.3.</span> <span class="toc-text">3.5.3 Tras-GGFG-DXd和DS-8201a的物理化学和功能等效性。</span></a></li><li class="toc-item toc-level-5"><a class="toc-link" href="#3-5-4-mAb-T1000-exatecan%E5%9C%A8PDX%E6%A8%A1%E5%9E%8B%E4%B8%AD%E6%98%BE%E7%A4%BA%E5%87%BA%E6%9B%B4%E9%AB%98%E7%9A%84%E6%8A%97%E8%82%BF%E7%98%A4%E6%95%88%E5%8A%9B%E5%92%8C%E6%9B%B4%E5%A5%BD%E7%9A%84%E7%98%A4%E5%86%85%E8%8D%AF%E6%95%88%E5%AD%A6%E5%8F%8D%E5%BA%94%E3%80%82"><span class="toc-number">4.4.4.</span> <span class="toc-text">3.5.4 mAb-T1000-exatecan在PDX模型中显示出更高的抗肿瘤效力和更好的瘤内药效学反应。</span></a></li><li class="toc-item toc-level-5"><a class="toc-link" href="#3-5-5-mAb-T1000-exatecan%E9%80%9A%E8%BF%87%E6%94%B9%E5%96%84%E6%B2%BB%E7%96%97%E6%8C%87%E6%95%B0%E5%92%8C%E8%82%BF%E7%98%A4%E5%86%85%E8%8D%AF%E6%95%88%E5%AD%A6%E5%8F%8D%E5%BA%94%E5%85%8B%E6%9C%8D%E6%B2%BB%E7%96%97%E8%80%90%E8%8D%AF%E6%80%A7%E3%80%82"><span class="toc-number">4.4.5.</span> <span class="toc-text">3.5.5 mAb-T1000-exatecan通过改善治疗指数和肿瘤内药效学反应克服治疗耐药性。</span></a></li><li class="toc-item toc-level-5"><a class="toc-link" href="#3-5-6-mAb-T1000-exatecan%E6%88%96MDR%E6%8A%91%E5%88%B6%E5%89%82%E4%B8%8EDXd-SN-38-ADC%E7%9A%84%E7%BB%84%E5%90%88%E5%85%8B%E6%9C%8DMDR%E8%80%90%E8%8D%AF%E6%80%A7%E3%80%82"><span class="toc-number">4.4.6.</span> <span class="toc-text">3.5.6 mAb-T1000-exatecan或MDR抑制剂与DXd&#x2F;SN-38 ADC的组合克服MDR耐药性。</span></a></li><li class="toc-item toc-level-5"><a class="toc-link" href="#3-5-7-%E5%85%B7%E6%9C%89EGFR%E4%B8%89%E7%AA%81%E5%8F%98%E7%9A%84%E6%82%A3%E8%80%85%E6%BA%90%E6%80%A7%E5%BC%82%E7%A7%8D%E7%A7%BB%E6%A4%8D%EF%BC%88PDX%EF%BC%89%E6%A8%A1%E5%9E%8B%E3%80%82"><span class="toc-number">4.4.7.</span> <span class="toc-text">3.5.7 具有EGFR三突变的患者源性异种移植（PDX）模型。</span></a></li></ol></li><li class="toc-item toc-level-4"><a class="toc-link" href="#3-5-%E6%B2%BB%E7%96%97%E5%BA%94%E7%94%A8"><span class="toc-number">4.5.</span> <span class="toc-text">3.5 治疗应用</span></a><ol class="toc-child"><li class="toc-item toc-level-5"><a class="toc-link" href="#3-5-1-Exatecan-MTX-1000%E5%92%8CPARP-ATR%E6%8A%91%E5%88%B6%E5%89%82%E5%9C%A8%E7%BB%93%E8%82%A0%E7%99%8C%E7%BB%86%E8%83%9E%E4%B8%AD%E5%8D%8F%E5%90%8C%E4%BD%9C%E7%94%A8%E3%80%82"><span class="toc-number">4.5.1.</span> <span class="toc-text">3.5.1 Exatecan&#x2F;MTX-1000和PARP&#x2F;ATR抑制剂在结肠癌细胞中协同作用。</span></a></li><li class="toc-item toc-level-5"><a class="toc-link" href="#3-5-2-MTX-1000%E8%AF%B1%E5%AF%BC%E5%85%8D%E7%96%AB%E5%8E%9F%E6%80%A7%E7%BB%86%E8%83%9E%E6%AD%BB%E4%BA%A1%E5%B9%B6%E5%A2%9E%E5%BC%BA%E6%8A%97PD-1%E7%9A%84%E6%8A%97%E8%82%BF%E7%98%A4%E5%85%8D%E7%96%AB%E4%BD%9C%E7%94%A8"><span class="toc-number">4.5.2.</span> <span class="toc-text">3.5.2 MTX-1000诱导免疫原性细胞死亡并增强抗PD-1的抗肿瘤免疫作用</span></a></li></ol></li></ol></li><li class="toc-item toc-level-3"><a class="toc-link" href="#%E5%9B%9B%E3%80%81%E5%A5%97%E8%B7%AF%E6%80%BB%E7%BB%93"><span class="toc-number">5.</span> <span class="toc-text">四、套路总结</span></a><ol class="toc-child"><li class="toc-item toc-level-4"><a class="toc-link" href="#4-1-%E7%96%BE%E7%97%85"><span class="toc-number">5.1.</span> <span class="toc-text">4.1 疾病</span></a></li><li class="toc-item toc-level-4"><a class="toc-link" href="#4-2-%E8%A1%A8%E5%9E%8B"><span class="toc-number">5.2.</span> <span class="toc-text">4.2 表型</span></a></li><li class="toc-item toc-level-4"><a class="toc-link" href="#4-3-%E6%96%B9%E6%B3%95"><span class="toc-number">5.3.</span> <span class="toc-text">4.3 方法</span></a><ol class="toc-child"><li class="toc-item toc-level-5"><a class="toc-link" href="#4-3-1-Synthesis-of-T-Moiety"><span class="toc-number">5.3.1.</span> <span class="toc-text">4.3.1 Synthesis of T Moiety</span></a></li><li class="toc-item toc-level-5"><a class="toc-link" href="#4-3-2-Antibodies-and-ADCs-and-Compounds"><span class="toc-number">5.3.2.</span> <span class="toc-text">4.3.2 Antibodies and ADCs, and Compounds</span></a></li><li class="toc-item toc-level-5"><a class="toc-link" href="#4-3-3-ADC-Preparation"><span class="toc-number">5.3.3.</span> <span class="toc-text">4.3.3 ADC Preparation</span></a></li><li class="toc-item toc-level-5"><a class="toc-link" href="#4-3-4-ADC-Concentration-DAR-and-Aggregation-Measurement"><span class="toc-number">5.3.4.</span> <span class="toc-text">4.3.4 ADC Concentration, DAR, and Aggregation Measurement</span></a></li><li class="toc-item toc-level-5"><a class="toc-link" href="#4-3-5-Flow-Cytometry"><span class="toc-number">5.3.5.</span> <span class="toc-text">4.3.5 Flow Cytometry</span></a></li><li class="toc-item toc-level-5"><a class="toc-link" href="#4-3-6-Cell-Lines-and-PDX-Models"><span class="toc-number">5.3.6.</span> <span class="toc-text">4.3.6 Cell Lines and PDX Models</span></a></li><li class="toc-item toc-level-5"><a class="toc-link" href="#4-3-7-Cytotoxic-Assay"><span class="toc-number">5.3.7.</span> <span class="toc-text">4.3.7 Cytotoxic Assay</span></a></li><li class="toc-item toc-level-5"><a class="toc-link" href="#4-3-8-Cell-Line-and-PDX-Studies"><span class="toc-number">5.3.8.</span> <span class="toc-text">4.3.8 Cell Line and PDX Studies</span></a></li><li class="toc-item toc-level-5"><a class="toc-link" href="#4-3-9-Syngeneic-Model"><span class="toc-number">5.3.9.</span> <span class="toc-text">4.3.9 Syngeneic Model</span></a></li><li class="toc-item toc-level-5"><a class="toc-link" href="#4-3-10-Tissue-Multiplex-IHC"><span class="toc-number">5.3.10.</span> <span class="toc-text">4.3.10 Tissue Multiplex IHC</span></a></li><li class="toc-item toc-level-5"><a class="toc-link" href="#4-3-11-PK-of-MTX-1000-DS-8201a-in-Rat-Mouse"><span class="toc-number">5.3.11.</span> <span class="toc-text">4.3.11 PK of MTX-1000&#x2F;DS-8201a in Rat&#x2F;Mouse</span></a></li><li class="toc-item toc-level-5"><a class="toc-link" href="#4-3-12-In-Vitro-Stability-of-MTX-1000-DS-8201a-in-Plasma"><span class="toc-number">5.3.12.</span> <span class="toc-text">4.3.12 In Vitro Stability of MTX-1000&#x2F;DS-8201a in Plasma</span></a></li><li class="toc-item toc-level-5"><a class="toc-link" href="#4-3-13-ELISA"><span class="toc-number">5.3.13.</span> <span class="toc-text">4.3.13 ELISA</span></a></li><li class="toc-item toc-level-5"><a class="toc-link" href="#4-3-14-Immunoblotting"><span class="toc-number">5.3.14.</span> <span class="toc-text">4.3.14 Immunoblotting</span></a></li><li class="toc-item toc-level-5"><a class="toc-link" href="#4-3-15-Detection-of-Cellular-TOP1ccs"><span class="toc-number">5.3.15.</span> <span class="toc-text">4.3.15 Detection of Cellular TOP1ccs</span></a></li><li class="toc-item toc-level-5"><a class="toc-link" href="#4-3-16-Toxicity-Studies-in-Rats-and-Monkeys"><span class="toc-number">5.3.16.</span> <span class="toc-text">4.3.16 Toxicity Studies in Rats and Monkeys</span></a></li><li class="toc-item toc-level-5"><a class="toc-link" href="#4-3-17-Organoids-Preparation-for-Drug-Tests"><span class="toc-number">5.3.17.</span> <span class="toc-text">4.3.17 Organoids Preparation for Drug Tests</span></a></li><li class="toc-item toc-level-5"><a class="toc-link" href="#4-3-18-Colon-Cancer-Organoids-Drug-Test-Assays"><span class="toc-number">5.3.18.</span> <span class="toc-text">4.3.18 Colon Cancer Organoids Drug Test Assays</span></a></li></ol></li><li class="toc-item toc-level-4"><a class="toc-link" href="#4-4-%E6%A8%A1%E5%9E%8B"><span class="toc-number">5.4.</span> <span class="toc-text">4.4 模型</span></a></li><li class="toc-item toc-level-4"><a class="toc-link" href="#4-5-%E6%A0%87%E5%BF%97%E7%89%A9"><span class="toc-number">5.5.</span> <span class="toc-text">4.5 标志物</span></a></li></ol></li></ol>
                    </div>
                </span>
            </div>
        </div>
        
    </div>
</aside>


        
          

                

                      

                            

                                
                                      
          </div>
        </div>
      </div>
      <footer id="footer">
  <div class="outer">
    <div id="footer-info">
    	<div class="footer-left">
    		&copy; 2025 Molinzai
    	</div>
      	<div class="footer-right">
      		<a href="http://hexo.io/" target="_blank">Hexo</a>  Theme <a href="https://github.com/litten/hexo-theme-yilia" target="_blank">Yilia</a> by Litten
      	</div>
    </div>
  </div>
  
  <span id="busuanzi_container_site_pv">    本站总访问量<span id="busuanzi_value_site_pv"></span>次</span>
  <span class="post-meta-divider">|</span>
  
  <span id="busuanzi_container_site_uv">  本站访客数<span id="busuanzi_value_site_uv"></span>人次</span>
  <script async src="//busuanzi.ibruce.info/busuanzi/2.3/busuanzi.pure.mini.js"></script>
</footer>
    </div>
    <script>
	var yiliaConfig = {
		mathjax: true,
		isHome: false,
		isPost: true,
		isArchive: false,
		isTag: false,
		isCategory: false,
		open_in_new: false,
		toc_hide_index: true,
		root: "/",
		innerArchive: true,
		showTags: false
	}
</script>

<script>!function(t){function n(e){if(r[e])return r[e].exports;var i=r[e]={exports:{},id:e,loaded:!1};return t[e].call(i.exports,i,i.exports,n),i.loaded=!0,i.exports}var r={};n.m=t,n.c=r,n.p="./",n(0)}([function(t,n,r){r(195),t.exports=r(191)},function(t,n,r){var e=r(3),i=r(52),o=r(27),u=r(28),c=r(53),f="prototype",a=function(t,n,r){var s,l,h,v,p=t&a.F,d=t&a.G,y=t&a.S,g=t&a.P,b=t&a.B,m=d?e:y?e[n]||(e[n]={}):(e[n]||{})[f],x=d?i:i[n]||(i[n]={}),w=x[f]||(x[f]={});d&&(r=n);for(s in r)l=!p&&m&&void 0!==m[s],h=(l?m:r)[s],v=b&&l?c(h,e):g&&"function"==typeof h?c(Function.call,h):h,m&&u(m,s,h,t&a.U),x[s]!=h&&o(x,s,v),g&&w[s]!=h&&(w[s]=h)};e.core=i,a.F=1,a.G=2,a.S=4,a.P=8,a.B=16,a.W=32,a.U=64,a.R=128,t.exports=a},function(t,n,r){var e=r(6);t.exports=function(t){if(!e(t))throw TypeError(t+" is not an object!");return t}},function(t,n){var r=t.exports="undefined"!=typeof window&&window.Math==Math?window:"undefined"!=typeof self&&self.Math==Math?self:Function("return this")();"number"==typeof __g&&(__g=r)},function(t,n){t.exports=function(t){try{return!!t()}catch(t){return!0}}},function(t,n){var r=t.exports="undefined"!=typeof window&&window.Math==Math?window:"undefined"!=typeof self&&self.Math==Math?self:Function("return this")();"number"==typeof __g&&(__g=r)},function(t,n){t.exports=function(t){return"object"==typeof t?null!==t:"function"==typeof t}},function(t,n,r){var e=r(126)("wks"),i=r(76),o=r(3).Symbol,u="function"==typeof o;(t.exports=function(t){return e[t]||(e[t]=u&&o[t]||(u?o:i)("Symbol."+t))}).store=e},function(t,n){var r={}.hasOwnProperty;t.exports=function(t,n){return r.call(t,n)}},function(t,n,r){var e=r(94),i=r(33);t.exports=function(t){return e(i(t))}},function(t,n,r){t.exports=!r(4)(function(){return 7!=Object.defineProperty({},"a",{get:function(){return 7}}).a})},function(t,n,r){var e=r(2),i=r(167),o=r(50),u=Object.defineProperty;n.f=r(10)?Object.defineProperty:function(t,n,r){if(e(t),n=o(n,!0),e(r),i)try{return u(t,n,r)}catch(t){}if("get"in r||"set"in r)throw TypeError("Accessors not supported!");return"value"in r&&(t[n]=r.value),t}},function(t,n,r){t.exports=!r(18)(function(){return 7!=Object.defineProperty({},"a",{get:function(){return 7}}).a})},function(t,n,r){var e=r(14),i=r(22);t.exports=r(12)?function(t,n,r){return e.f(t,n,i(1,r))}:function(t,n,r){return t[n]=r,t}},function(t,n,r){var e=r(20),i=r(58),o=r(42),u=Object.defineProperty;n.f=r(12)?Object.defineProperty:function(t,n,r){if(e(t),n=o(n,!0),e(r),i)try{return u(t,n,r)}catch(t){}if("get"in r||"set"in r)throw TypeError("Accessors not supported!");return"value"in r&&(t[n]=r.value),t}},function(t,n,r){var e=r(40)("wks"),i=r(23),o=r(5).Symbol,u="function"==typeof o;(t.exports=function(t){return e[t]||(e[t]=u&&o[t]||(u?o:i)("Symbol."+t))}).store=e},function(t,n,r){var e=r(67),i=Math.min;t.exports=function(t){return t>0?i(e(t),9007199254740991):0}},function(t,n,r){var e=r(46);t.exports=function(t){return Object(e(t))}},function(t,n){t.exports=function(t){try{return!!t()}catch(t){return!0}}},function(t,n,r){var e=r(63),i=r(34);t.exports=Object.keys||function(t){return e(t,i)}},function(t,n,r){var e=r(21);t.exports=function(t){if(!e(t))throw TypeError(t+" is not an object!");return t}},function(t,n){t.exports=function(t){return"object"==typeof t?null!==t:"function"==typeof t}},function(t,n){t.exports=function(t,n){return{enumerable:!(1&t),configurable:!(2&t),writable:!(4&t),value:n}}},function(t,n){var r=0,e=Math.random();t.exports=function(t){return"Symbol(".concat(void 0===t?"":t,")_",(++r+e).toString(36))}},function(t,n){var r={}.hasOwnProperty;t.exports=function(t,n){return r.call(t,n)}},function(t,n){var r=t.exports={version:"2.4.0"};"number"==typeof __e&&(__e=r)},function(t,n){t.exports=function(t){if("function"!=typeof t)throw TypeError(t+" is not a function!");return t}},function(t,n,r){var e=r(11),i=r(66);t.exports=r(10)?function(t,n,r){return e.f(t,n,i(1,r))}:function(t,n,r){return t[n]=r,t}},function(t,n,r){var e=r(3),i=r(27),o=r(24),u=r(76)("src"),c="toString",f=Function[c],a=(""+f).split(c);r(52).inspectSource=function(t){return f.call(t)},(t.exports=function(t,n,r,c){var f="function"==typeof r;f&&(o(r,"name")||i(r,"name",n)),t[n]!==r&&(f&&(o(r,u)||i(r,u,t[n]?""+t[n]:a.join(String(n)))),t===e?t[n]=r:c?t[n]?t[n]=r:i(t,n,r):(delete t[n],i(t,n,r)))})(Function.prototype,c,function(){return"function"==typeof this&&this[u]||f.call(this)})},function(t,n,r){var e=r(1),i=r(4),o=r(46),u=function(t,n,r,e){var i=String(o(t)),u="<"+n;return""!==r&&(u+=" "+r+'="'+String(e).replace(/"/g,"&quot;")+'"'),u+">"+i+"</"+n+">"};t.exports=function(t,n){var r={};r[t]=n(u),e(e.P+e.F*i(function(){var n=""[t]('"');return n!==n.toLowerCase()||n.split('"').length>3}),"String",r)}},function(t,n,r){var e=r(115),i=r(46);t.exports=function(t){return e(i(t))}},function(t,n,r){var e=r(116),i=r(66),o=r(30),u=r(50),c=r(24),f=r(167),a=Object.getOwnPropertyDescriptor;n.f=r(10)?a:function(t,n){if(t=o(t),n=u(n,!0),f)try{return a(t,n)}catch(t){}if(c(t,n))return i(!e.f.call(t,n),t[n])}},function(t,n,r){var e=r(24),i=r(17),o=r(145)("IE_PROTO"),u=Object.prototype;t.exports=Object.getPrototypeOf||function(t){return t=i(t),e(t,o)?t[o]:"function"==typeof t.constructor&&t instanceof t.constructor?t.constructor.prototype:t instanceof Object?u:null}},function(t,n){t.exports=function(t){if(void 0==t)throw TypeError("Can't call method on  "+t);return t}},function(t,n){t.exports="constructor,hasOwnProperty,isPrototypeOf,propertyIsEnumerable,toLocaleString,toString,valueOf".split(",")},function(t,n){t.exports={}},function(t,n){t.exports=!0},function(t,n){n.f={}.propertyIsEnumerable},function(t,n,r){var e=r(14).f,i=r(8),o=r(15)("toStringTag");t.exports=function(t,n,r){t&&!i(t=r?t:t.prototype,o)&&e(t,o,{configurable:!0,value:n})}},function(t,n,r){var e=r(40)("keys"),i=r(23);t.exports=function(t){return e[t]||(e[t]=i(t))}},function(t,n,r){var e=r(5),i="__core-js_shared__",o=e[i]||(e[i]={});t.exports=function(t){return o[t]||(o[t]={})}},function(t,n){var r=Math.ceil,e=Math.floor;t.exports=function(t){return isNaN(t=+t)?0:(t>0?e:r)(t)}},function(t,n,r){var e=r(21);t.exports=function(t,n){if(!e(t))return t;var r,i;if(n&&"function"==typeof(r=t.toString)&&!e(i=r.call(t)))return i;if("function"==typeof(r=t.valueOf)&&!e(i=r.call(t)))return i;if(!n&&"function"==typeof(r=t.toString)&&!e(i=r.call(t)))return i;throw TypeError("Can't convert object to primitive value")}},function(t,n,r){var e=r(5),i=r(25),o=r(36),u=r(44),c=r(14).f;t.exports=function(t){var n=i.Symbol||(i.Symbol=o?{}:e.Symbol||{});"_"==t.charAt(0)||t in n||c(n,t,{value:u.f(t)})}},function(t,n,r){n.f=r(15)},function(t,n){var r={}.toString;t.exports=function(t){return r.call(t).slice(8,-1)}},function(t,n){t.exports=function(t){if(void 0==t)throw TypeError("Can't call method on  "+t);return t}},function(t,n,r){var e=r(4);t.exports=function(t,n){return!!t&&e(function(){n?t.call(null,function(){},1):t.call(null)})}},function(t,n,r){var e=r(53),i=r(115),o=r(17),u=r(16),c=r(203);t.exports=function(t,n){var r=1==t,f=2==t,a=3==t,s=4==t,l=6==t,h=5==t||l,v=n||c;return function(n,c,p){for(var d,y,g=o(n),b=i(g),m=e(c,p,3),x=u(b.length),w=0,S=r?v(n,x):f?v(n,0):void 0;x>w;w++)if((h||w in b)&&(d=b[w],y=m(d,w,g),t))if(r)S[w]=y;else if(y)switch(t){case 3:return!0;case 5:return d;case 6:return w;case 2:S.push(d)}else if(s)return!1;return l?-1:a||s?s:S}}},function(t,n,r){var e=r(1),i=r(52),o=r(4);t.exports=function(t,n){var r=(i.Object||{})[t]||Object[t],u={};u[t]=n(r),e(e.S+e.F*o(function(){r(1)}),"Object",u)}},function(t,n,r){var e=r(6);t.exports=function(t,n){if(!e(t))return t;var r,i;if(n&&"function"==typeof(r=t.toString)&&!e(i=r.call(t)))return i;if("function"==typeof(r=t.valueOf)&&!e(i=r.call(t)))return i;if(!n&&"function"==typeof(r=t.toString)&&!e(i=r.call(t)))return i;throw TypeError("Can't convert object to primitive value")}},function(t,n,r){var e=r(5),i=r(25),o=r(91),u=r(13),c="prototype",f=function(t,n,r){var a,s,l,h=t&f.F,v=t&f.G,p=t&f.S,d=t&f.P,y=t&f.B,g=t&f.W,b=v?i:i[n]||(i[n]={}),m=b[c],x=v?e:p?e[n]:(e[n]||{})[c];v&&(r=n);for(a in r)(s=!h&&x&&void 0!==x[a])&&a in b||(l=s?x[a]:r[a],b[a]=v&&"function"!=typeof x[a]?r[a]:y&&s?o(l,e):g&&x[a]==l?function(t){var n=function(n,r,e){if(this instanceof t){switch(arguments.length){case 0:return new t;case 1:return new t(n);case 2:return new t(n,r)}return new t(n,r,e)}return t.apply(this,arguments)};return n[c]=t[c],n}(l):d&&"function"==typeof l?o(Function.call,l):l,d&&((b.virtual||(b.virtual={}))[a]=l,t&f.R&&m&&!m[a]&&u(m,a,l)))};f.F=1,f.G=2,f.S=4,f.P=8,f.B=16,f.W=32,f.U=64,f.R=128,t.exports=f},function(t,n){var r=t.exports={version:"2.4.0"};"number"==typeof __e&&(__e=r)},function(t,n,r){var e=r(26);t.exports=function(t,n,r){if(e(t),void 0===n)return t;switch(r){case 1:return function(r){return t.call(n,r)};case 2:return function(r,e){return t.call(n,r,e)};case 3:return function(r,e,i){return t.call(n,r,e,i)}}return function(){return t.apply(n,arguments)}}},function(t,n,r){var e=r(183),i=r(1),o=r(126)("metadata"),u=o.store||(o.store=new(r(186))),c=function(t,n,r){var i=u.get(t);if(!i){if(!r)return;u.set(t,i=new e)}var o=i.get(n);if(!o){if(!r)return;i.set(n,o=new e)}return o},f=function(t,n,r){var e=c(n,r,!1);return void 0!==e&&e.has(t)},a=function(t,n,r){var e=c(n,r,!1);return void 0===e?void 0:e.get(t)},s=function(t,n,r,e){c(r,e,!0).set(t,n)},l=function(t,n){var r=c(t,n,!1),e=[];return r&&r.forEach(function(t,n){e.push(n)}),e},h=function(t){return void 0===t||"symbol"==typeof t?t:String(t)},v=function(t){i(i.S,"Reflect",t)};t.exports={store:u,map:c,has:f,get:a,set:s,keys:l,key:h,exp:v}},function(t,n,r){"use strict";if(r(10)){var e=r(69),i=r(3),o=r(4),u=r(1),c=r(127),f=r(152),a=r(53),s=r(68),l=r(66),h=r(27),v=r(73),p=r(67),d=r(16),y=r(75),g=r(50),b=r(24),m=r(180),x=r(114),w=r(6),S=r(17),_=r(137),O=r(70),E=r(32),P=r(71).f,j=r(154),F=r(76),M=r(7),A=r(48),N=r(117),T=r(146),I=r(155),k=r(80),L=r(123),R=r(74),C=r(130),D=r(160),U=r(11),W=r(31),G=U.f,B=W.f,V=i.RangeError,z=i.TypeError,q=i.Uint8Array,K="ArrayBuffer",J="Shared"+K,Y="BYTES_PER_ELEMENT",H="prototype",$=Array[H],X=f.ArrayBuffer,Q=f.DataView,Z=A(0),tt=A(2),nt=A(3),rt=A(4),et=A(5),it=A(6),ot=N(!0),ut=N(!1),ct=I.values,ft=I.keys,at=I.entries,st=$.lastIndexOf,lt=$.reduce,ht=$.reduceRight,vt=$.join,pt=$.sort,dt=$.slice,yt=$.toString,gt=$.toLocaleString,bt=M("iterator"),mt=M("toStringTag"),xt=F("typed_constructor"),wt=F("def_constructor"),St=c.CONSTR,_t=c.TYPED,Ot=c.VIEW,Et="Wrong length!",Pt=A(1,function(t,n){return Tt(T(t,t[wt]),n)}),jt=o(function(){return 1===new q(new Uint16Array([1]).buffer)[0]}),Ft=!!q&&!!q[H].set&&o(function(){new q(1).set({})}),Mt=function(t,n){if(void 0===t)throw z(Et);var r=+t,e=d(t);if(n&&!m(r,e))throw V(Et);return e},At=function(t,n){var r=p(t);if(r<0||r%n)throw V("Wrong offset!");return r},Nt=function(t){if(w(t)&&_t in t)return t;throw z(t+" is not a typed array!")},Tt=function(t,n){if(!(w(t)&&xt in t))throw z("It is not a typed array constructor!");return new t(n)},It=function(t,n){return kt(T(t,t[wt]),n)},kt=function(t,n){for(var r=0,e=n.length,i=Tt(t,e);e>r;)i[r]=n[r++];return i},Lt=function(t,n,r){G(t,n,{get:function(){return this._d[r]}})},Rt=function(t){var n,r,e,i,o,u,c=S(t),f=arguments.length,s=f>1?arguments[1]:void 0,l=void 0!==s,h=j(c);if(void 0!=h&&!_(h)){for(u=h.call(c),e=[],n=0;!(o=u.next()).done;n++)e.push(o.value);c=e}for(l&&f>2&&(s=a(s,arguments[2],2)),n=0,r=d(c.length),i=Tt(this,r);r>n;n++)i[n]=l?s(c[n],n):c[n];return i},Ct=function(){for(var t=0,n=arguments.length,r=Tt(this,n);n>t;)r[t]=arguments[t++];return r},Dt=!!q&&o(function(){gt.call(new q(1))}),Ut=function(){return gt.apply(Dt?dt.call(Nt(this)):Nt(this),arguments)},Wt={copyWithin:function(t,n){return D.call(Nt(this),t,n,arguments.length>2?arguments[2]:void 0)},every:function(t){return rt(Nt(this),t,arguments.length>1?arguments[1]:void 0)},fill:function(t){return C.apply(Nt(this),arguments)},filter:function(t){return It(this,tt(Nt(this),t,arguments.length>1?arguments[1]:void 0))},find:function(t){return et(Nt(this),t,arguments.length>1?arguments[1]:void 0)},findIndex:function(t){return it(Nt(this),t,arguments.length>1?arguments[1]:void 0)},forEach:function(t){Z(Nt(this),t,arguments.length>1?arguments[1]:void 0)},indexOf:function(t){return ut(Nt(this),t,arguments.length>1?arguments[1]:void 0)},includes:function(t){return ot(Nt(this),t,arguments.length>1?arguments[1]:void 0)},join:function(t){return vt.apply(Nt(this),arguments)},lastIndexOf:function(t){return st.apply(Nt(this),arguments)},map:function(t){return Pt(Nt(this),t,arguments.length>1?arguments[1]:void 0)},reduce:function(t){return lt.apply(Nt(this),arguments)},reduceRight:function(t){return ht.apply(Nt(this),arguments)},reverse:function(){for(var t,n=this,r=Nt(n).length,e=Math.floor(r/2),i=0;i<e;)t=n[i],n[i++]=n[--r],n[r]=t;return n},some:function(t){return nt(Nt(this),t,arguments.length>1?arguments[1]:void 0)},sort:function(t){return pt.call(Nt(this),t)},subarray:function(t,n){var r=Nt(this),e=r.length,i=y(t,e);return new(T(r,r[wt]))(r.buffer,r.byteOffset+i*r.BYTES_PER_ELEMENT,d((void 0===n?e:y(n,e))-i))}},Gt=function(t,n){return It(this,dt.call(Nt(this),t,n))},Bt=function(t){Nt(this);var n=At(arguments[1],1),r=this.length,e=S(t),i=d(e.length),o=0;if(i+n>r)throw V(Et);for(;o<i;)this[n+o]=e[o++]},Vt={entries:function(){return at.call(Nt(this))},keys:function(){return ft.call(Nt(this))},values:function(){return ct.call(Nt(this))}},zt=function(t,n){return w(t)&&t[_t]&&"symbol"!=typeof n&&n in t&&String(+n)==String(n)},qt=function(t,n){return zt(t,n=g(n,!0))?l(2,t[n]):B(t,n)},Kt=function(t,n,r){return!(zt(t,n=g(n,!0))&&w(r)&&b(r,"value"))||b(r,"get")||b(r,"set")||r.configurable||b(r,"writable")&&!r.writable||b(r,"enumerable")&&!r.enumerable?G(t,n,r):(t[n]=r.value,t)};St||(W.f=qt,U.f=Kt),u(u.S+u.F*!St,"Object",{getOwnPropertyDescriptor:qt,defineProperty:Kt}),o(function(){yt.call({})})&&(yt=gt=function(){return vt.call(this)});var Jt=v({},Wt);v(Jt,Vt),h(Jt,bt,Vt.values),v(Jt,{slice:Gt,set:Bt,constructor:function(){},toString:yt,toLocaleString:Ut}),Lt(Jt,"buffer","b"),Lt(Jt,"byteOffset","o"),Lt(Jt,"byteLength","l"),Lt(Jt,"length","e"),G(Jt,mt,{get:function(){return this[_t]}}),t.exports=function(t,n,r,f){f=!!f;var a=t+(f?"Clamped":"")+"Array",l="Uint8Array"!=a,v="get"+t,p="set"+t,y=i[a],g=y||{},b=y&&E(y),m=!y||!c.ABV,S={},_=y&&y[H],j=function(t,r){var e=t._d;return e.v[v](r*n+e.o,jt)},F=function(t,r,e){var i=t._d;f&&(e=(e=Math.round(e))<0?0:e>255?255:255&e),i.v[p](r*n+i.o,e,jt)},M=function(t,n){G(t,n,{get:function(){return j(this,n)},set:function(t){return F(this,n,t)},enumerable:!0})};m?(y=r(function(t,r,e,i){s(t,y,a,"_d");var o,u,c,f,l=0,v=0;if(w(r)){if(!(r instanceof X||(f=x(r))==K||f==J))return _t in r?kt(y,r):Rt.call(y,r);o=r,v=At(e,n);var p=r.byteLength;if(void 0===i){if(p%n)throw V(Et);if((u=p-v)<0)throw V(Et)}else if((u=d(i)*n)+v>p)throw V(Et);c=u/n}else c=Mt(r,!0),u=c*n,o=new X(u);for(h(t,"_d",{b:o,o:v,l:u,e:c,v:new Q(o)});l<c;)M(t,l++)}),_=y[H]=O(Jt),h(_,"constructor",y)):L(function(t){new y(null),new y(t)},!0)||(y=r(function(t,r,e,i){s(t,y,a);var o;return w(r)?r instanceof X||(o=x(r))==K||o==J?void 0!==i?new g(r,At(e,n),i):void 0!==e?new g(r,At(e,n)):new g(r):_t in r?kt(y,r):Rt.call(y,r):new g(Mt(r,l))}),Z(b!==Function.prototype?P(g).concat(P(b)):P(g),function(t){t in y||h(y,t,g[t])}),y[H]=_,e||(_.constructor=y));var A=_[bt],N=!!A&&("values"==A.name||void 0==A.name),T=Vt.values;h(y,xt,!0),h(_,_t,a),h(_,Ot,!0),h(_,wt,y),(f?new y(1)[mt]==a:mt in _)||G(_,mt,{get:function(){return a}}),S[a]=y,u(u.G+u.W+u.F*(y!=g),S),u(u.S,a,{BYTES_PER_ELEMENT:n,from:Rt,of:Ct}),Y in _||h(_,Y,n),u(u.P,a,Wt),R(a),u(u.P+u.F*Ft,a,{set:Bt}),u(u.P+u.F*!N,a,Vt),u(u.P+u.F*(_.toString!=yt),a,{toString:yt}),u(u.P+u.F*o(function(){new y(1).slice()}),a,{slice:Gt}),u(u.P+u.F*(o(function(){return[1,2].toLocaleString()!=new y([1,2]).toLocaleString()})||!o(function(){_.toLocaleString.call([1,2])})),a,{toLocaleString:Ut}),k[a]=N?A:T,e||N||h(_,bt,T)}}else t.exports=function(){}},function(t,n){var r={}.toString;t.exports=function(t){return r.call(t).slice(8,-1)}},function(t,n,r){var e=r(21),i=r(5).document,o=e(i)&&e(i.createElement);t.exports=function(t){return o?i.createElement(t):{}}},function(t,n,r){t.exports=!r(12)&&!r(18)(function(){return 7!=Object.defineProperty(r(57)("div"),"a",{get:function(){return 7}}).a})},function(t,n,r){"use strict";var e=r(36),i=r(51),o=r(64),u=r(13),c=r(8),f=r(35),a=r(96),s=r(38),l=r(103),h=r(15)("iterator"),v=!([].keys&&"next"in[].keys()),p="keys",d="values",y=function(){return this};t.exports=function(t,n,r,g,b,m,x){a(r,n,g);var w,S,_,O=function(t){if(!v&&t in F)return F[t];switch(t){case p:case d:return function(){return new r(this,t)}}return function(){return new r(this,t)}},E=n+" Iterator",P=b==d,j=!1,F=t.prototype,M=F[h]||F["@@iterator"]||b&&F[b],A=M||O(b),N=b?P?O("entries"):A:void 0,T="Array"==n?F.entries||M:M;if(T&&(_=l(T.call(new t)))!==Object.prototype&&(s(_,E,!0),e||c(_,h)||u(_,h,y)),P&&M&&M.name!==d&&(j=!0,A=function(){return M.call(this)}),e&&!x||!v&&!j&&F[h]||u(F,h,A),f[n]=A,f[E]=y,b)if(w={values:P?A:O(d),keys:m?A:O(p),entries:N},x)for(S in w)S in F||o(F,S,w[S]);else i(i.P+i.F*(v||j),n,w);return w}},function(t,n,r){var e=r(20),i=r(100),o=r(34),u=r(39)("IE_PROTO"),c=function(){},f="prototype",a=function(){var t,n=r(57)("iframe"),e=o.length;for(n.style.display="none",r(93).appendChild(n),n.src="javascript:",t=n.contentWindow.document,t.open(),t.write("<script>document.F=Object<\/script>"),t.close(),a=t.F;e--;)delete a[f][o[e]];return a()};t.exports=Object.create||function(t,n){var r;return null!==t?(c[f]=e(t),r=new c,c[f]=null,r[u]=t):r=a(),void 0===n?r:i(r,n)}},function(t,n,r){var e=r(63),i=r(34).concat("length","prototype");n.f=Object.getOwnPropertyNames||function(t){return e(t,i)}},function(t,n){n.f=Object.getOwnPropertySymbols},function(t,n,r){var e=r(8),i=r(9),o=r(90)(!1),u=r(39)("IE_PROTO");t.exports=function(t,n){var r,c=i(t),f=0,a=[];for(r in c)r!=u&&e(c,r)&&a.push(r);for(;n.length>f;)e(c,r=n[f++])&&(~o(a,r)||a.push(r));return a}},function(t,n,r){t.exports=r(13)},function(t,n,r){var e=r(76)("meta"),i=r(6),o=r(24),u=r(11).f,c=0,f=Object.isExtensible||function(){return!0},a=!r(4)(function(){return f(Object.preventExtensions({}))}),s=function(t){u(t,e,{value:{i:"O"+ ++c,w:{}}})},l=function(t,n){if(!i(t))return"symbol"==typeof t?t:("string"==typeof t?"S":"P")+t;if(!o(t,e)){if(!f(t))return"F";if(!n)return"E";s(t)}return t[e].i},h=function(t,n){if(!o(t,e)){if(!f(t))return!0;if(!n)return!1;s(t)}return t[e].w},v=function(t){return a&&p.NEED&&f(t)&&!o(t,e)&&s(t),t},p=t.exports={KEY:e,NEED:!1,fastKey:l,getWeak:h,onFreeze:v}},function(t,n){t.exports=function(t,n){return{enumerable:!(1&t),configurable:!(2&t),writable:!(4&t),value:n}}},function(t,n){var r=Math.ceil,e=Math.floor;t.exports=function(t){return isNaN(t=+t)?0:(t>0?e:r)(t)}},function(t,n){t.exports=function(t,n,r,e){if(!(t instanceof n)||void 0!==e&&e in t)throw TypeError(r+": incorrect invocation!");return t}},function(t,n){t.exports=!1},function(t,n,r){var e=r(2),i=r(173),o=r(133),u=r(145)("IE_PROTO"),c=function(){},f="prototype",a=function(){var t,n=r(132)("iframe"),e=o.length;for(n.style.display="none",r(135).appendChild(n),n.src="javascript:",t=n.contentWindow.document,t.open(),t.write("<script>document.F=Object<\/script>"),t.close(),a=t.F;e--;)delete a[f][o[e]];return a()};t.exports=Object.create||function(t,n){var r;return null!==t?(c[f]=e(t),r=new c,c[f]=null,r[u]=t):r=a(),void 0===n?r:i(r,n)}},function(t,n,r){var e=r(175),i=r(133).concat("length","prototype");n.f=Object.getOwnPropertyNames||function(t){return e(t,i)}},function(t,n,r){var e=r(175),i=r(133);t.exports=Object.keys||function(t){return e(t,i)}},function(t,n,r){var e=r(28);t.exports=function(t,n,r){for(var i in n)e(t,i,n[i],r);return t}},function(t,n,r){"use strict";var e=r(3),i=r(11),o=r(10),u=r(7)("species");t.exports=function(t){var n=e[t];o&&n&&!n[u]&&i.f(n,u,{configurable:!0,get:function(){return this}})}},function(t,n,r){var e=r(67),i=Math.max,o=Math.min;t.exports=function(t,n){return t=e(t),t<0?i(t+n,0):o(t,n)}},function(t,n){var r=0,e=Math.random();t.exports=function(t){return"Symbol(".concat(void 0===t?"":t,")_",(++r+e).toString(36))}},function(t,n,r){var e=r(33);t.exports=function(t){return Object(e(t))}},function(t,n,r){var e=r(7)("unscopables"),i=Array.prototype;void 0==i[e]&&r(27)(i,e,{}),t.exports=function(t){i[e][t]=!0}},function(t,n,r){var e=r(53),i=r(169),o=r(137),u=r(2),c=r(16),f=r(154),a={},s={},n=t.exports=function(t,n,r,l,h){var v,p,d,y,g=h?function(){return t}:f(t),b=e(r,l,n?2:1),m=0;if("function"!=typeof g)throw TypeError(t+" is not iterable!");if(o(g)){for(v=c(t.length);v>m;m++)if((y=n?b(u(p=t[m])[0],p[1]):b(t[m]))===a||y===s)return y}else for(d=g.call(t);!(p=d.next()).done;)if((y=i(d,b,p.value,n))===a||y===s)return y};n.BREAK=a,n.RETURN=s},function(t,n){t.exports={}},function(t,n,r){var e=r(11).f,i=r(24),o=r(7)("toStringTag");t.exports=function(t,n,r){t&&!i(t=r?t:t.prototype,o)&&e(t,o,{configurable:!0,value:n})}},function(t,n,r){var e=r(1),i=r(46),o=r(4),u=r(150),c="["+u+"]",f="​",a=RegExp("^"+c+c+"*"),s=RegExp(c+c+"*$"),l=function(t,n,r){var i={},c=o(function(){return!!u[t]()||f[t]()!=f}),a=i[t]=c?n(h):u[t];r&&(i[r]=a),e(e.P+e.F*c,"String",i)},h=l.trim=function(t,n){return t=String(i(t)),1&n&&(t=t.replace(a,"")),2&n&&(t=t.replace(s,"")),t};t.exports=l},function(t,n,r){t.exports={default:r(86),__esModule:!0}},function(t,n,r){t.exports={default:r(87),__esModule:!0}},function(t,n,r){"use strict";function e(t){return t&&t.__esModule?t:{default:t}}n.__esModule=!0;var i=r(84),o=e(i),u=r(83),c=e(u),f="function"==typeof c.default&&"symbol"==typeof o.default?function(t){return typeof t}:function(t){return t&&"function"==typeof c.default&&t.constructor===c.default&&t!==c.default.prototype?"symbol":typeof t};n.default="function"==typeof c.default&&"symbol"===f(o.default)?function(t){return void 0===t?"undefined":f(t)}:function(t){return t&&"function"==typeof c.default&&t.constructor===c.default&&t!==c.default.prototype?"symbol":void 0===t?"undefined":f(t)}},function(t,n,r){r(110),r(108),r(111),r(112),t.exports=r(25).Symbol},function(t,n,r){r(109),r(113),t.exports=r(44).f("iterator")},function(t,n){t.exports=function(t){if("function"!=typeof t)throw TypeError(t+" is not a function!");return t}},function(t,n){t.exports=function(){}},function(t,n,r){var e=r(9),i=r(106),o=r(105);t.exports=function(t){return function(n,r,u){var c,f=e(n),a=i(f.length),s=o(u,a);if(t&&r!=r){for(;a>s;)if((c=f[s++])!=c)return!0}else for(;a>s;s++)if((t||s in f)&&f[s]===r)return t||s||0;return!t&&-1}}},function(t,n,r){var e=r(88);t.exports=function(t,n,r){if(e(t),void 0===n)return t;switch(r){case 1:return function(r){return t.call(n,r)};case 2:return function(r,e){return t.call(n,r,e)};case 3:return function(r,e,i){return t.call(n,r,e,i)}}return function(){return t.apply(n,arguments)}}},function(t,n,r){var e=r(19),i=r(62),o=r(37);t.exports=function(t){var n=e(t),r=i.f;if(r)for(var u,c=r(t),f=o.f,a=0;c.length>a;)f.call(t,u=c[a++])&&n.push(u);return n}},function(t,n,r){t.exports=r(5).document&&document.documentElement},function(t,n,r){var e=r(56);t.exports=Object("z").propertyIsEnumerable(0)?Object:function(t){return"String"==e(t)?t.split(""):Object(t)}},function(t,n,r){var e=r(56);t.exports=Array.isArray||function(t){return"Array"==e(t)}},function(t,n,r){"use strict";var e=r(60),i=r(22),o=r(38),u={};r(13)(u,r(15)("iterator"),function(){return this}),t.exports=function(t,n,r){t.prototype=e(u,{next:i(1,r)}),o(t,n+" Iterator")}},function(t,n){t.exports=function(t,n){return{value:n,done:!!t}}},function(t,n,r){var e=r(19),i=r(9);t.exports=function(t,n){for(var r,o=i(t),u=e(o),c=u.length,f=0;c>f;)if(o[r=u[f++]]===n)return r}},function(t,n,r){var e=r(23)("meta"),i=r(21),o=r(8),u=r(14).f,c=0,f=Object.isExtensible||function(){return!0},a=!r(18)(function(){return f(Object.preventExtensions({}))}),s=function(t){u(t,e,{value:{i:"O"+ ++c,w:{}}})},l=function(t,n){if(!i(t))return"symbol"==typeof t?t:("string"==typeof t?"S":"P")+t;if(!o(t,e)){if(!f(t))return"F";if(!n)return"E";s(t)}return t[e].i},h=function(t,n){if(!o(t,e)){if(!f(t))return!0;if(!n)return!1;s(t)}return t[e].w},v=function(t){return a&&p.NEED&&f(t)&&!o(t,e)&&s(t),t},p=t.exports={KEY:e,NEED:!1,fastKey:l,getWeak:h,onFreeze:v}},function(t,n,r){var e=r(14),i=r(20),o=r(19);t.exports=r(12)?Object.defineProperties:function(t,n){i(t);for(var r,u=o(n),c=u.length,f=0;c>f;)e.f(t,r=u[f++],n[r]);return t}},function(t,n,r){var e=r(37),i=r(22),o=r(9),u=r(42),c=r(8),f=r(58),a=Object.getOwnPropertyDescriptor;n.f=r(12)?a:function(t,n){if(t=o(t),n=u(n,!0),f)try{return a(t,n)}catch(t){}if(c(t,n))return i(!e.f.call(t,n),t[n])}},function(t,n,r){var e=r(9),i=r(61).f,o={}.toString,u="object"==typeof window&&window&&Object.getOwnPropertyNames?Object.getOwnPropertyNames(window):[],c=function(t){try{return i(t)}catch(t){return u.slice()}};t.exports.f=function(t){return u&&"[object Window]"==o.call(t)?c(t):i(e(t))}},function(t,n,r){var e=r(8),i=r(77),o=r(39)("IE_PROTO"),u=Object.prototype;t.exports=Object.getPrototypeOf||function(t){return t=i(t),e(t,o)?t[o]:"function"==typeof t.constructor&&t instanceof t.constructor?t.constructor.prototype:t instanceof Object?u:null}},function(t,n,r){var e=r(41),i=r(33);t.exports=function(t){return function(n,r){var o,u,c=String(i(n)),f=e(r),a=c.length;return f<0||f>=a?t?"":void 0:(o=c.charCodeAt(f),o<55296||o>56319||f+1===a||(u=c.charCodeAt(f+1))<56320||u>57343?t?c.charAt(f):o:t?c.slice(f,f+2):u-56320+(o-55296<<10)+65536)}}},function(t,n,r){var e=r(41),i=Math.max,o=Math.min;t.exports=function(t,n){return t=e(t),t<0?i(t+n,0):o(t,n)}},function(t,n,r){var e=r(41),i=Math.min;t.exports=function(t){return t>0?i(e(t),9007199254740991):0}},function(t,n,r){"use strict";var e=r(89),i=r(97),o=r(35),u=r(9);t.exports=r(59)(Array,"Array",function(t,n){this._t=u(t),this._i=0,this._k=n},function(){var t=this._t,n=this._k,r=this._i++;return!t||r>=t.length?(this._t=void 0,i(1)):"keys"==n?i(0,r):"values"==n?i(0,t[r]):i(0,[r,t[r]])},"values"),o.Arguments=o.Array,e("keys"),e("values"),e("entries")},function(t,n){},function(t,n,r){"use strict";var e=r(104)(!0);r(59)(String,"String",function(t){this._t=String(t),this._i=0},function(){var t,n=this._t,r=this._i;return r>=n.length?{value:void 0,done:!0}:(t=e(n,r),this._i+=t.length,{value:t,done:!1})})},function(t,n,r){"use strict";var e=r(5),i=r(8),o=r(12),u=r(51),c=r(64),f=r(99).KEY,a=r(18),s=r(40),l=r(38),h=r(23),v=r(15),p=r(44),d=r(43),y=r(98),g=r(92),b=r(95),m=r(20),x=r(9),w=r(42),S=r(22),_=r(60),O=r(102),E=r(101),P=r(14),j=r(19),F=E.f,M=P.f,A=O.f,N=e.Symbol,T=e.JSON,I=T&&T.stringify,k="prototype",L=v("_hidden"),R=v("toPrimitive"),C={}.propertyIsEnumerable,D=s("symbol-registry"),U=s("symbols"),W=s("op-symbols"),G=Object[k],B="function"==typeof N,V=e.QObject,z=!V||!V[k]||!V[k].findChild,q=o&&a(function(){return 7!=_(M({},"a",{get:function(){return M(this,"a",{value:7}).a}})).a})?function(t,n,r){var e=F(G,n);e&&delete G[n],M(t,n,r),e&&t!==G&&M(G,n,e)}:M,K=function(t){var n=U[t]=_(N[k]);return n._k=t,n},J=B&&"symbol"==typeof N.iterator?function(t){return"symbol"==typeof t}:function(t){return t instanceof N},Y=function(t,n,r){return t===G&&Y(W,n,r),m(t),n=w(n,!0),m(r),i(U,n)?(r.enumerable?(i(t,L)&&t[L][n]&&(t[L][n]=!1),r=_(r,{enumerable:S(0,!1)})):(i(t,L)||M(t,L,S(1,{})),t[L][n]=!0),q(t,n,r)):M(t,n,r)},H=function(t,n){m(t);for(var r,e=g(n=x(n)),i=0,o=e.length;o>i;)Y(t,r=e[i++],n[r]);return t},$=function(t,n){return void 0===n?_(t):H(_(t),n)},X=function(t){var n=C.call(this,t=w(t,!0));return!(this===G&&i(U,t)&&!i(W,t))&&(!(n||!i(this,t)||!i(U,t)||i(this,L)&&this[L][t])||n)},Q=function(t,n){if(t=x(t),n=w(n,!0),t!==G||!i(U,n)||i(W,n)){var r=F(t,n);return!r||!i(U,n)||i(t,L)&&t[L][n]||(r.enumerable=!0),r}},Z=function(t){for(var n,r=A(x(t)),e=[],o=0;r.length>o;)i(U,n=r[o++])||n==L||n==f||e.push(n);return e},tt=function(t){for(var n,r=t===G,e=A(r?W:x(t)),o=[],u=0;e.length>u;)!i(U,n=e[u++])||r&&!i(G,n)||o.push(U[n]);return o};B||(N=function(){if(this instanceof N)throw TypeError("Symbol is not a constructor!");var t=h(arguments.length>0?arguments[0]:void 0),n=function(r){this===G&&n.call(W,r),i(this,L)&&i(this[L],t)&&(this[L][t]=!1),q(this,t,S(1,r))};return o&&z&&q(G,t,{configurable:!0,set:n}),K(t)},c(N[k],"toString",function(){return this._k}),E.f=Q,P.f=Y,r(61).f=O.f=Z,r(37).f=X,r(62).f=tt,o&&!r(36)&&c(G,"propertyIsEnumerable",X,!0),p.f=function(t){return K(v(t))}),u(u.G+u.W+u.F*!B,{Symbol:N});for(var nt="hasInstance,isConcatSpreadable,iterator,match,replace,search,species,split,toPrimitive,toStringTag,unscopables".split(","),rt=0;nt.length>rt;)v(nt[rt++]);for(var nt=j(v.store),rt=0;nt.length>rt;)d(nt[rt++]);u(u.S+u.F*!B,"Symbol",{for:function(t){return i(D,t+="")?D[t]:D[t]=N(t)},keyFor:function(t){if(J(t))return y(D,t);throw TypeError(t+" is not a symbol!")},useSetter:function(){z=!0},useSimple:function(){z=!1}}),u(u.S+u.F*!B,"Object",{create:$,defineProperty:Y,defineProperties:H,getOwnPropertyDescriptor:Q,getOwnPropertyNames:Z,getOwnPropertySymbols:tt}),T&&u(u.S+u.F*(!B||a(function(){var t=N();return"[null]"!=I([t])||"{}"!=I({a:t})||"{}"!=I(Object(t))})),"JSON",{stringify:function(t){if(void 0!==t&&!J(t)){for(var n,r,e=[t],i=1;arguments.length>i;)e.push(arguments[i++]);return n=e[1],"function"==typeof n&&(r=n),!r&&b(n)||(n=function(t,n){if(r&&(n=r.call(this,t,n)),!J(n))return n}),e[1]=n,I.apply(T,e)}}}),N[k][R]||r(13)(N[k],R,N[k].valueOf),l(N,"Symbol"),l(Math,"Math",!0),l(e.JSON,"JSON",!0)},function(t,n,r){r(43)("asyncIterator")},function(t,n,r){r(43)("observable")},function(t,n,r){r(107);for(var e=r(5),i=r(13),o=r(35),u=r(15)("toStringTag"),c=["NodeList","DOMTokenList","MediaList","StyleSheetList","CSSRuleList"],f=0;f<5;f++){var a=c[f],s=e[a],l=s&&s.prototype;l&&!l[u]&&i(l,u,a),o[a]=o.Array}},function(t,n,r){var e=r(45),i=r(7)("toStringTag"),o="Arguments"==e(function(){return arguments}()),u=function(t,n){try{return t[n]}catch(t){}};t.exports=function(t){var n,r,c;return void 0===t?"Undefined":null===t?"Null":"string"==typeof(r=u(n=Object(t),i))?r:o?e(n):"Object"==(c=e(n))&&"function"==typeof n.callee?"Arguments":c}},function(t,n,r){var e=r(45);t.exports=Object("z").propertyIsEnumerable(0)?Object:function(t){return"String"==e(t)?t.split(""):Object(t)}},function(t,n){n.f={}.propertyIsEnumerable},function(t,n,r){var e=r(30),i=r(16),o=r(75);t.exports=function(t){return function(n,r,u){var c,f=e(n),a=i(f.length),s=o(u,a);if(t&&r!=r){for(;a>s;)if((c=f[s++])!=c)return!0}else for(;a>s;s++)if((t||s in f)&&f[s]===r)return t||s||0;return!t&&-1}}},function(t,n,r){"use strict";var e=r(3),i=r(1),o=r(28),u=r(73),c=r(65),f=r(79),a=r(68),s=r(6),l=r(4),h=r(123),v=r(81),p=r(136);t.exports=function(t,n,r,d,y,g){var b=e[t],m=b,x=y?"set":"add",w=m&&m.prototype,S={},_=function(t){var n=w[t];o(w,t,"delete"==t?function(t){return!(g&&!s(t))&&n.call(this,0===t?0:t)}:"has"==t?function(t){return!(g&&!s(t))&&n.call(this,0===t?0:t)}:"get"==t?function(t){return g&&!s(t)?void 0:n.call(this,0===t?0:t)}:"add"==t?function(t){return n.call(this,0===t?0:t),this}:function(t,r){return n.call(this,0===t?0:t,r),this})};if("function"==typeof m&&(g||w.forEach&&!l(function(){(new m).entries().next()}))){var O=new m,E=O[x](g?{}:-0,1)!=O,P=l(function(){O.has(1)}),j=h(function(t){new m(t)}),F=!g&&l(function(){for(var t=new m,n=5;n--;)t[x](n,n);return!t.has(-0)});j||(m=n(function(n,r){a(n,m,t);var e=p(new b,n,m);return void 0!=r&&f(r,y,e[x],e),e}),m.prototype=w,w.constructor=m),(P||F)&&(_("delete"),_("has"),y&&_("get")),(F||E)&&_(x),g&&w.clear&&delete w.clear}else m=d.getConstructor(n,t,y,x),u(m.prototype,r),c.NEED=!0;return v(m,t),S[t]=m,i(i.G+i.W+i.F*(m!=b),S),g||d.setStrong(m,t,y),m}},function(t,n,r){"use strict";var e=r(27),i=r(28),o=r(4),u=r(46),c=r(7);t.exports=function(t,n,r){var f=c(t),a=r(u,f,""[t]),s=a[0],l=a[1];o(function(){var n={};return n[f]=function(){return 7},7!=""[t](n)})&&(i(String.prototype,t,s),e(RegExp.prototype,f,2==n?function(t,n){return l.call(t,this,n)}:function(t){return l.call(t,this)}))}
},function(t,n,r){"use strict";var e=r(2);t.exports=function(){var t=e(this),n="";return t.global&&(n+="g"),t.ignoreCase&&(n+="i"),t.multiline&&(n+="m"),t.unicode&&(n+="u"),t.sticky&&(n+="y"),n}},function(t,n){t.exports=function(t,n,r){var e=void 0===r;switch(n.length){case 0:return e?t():t.call(r);case 1:return e?t(n[0]):t.call(r,n[0]);case 2:return e?t(n[0],n[1]):t.call(r,n[0],n[1]);case 3:return e?t(n[0],n[1],n[2]):t.call(r,n[0],n[1],n[2]);case 4:return e?t(n[0],n[1],n[2],n[3]):t.call(r,n[0],n[1],n[2],n[3])}return t.apply(r,n)}},function(t,n,r){var e=r(6),i=r(45),o=r(7)("match");t.exports=function(t){var n;return e(t)&&(void 0!==(n=t[o])?!!n:"RegExp"==i(t))}},function(t,n,r){var e=r(7)("iterator"),i=!1;try{var o=[7][e]();o.return=function(){i=!0},Array.from(o,function(){throw 2})}catch(t){}t.exports=function(t,n){if(!n&&!i)return!1;var r=!1;try{var o=[7],u=o[e]();u.next=function(){return{done:r=!0}},o[e]=function(){return u},t(o)}catch(t){}return r}},function(t,n,r){t.exports=r(69)||!r(4)(function(){var t=Math.random();__defineSetter__.call(null,t,function(){}),delete r(3)[t]})},function(t,n){n.f=Object.getOwnPropertySymbols},function(t,n,r){var e=r(3),i="__core-js_shared__",o=e[i]||(e[i]={});t.exports=function(t){return o[t]||(o[t]={})}},function(t,n,r){for(var e,i=r(3),o=r(27),u=r(76),c=u("typed_array"),f=u("view"),a=!(!i.ArrayBuffer||!i.DataView),s=a,l=0,h="Int8Array,Uint8Array,Uint8ClampedArray,Int16Array,Uint16Array,Int32Array,Uint32Array,Float32Array,Float64Array".split(",");l<9;)(e=i[h[l++]])?(o(e.prototype,c,!0),o(e.prototype,f,!0)):s=!1;t.exports={ABV:a,CONSTR:s,TYPED:c,VIEW:f}},function(t,n){"use strict";var r={versions:function(){var t=window.navigator.userAgent;return{trident:t.indexOf("Trident")>-1,presto:t.indexOf("Presto")>-1,webKit:t.indexOf("AppleWebKit")>-1,gecko:t.indexOf("Gecko")>-1&&-1==t.indexOf("KHTML"),mobile:!!t.match(/AppleWebKit.*Mobile.*/),ios:!!t.match(/\(i[^;]+;( U;)? CPU.+Mac OS X/),android:t.indexOf("Android")>-1||t.indexOf("Linux")>-1,iPhone:t.indexOf("iPhone")>-1||t.indexOf("Mac")>-1,iPad:t.indexOf("iPad")>-1,webApp:-1==t.indexOf("Safari"),weixin:-1==t.indexOf("MicroMessenger")}}()};t.exports=r},function(t,n,r){"use strict";var e=r(85),i=function(t){return t&&t.__esModule?t:{default:t}}(e),o=function(){function t(t,n,e){return n||e?String.fromCharCode(n||e):r[t]||t}function n(t){return e[t]}var r={"&quot;":'"',"&lt;":"<","&gt;":">","&amp;":"&","&nbsp;":" "},e={};for(var u in r)e[r[u]]=u;return r["&apos;"]="'",e["'"]="&#39;",{encode:function(t){return t?(""+t).replace(/['<> "&]/g,n).replace(/\r?\n/g,"<br/>").replace(/\s/g,"&nbsp;"):""},decode:function(n){return n?(""+n).replace(/<br\s*\/?>/gi,"\n").replace(/&quot;|&lt;|&gt;|&amp;|&nbsp;|&apos;|&#(\d+);|&#(\d+)/g,t).replace(/\u00a0/g," "):""},encodeBase16:function(t){if(!t)return t;t+="";for(var n=[],r=0,e=t.length;e>r;r++)n.push(t.charCodeAt(r).toString(16).toUpperCase());return n.join("")},encodeBase16forJSON:function(t){if(!t)return t;t=t.replace(/[\u4E00-\u9FBF]/gi,function(t){return escape(t).replace("%u","\\u")});for(var n=[],r=0,e=t.length;e>r;r++)n.push(t.charCodeAt(r).toString(16).toUpperCase());return n.join("")},decodeBase16:function(t){if(!t)return t;t+="";for(var n=[],r=0,e=t.length;e>r;r+=2)n.push(String.fromCharCode("0x"+t.slice(r,r+2)));return n.join("")},encodeObject:function(t){if(t instanceof Array)for(var n=0,r=t.length;r>n;n++)t[n]=o.encodeObject(t[n]);else if("object"==(void 0===t?"undefined":(0,i.default)(t)))for(var e in t)t[e]=o.encodeObject(t[e]);else if("string"==typeof t)return o.encode(t);return t},loadScript:function(t){var n=document.createElement("script");document.getElementsByTagName("body")[0].appendChild(n),n.setAttribute("src",t)},addLoadEvent:function(t){var n=window.onload;"function"!=typeof window.onload?window.onload=t:window.onload=function(){n(),t()}}}}();t.exports=o},function(t,n,r){"use strict";var e=r(17),i=r(75),o=r(16);t.exports=function(t){for(var n=e(this),r=o(n.length),u=arguments.length,c=i(u>1?arguments[1]:void 0,r),f=u>2?arguments[2]:void 0,a=void 0===f?r:i(f,r);a>c;)n[c++]=t;return n}},function(t,n,r){"use strict";var e=r(11),i=r(66);t.exports=function(t,n,r){n in t?e.f(t,n,i(0,r)):t[n]=r}},function(t,n,r){var e=r(6),i=r(3).document,o=e(i)&&e(i.createElement);t.exports=function(t){return o?i.createElement(t):{}}},function(t,n){t.exports="constructor,hasOwnProperty,isPrototypeOf,propertyIsEnumerable,toLocaleString,toString,valueOf".split(",")},function(t,n,r){var e=r(7)("match");t.exports=function(t){var n=/./;try{"/./"[t](n)}catch(r){try{return n[e]=!1,!"/./"[t](n)}catch(t){}}return!0}},function(t,n,r){t.exports=r(3).document&&document.documentElement},function(t,n,r){var e=r(6),i=r(144).set;t.exports=function(t,n,r){var o,u=n.constructor;return u!==r&&"function"==typeof u&&(o=u.prototype)!==r.prototype&&e(o)&&i&&i(t,o),t}},function(t,n,r){var e=r(80),i=r(7)("iterator"),o=Array.prototype;t.exports=function(t){return void 0!==t&&(e.Array===t||o[i]===t)}},function(t,n,r){var e=r(45);t.exports=Array.isArray||function(t){return"Array"==e(t)}},function(t,n,r){"use strict";var e=r(70),i=r(66),o=r(81),u={};r(27)(u,r(7)("iterator"),function(){return this}),t.exports=function(t,n,r){t.prototype=e(u,{next:i(1,r)}),o(t,n+" Iterator")}},function(t,n,r){"use strict";var e=r(69),i=r(1),o=r(28),u=r(27),c=r(24),f=r(80),a=r(139),s=r(81),l=r(32),h=r(7)("iterator"),v=!([].keys&&"next"in[].keys()),p="keys",d="values",y=function(){return this};t.exports=function(t,n,r,g,b,m,x){a(r,n,g);var w,S,_,O=function(t){if(!v&&t in F)return F[t];switch(t){case p:case d:return function(){return new r(this,t)}}return function(){return new r(this,t)}},E=n+" Iterator",P=b==d,j=!1,F=t.prototype,M=F[h]||F["@@iterator"]||b&&F[b],A=M||O(b),N=b?P?O("entries"):A:void 0,T="Array"==n?F.entries||M:M;if(T&&(_=l(T.call(new t)))!==Object.prototype&&(s(_,E,!0),e||c(_,h)||u(_,h,y)),P&&M&&M.name!==d&&(j=!0,A=function(){return M.call(this)}),e&&!x||!v&&!j&&F[h]||u(F,h,A),f[n]=A,f[E]=y,b)if(w={values:P?A:O(d),keys:m?A:O(p),entries:N},x)for(S in w)S in F||o(F,S,w[S]);else i(i.P+i.F*(v||j),n,w);return w}},function(t,n){var r=Math.expm1;t.exports=!r||r(10)>22025.465794806718||r(10)<22025.465794806718||-2e-17!=r(-2e-17)?function(t){return 0==(t=+t)?t:t>-1e-6&&t<1e-6?t+t*t/2:Math.exp(t)-1}:r},function(t,n){t.exports=Math.sign||function(t){return 0==(t=+t)||t!=t?t:t<0?-1:1}},function(t,n,r){var e=r(3),i=r(151).set,o=e.MutationObserver||e.WebKitMutationObserver,u=e.process,c=e.Promise,f="process"==r(45)(u);t.exports=function(){var t,n,r,a=function(){var e,i;for(f&&(e=u.domain)&&e.exit();t;){i=t.fn,t=t.next;try{i()}catch(e){throw t?r():n=void 0,e}}n=void 0,e&&e.enter()};if(f)r=function(){u.nextTick(a)};else if(o){var s=!0,l=document.createTextNode("");new o(a).observe(l,{characterData:!0}),r=function(){l.data=s=!s}}else if(c&&c.resolve){var h=c.resolve();r=function(){h.then(a)}}else r=function(){i.call(e,a)};return function(e){var i={fn:e,next:void 0};n&&(n.next=i),t||(t=i,r()),n=i}}},function(t,n,r){var e=r(6),i=r(2),o=function(t,n){if(i(t),!e(n)&&null!==n)throw TypeError(n+": can't set as prototype!")};t.exports={set:Object.setPrototypeOf||("__proto__"in{}?function(t,n,e){try{e=r(53)(Function.call,r(31).f(Object.prototype,"__proto__").set,2),e(t,[]),n=!(t instanceof Array)}catch(t){n=!0}return function(t,r){return o(t,r),n?t.__proto__=r:e(t,r),t}}({},!1):void 0),check:o}},function(t,n,r){var e=r(126)("keys"),i=r(76);t.exports=function(t){return e[t]||(e[t]=i(t))}},function(t,n,r){var e=r(2),i=r(26),o=r(7)("species");t.exports=function(t,n){var r,u=e(t).constructor;return void 0===u||void 0==(r=e(u)[o])?n:i(r)}},function(t,n,r){var e=r(67),i=r(46);t.exports=function(t){return function(n,r){var o,u,c=String(i(n)),f=e(r),a=c.length;return f<0||f>=a?t?"":void 0:(o=c.charCodeAt(f),o<55296||o>56319||f+1===a||(u=c.charCodeAt(f+1))<56320||u>57343?t?c.charAt(f):o:t?c.slice(f,f+2):u-56320+(o-55296<<10)+65536)}}},function(t,n,r){var e=r(122),i=r(46);t.exports=function(t,n,r){if(e(n))throw TypeError("String#"+r+" doesn't accept regex!");return String(i(t))}},function(t,n,r){"use strict";var e=r(67),i=r(46);t.exports=function(t){var n=String(i(this)),r="",o=e(t);if(o<0||o==1/0)throw RangeError("Count can't be negative");for(;o>0;(o>>>=1)&&(n+=n))1&o&&(r+=n);return r}},function(t,n){t.exports="\t\n\v\f\r   ᠎             　\u2028\u2029\ufeff"},function(t,n,r){var e,i,o,u=r(53),c=r(121),f=r(135),a=r(132),s=r(3),l=s.process,h=s.setImmediate,v=s.clearImmediate,p=s.MessageChannel,d=0,y={},g="onreadystatechange",b=function(){var t=+this;if(y.hasOwnProperty(t)){var n=y[t];delete y[t],n()}},m=function(t){b.call(t.data)};h&&v||(h=function(t){for(var n=[],r=1;arguments.length>r;)n.push(arguments[r++]);return y[++d]=function(){c("function"==typeof t?t:Function(t),n)},e(d),d},v=function(t){delete y[t]},"process"==r(45)(l)?e=function(t){l.nextTick(u(b,t,1))}:p?(i=new p,o=i.port2,i.port1.onmessage=m,e=u(o.postMessage,o,1)):s.addEventListener&&"function"==typeof postMessage&&!s.importScripts?(e=function(t){s.postMessage(t+"","*")},s.addEventListener("message",m,!1)):e=g in a("script")?function(t){f.appendChild(a("script"))[g]=function(){f.removeChild(this),b.call(t)}}:function(t){setTimeout(u(b,t,1),0)}),t.exports={set:h,clear:v}},function(t,n,r){"use strict";var e=r(3),i=r(10),o=r(69),u=r(127),c=r(27),f=r(73),a=r(4),s=r(68),l=r(67),h=r(16),v=r(71).f,p=r(11).f,d=r(130),y=r(81),g="ArrayBuffer",b="DataView",m="prototype",x="Wrong length!",w="Wrong index!",S=e[g],_=e[b],O=e.Math,E=e.RangeError,P=e.Infinity,j=S,F=O.abs,M=O.pow,A=O.floor,N=O.log,T=O.LN2,I="buffer",k="byteLength",L="byteOffset",R=i?"_b":I,C=i?"_l":k,D=i?"_o":L,U=function(t,n,r){var e,i,o,u=Array(r),c=8*r-n-1,f=(1<<c)-1,a=f>>1,s=23===n?M(2,-24)-M(2,-77):0,l=0,h=t<0||0===t&&1/t<0?1:0;for(t=F(t),t!=t||t===P?(i=t!=t?1:0,e=f):(e=A(N(t)/T),t*(o=M(2,-e))<1&&(e--,o*=2),t+=e+a>=1?s/o:s*M(2,1-a),t*o>=2&&(e++,o/=2),e+a>=f?(i=0,e=f):e+a>=1?(i=(t*o-1)*M(2,n),e+=a):(i=t*M(2,a-1)*M(2,n),e=0));n>=8;u[l++]=255&i,i/=256,n-=8);for(e=e<<n|i,c+=n;c>0;u[l++]=255&e,e/=256,c-=8);return u[--l]|=128*h,u},W=function(t,n,r){var e,i=8*r-n-1,o=(1<<i)-1,u=o>>1,c=i-7,f=r-1,a=t[f--],s=127&a;for(a>>=7;c>0;s=256*s+t[f],f--,c-=8);for(e=s&(1<<-c)-1,s>>=-c,c+=n;c>0;e=256*e+t[f],f--,c-=8);if(0===s)s=1-u;else{if(s===o)return e?NaN:a?-P:P;e+=M(2,n),s-=u}return(a?-1:1)*e*M(2,s-n)},G=function(t){return t[3]<<24|t[2]<<16|t[1]<<8|t[0]},B=function(t){return[255&t]},V=function(t){return[255&t,t>>8&255]},z=function(t){return[255&t,t>>8&255,t>>16&255,t>>24&255]},q=function(t){return U(t,52,8)},K=function(t){return U(t,23,4)},J=function(t,n,r){p(t[m],n,{get:function(){return this[r]}})},Y=function(t,n,r,e){var i=+r,o=l(i);if(i!=o||o<0||o+n>t[C])throw E(w);var u=t[R]._b,c=o+t[D],f=u.slice(c,c+n);return e?f:f.reverse()},H=function(t,n,r,e,i,o){var u=+r,c=l(u);if(u!=c||c<0||c+n>t[C])throw E(w);for(var f=t[R]._b,a=c+t[D],s=e(+i),h=0;h<n;h++)f[a+h]=s[o?h:n-h-1]},$=function(t,n){s(t,S,g);var r=+n,e=h(r);if(r!=e)throw E(x);return e};if(u.ABV){if(!a(function(){new S})||!a(function(){new S(.5)})){S=function(t){return new j($(this,t))};for(var X,Q=S[m]=j[m],Z=v(j),tt=0;Z.length>tt;)(X=Z[tt++])in S||c(S,X,j[X]);o||(Q.constructor=S)}var nt=new _(new S(2)),rt=_[m].setInt8;nt.setInt8(0,2147483648),nt.setInt8(1,2147483649),!nt.getInt8(0)&&nt.getInt8(1)||f(_[m],{setInt8:function(t,n){rt.call(this,t,n<<24>>24)},setUint8:function(t,n){rt.call(this,t,n<<24>>24)}},!0)}else S=function(t){var n=$(this,t);this._b=d.call(Array(n),0),this[C]=n},_=function(t,n,r){s(this,_,b),s(t,S,b);var e=t[C],i=l(n);if(i<0||i>e)throw E("Wrong offset!");if(r=void 0===r?e-i:h(r),i+r>e)throw E(x);this[R]=t,this[D]=i,this[C]=r},i&&(J(S,k,"_l"),J(_,I,"_b"),J(_,k,"_l"),J(_,L,"_o")),f(_[m],{getInt8:function(t){return Y(this,1,t)[0]<<24>>24},getUint8:function(t){return Y(this,1,t)[0]},getInt16:function(t){var n=Y(this,2,t,arguments[1]);return(n[1]<<8|n[0])<<16>>16},getUint16:function(t){var n=Y(this,2,t,arguments[1]);return n[1]<<8|n[0]},getInt32:function(t){return G(Y(this,4,t,arguments[1]))},getUint32:function(t){return G(Y(this,4,t,arguments[1]))>>>0},getFloat32:function(t){return W(Y(this,4,t,arguments[1]),23,4)},getFloat64:function(t){return W(Y(this,8,t,arguments[1]),52,8)},setInt8:function(t,n){H(this,1,t,B,n)},setUint8:function(t,n){H(this,1,t,B,n)},setInt16:function(t,n){H(this,2,t,V,n,arguments[2])},setUint16:function(t,n){H(this,2,t,V,n,arguments[2])},setInt32:function(t,n){H(this,4,t,z,n,arguments[2])},setUint32:function(t,n){H(this,4,t,z,n,arguments[2])},setFloat32:function(t,n){H(this,4,t,K,n,arguments[2])},setFloat64:function(t,n){H(this,8,t,q,n,arguments[2])}});y(S,g),y(_,b),c(_[m],u.VIEW,!0),n[g]=S,n[b]=_},function(t,n,r){var e=r(3),i=r(52),o=r(69),u=r(182),c=r(11).f;t.exports=function(t){var n=i.Symbol||(i.Symbol=o?{}:e.Symbol||{});"_"==t.charAt(0)||t in n||c(n,t,{value:u.f(t)})}},function(t,n,r){var e=r(114),i=r(7)("iterator"),o=r(80);t.exports=r(52).getIteratorMethod=function(t){if(void 0!=t)return t[i]||t["@@iterator"]||o[e(t)]}},function(t,n,r){"use strict";var e=r(78),i=r(170),o=r(80),u=r(30);t.exports=r(140)(Array,"Array",function(t,n){this._t=u(t),this._i=0,this._k=n},function(){var t=this._t,n=this._k,r=this._i++;return!t||r>=t.length?(this._t=void 0,i(1)):"keys"==n?i(0,r):"values"==n?i(0,t[r]):i(0,[r,t[r]])},"values"),o.Arguments=o.Array,e("keys"),e("values"),e("entries")},function(t,n){function r(t,n){t.classList?t.classList.add(n):t.className+=" "+n}t.exports=r},function(t,n){function r(t,n){if(t.classList)t.classList.remove(n);else{var r=new RegExp("(^|\\b)"+n.split(" ").join("|")+"(\\b|$)","gi");t.className=t.className.replace(r," ")}}t.exports=r},function(t,n){function r(){throw new Error("setTimeout has not been defined")}function e(){throw new Error("clearTimeout has not been defined")}function i(t){if(s===setTimeout)return setTimeout(t,0);if((s===r||!s)&&setTimeout)return s=setTimeout,setTimeout(t,0);try{return s(t,0)}catch(n){try{return s.call(null,t,0)}catch(n){return s.call(this,t,0)}}}function o(t){if(l===clearTimeout)return clearTimeout(t);if((l===e||!l)&&clearTimeout)return l=clearTimeout,clearTimeout(t);try{return l(t)}catch(n){try{return l.call(null,t)}catch(n){return l.call(this,t)}}}function u(){d&&v&&(d=!1,v.length?p=v.concat(p):y=-1,p.length&&c())}function c(){if(!d){var t=i(u);d=!0;for(var n=p.length;n;){for(v=p,p=[];++y<n;)v&&v[y].run();y=-1,n=p.length}v=null,d=!1,o(t)}}function f(t,n){this.fun=t,this.array=n}function a(){}var s,l,h=t.exports={};!function(){try{s="function"==typeof setTimeout?setTimeout:r}catch(t){s=r}try{l="function"==typeof clearTimeout?clearTimeout:e}catch(t){l=e}}();var v,p=[],d=!1,y=-1;h.nextTick=function(t){var n=new Array(arguments.length-1);if(arguments.length>1)for(var r=1;r<arguments.length;r++)n[r-1]=arguments[r];p.push(new f(t,n)),1!==p.length||d||i(c)},f.prototype.run=function(){this.fun.apply(null,this.array)},h.title="browser",h.browser=!0,h.env={},h.argv=[],h.version="",h.versions={},h.on=a,h.addListener=a,h.once=a,h.off=a,h.removeListener=a,h.removeAllListeners=a,h.emit=a,h.prependListener=a,h.prependOnceListener=a,h.listeners=function(t){return[]},h.binding=function(t){throw new Error("process.binding is not supported")},h.cwd=function(){return"/"},h.chdir=function(t){throw new Error("process.chdir is not supported")},h.umask=function(){return 0}},function(t,n,r){var e=r(45);t.exports=function(t,n){if("number"!=typeof t&&"Number"!=e(t))throw TypeError(n);return+t}},function(t,n,r){"use strict";var e=r(17),i=r(75),o=r(16);t.exports=[].copyWithin||function(t,n){var r=e(this),u=o(r.length),c=i(t,u),f=i(n,u),a=arguments.length>2?arguments[2]:void 0,s=Math.min((void 0===a?u:i(a,u))-f,u-c),l=1;for(f<c&&c<f+s&&(l=-1,f+=s-1,c+=s-1);s-- >0;)f in r?r[c]=r[f]:delete r[c],c+=l,f+=l;return r}},function(t,n,r){var e=r(79);t.exports=function(t,n){var r=[];return e(t,!1,r.push,r,n),r}},function(t,n,r){var e=r(26),i=r(17),o=r(115),u=r(16);t.exports=function(t,n,r,c,f){e(n);var a=i(t),s=o(a),l=u(a.length),h=f?l-1:0,v=f?-1:1;if(r<2)for(;;){if(h in s){c=s[h],h+=v;break}if(h+=v,f?h<0:l<=h)throw TypeError("Reduce of empty array with no initial value")}for(;f?h>=0:l>h;h+=v)h in s&&(c=n(c,s[h],h,a));return c}},function(t,n,r){"use strict";var e=r(26),i=r(6),o=r(121),u=[].slice,c={},f=function(t,n,r){if(!(n in c)){for(var e=[],i=0;i<n;i++)e[i]="a["+i+"]";c[n]=Function("F,a","return new F("+e.join(",")+")")}return c[n](t,r)};t.exports=Function.bind||function(t){var n=e(this),r=u.call(arguments,1),c=function(){var e=r.concat(u.call(arguments));return this instanceof c?f(n,e.length,e):o(n,e,t)};return i(n.prototype)&&(c.prototype=n.prototype),c}},function(t,n,r){"use strict";var e=r(11).f,i=r(70),o=r(73),u=r(53),c=r(68),f=r(46),a=r(79),s=r(140),l=r(170),h=r(74),v=r(10),p=r(65).fastKey,d=v?"_s":"size",y=function(t,n){var r,e=p(n);if("F"!==e)return t._i[e];for(r=t._f;r;r=r.n)if(r.k==n)return r};t.exports={getConstructor:function(t,n,r,s){var l=t(function(t,e){c(t,l,n,"_i"),t._i=i(null),t._f=void 0,t._l=void 0,t[d]=0,void 0!=e&&a(e,r,t[s],t)});return o(l.prototype,{clear:function(){for(var t=this,n=t._i,r=t._f;r;r=r.n)r.r=!0,r.p&&(r.p=r.p.n=void 0),delete n[r.i];t._f=t._l=void 0,t[d]=0},delete:function(t){var n=this,r=y(n,t);if(r){var e=r.n,i=r.p;delete n._i[r.i],r.r=!0,i&&(i.n=e),e&&(e.p=i),n._f==r&&(n._f=e),n._l==r&&(n._l=i),n[d]--}return!!r},forEach:function(t){c(this,l,"forEach");for(var n,r=u(t,arguments.length>1?arguments[1]:void 0,3);n=n?n.n:this._f;)for(r(n.v,n.k,this);n&&n.r;)n=n.p},has:function(t){return!!y(this,t)}}),v&&e(l.prototype,"size",{get:function(){return f(this[d])}}),l},def:function(t,n,r){var e,i,o=y(t,n);return o?o.v=r:(t._l=o={i:i=p(n,!0),k:n,v:r,p:e=t._l,n:void 0,r:!1},t._f||(t._f=o),e&&(e.n=o),t[d]++,"F"!==i&&(t._i[i]=o)),t},getEntry:y,setStrong:function(t,n,r){s(t,n,function(t,n){this._t=t,this._k=n,this._l=void 0},function(){for(var t=this,n=t._k,r=t._l;r&&r.r;)r=r.p;return t._t&&(t._l=r=r?r.n:t._t._f)?"keys"==n?l(0,r.k):"values"==n?l(0,r.v):l(0,[r.k,r.v]):(t._t=void 0,l(1))},r?"entries":"values",!r,!0),h(n)}}},function(t,n,r){var e=r(114),i=r(161);t.exports=function(t){return function(){if(e(this)!=t)throw TypeError(t+"#toJSON isn't generic");return i(this)}}},function(t,n,r){"use strict";var e=r(73),i=r(65).getWeak,o=r(2),u=r(6),c=r(68),f=r(79),a=r(48),s=r(24),l=a(5),h=a(6),v=0,p=function(t){return t._l||(t._l=new d)},d=function(){this.a=[]},y=function(t,n){return l(t.a,function(t){return t[0]===n})};d.prototype={get:function(t){var n=y(this,t);if(n)return n[1]},has:function(t){return!!y(this,t)},set:function(t,n){var r=y(this,t);r?r[1]=n:this.a.push([t,n])},delete:function(t){var n=h(this.a,function(n){return n[0]===t});return~n&&this.a.splice(n,1),!!~n}},t.exports={getConstructor:function(t,n,r,o){var a=t(function(t,e){c(t,a,n,"_i"),t._i=v++,t._l=void 0,void 0!=e&&f(e,r,t[o],t)});return e(a.prototype,{delete:function(t){if(!u(t))return!1;var n=i(t);return!0===n?p(this).delete(t):n&&s(n,this._i)&&delete n[this._i]},has:function(t){if(!u(t))return!1;var n=i(t);return!0===n?p(this).has(t):n&&s(n,this._i)}}),a},def:function(t,n,r){var e=i(o(n),!0);return!0===e?p(t).set(n,r):e[t._i]=r,t},ufstore:p}},function(t,n,r){t.exports=!r(10)&&!r(4)(function(){return 7!=Object.defineProperty(r(132)("div"),"a",{get:function(){return 7}}).a})},function(t,n,r){var e=r(6),i=Math.floor;t.exports=function(t){return!e(t)&&isFinite(t)&&i(t)===t}},function(t,n,r){var e=r(2);t.exports=function(t,n,r,i){try{return i?n(e(r)[0],r[1]):n(r)}catch(n){var o=t.return;throw void 0!==o&&e(o.call(t)),n}}},function(t,n){t.exports=function(t,n){return{value:n,done:!!t}}},function(t,n){t.exports=Math.log1p||function(t){return(t=+t)>-1e-8&&t<1e-8?t-t*t/2:Math.log(1+t)}},function(t,n,r){"use strict";var e=r(72),i=r(125),o=r(116),u=r(17),c=r(115),f=Object.assign;t.exports=!f||r(4)(function(){var t={},n={},r=Symbol(),e="abcdefghijklmnopqrst";return t[r]=7,e.split("").forEach(function(t){n[t]=t}),7!=f({},t)[r]||Object.keys(f({},n)).join("")!=e})?function(t,n){for(var r=u(t),f=arguments.length,a=1,s=i.f,l=o.f;f>a;)for(var h,v=c(arguments[a++]),p=s?e(v).concat(s(v)):e(v),d=p.length,y=0;d>y;)l.call(v,h=p[y++])&&(r[h]=v[h]);return r}:f},function(t,n,r){var e=r(11),i=r(2),o=r(72);t.exports=r(10)?Object.defineProperties:function(t,n){i(t);for(var r,u=o(n),c=u.length,f=0;c>f;)e.f(t,r=u[f++],n[r]);return t}},function(t,n,r){var e=r(30),i=r(71).f,o={}.toString,u="object"==typeof window&&window&&Object.getOwnPropertyNames?Object.getOwnPropertyNames(window):[],c=function(t){try{return i(t)}catch(t){return u.slice()}};t.exports.f=function(t){return u&&"[object Window]"==o.call(t)?c(t):i(e(t))}},function(t,n,r){var e=r(24),i=r(30),o=r(117)(!1),u=r(145)("IE_PROTO");t.exports=function(t,n){var r,c=i(t),f=0,a=[];for(r in c)r!=u&&e(c,r)&&a.push(r);for(;n.length>f;)e(c,r=n[f++])&&(~o(a,r)||a.push(r));return a}},function(t,n,r){var e=r(72),i=r(30),o=r(116).f;t.exports=function(t){return function(n){for(var r,u=i(n),c=e(u),f=c.length,a=0,s=[];f>a;)o.call(u,r=c[a++])&&s.push(t?[r,u[r]]:u[r]);return s}}},function(t,n,r){var e=r(71),i=r(125),o=r(2),u=r(3).Reflect;t.exports=u&&u.ownKeys||function(t){var n=e.f(o(t)),r=i.f;return r?n.concat(r(t)):n}},function(t,n,r){var e=r(3).parseFloat,i=r(82).trim;t.exports=1/e(r(150)+"-0")!=-1/0?function(t){var n=i(String(t),3),r=e(n);return 0===r&&"-"==n.charAt(0)?-0:r}:e},function(t,n,r){var e=r(3).parseInt,i=r(82).trim,o=r(150),u=/^[\-+]?0[xX]/;t.exports=8!==e(o+"08")||22!==e(o+"0x16")?function(t,n){var r=i(String(t),3);return e(r,n>>>0||(u.test(r)?16:10))}:e},function(t,n){t.exports=Object.is||function(t,n){return t===n?0!==t||1/t==1/n:t!=t&&n!=n}},function(t,n,r){var e=r(16),i=r(149),o=r(46);t.exports=function(t,n,r,u){var c=String(o(t)),f=c.length,a=void 0===r?" ":String(r),s=e(n);if(s<=f||""==a)return c;var l=s-f,h=i.call(a,Math.ceil(l/a.length));return h.length>l&&(h=h.slice(0,l)),u?h+c:c+h}},function(t,n,r){n.f=r(7)},function(t,n,r){"use strict";var e=r(164);t.exports=r(118)("Map",function(t){return function(){return t(this,arguments.length>0?arguments[0]:void 0)}},{get:function(t){var n=e.getEntry(this,t);return n&&n.v},set:function(t,n){return e.def(this,0===t?0:t,n)}},e,!0)},function(t,n,r){r(10)&&"g"!=/./g.flags&&r(11).f(RegExp.prototype,"flags",{configurable:!0,get:r(120)})},function(t,n,r){"use strict";var e=r(164);t.exports=r(118)("Set",function(t){return function(){return t(this,arguments.length>0?arguments[0]:void 0)}},{add:function(t){return e.def(this,t=0===t?0:t,t)}},e)},function(t,n,r){"use strict";var e,i=r(48)(0),o=r(28),u=r(65),c=r(172),f=r(166),a=r(6),s=u.getWeak,l=Object.isExtensible,h=f.ufstore,v={},p=function(t){return function(){return t(this,arguments.length>0?arguments[0]:void 0)}},d={get:function(t){if(a(t)){var n=s(t);return!0===n?h(this).get(t):n?n[this._i]:void 0}},set:function(t,n){return f.def(this,t,n)}},y=t.exports=r(118)("WeakMap",p,d,f,!0,!0);7!=(new y).set((Object.freeze||Object)(v),7).get(v)&&(e=f.getConstructor(p),c(e.prototype,d),u.NEED=!0,i(["delete","has","get","set"],function(t){var n=y.prototype,r=n[t];o(n,t,function(n,i){if(a(n)&&!l(n)){this._f||(this._f=new e);var o=this._f[t](n,i);return"set"==t?this:o}return r.call(this,n,i)})}))},,,,function(t,n){"use strict";function r(){var t=document.querySelector("#page-nav");if(t&&!document.querySelector("#page-nav .extend.prev")&&(t.innerHTML='<a class="extend prev disabled" rel="prev">&laquo; Prev</a>'+t.innerHTML),t&&!document.querySelector("#page-nav .extend.next")&&(t.innerHTML=t.innerHTML+'<a class="extend next disabled" rel="next">Next &raquo;</a>'),yiliaConfig&&yiliaConfig.open_in_new){document.querySelectorAll(".article-entry a:not(.article-more-a)").forEach(function(t){var n=t.getAttribute("target");n&&""!==n||t.setAttribute("target","_blank")})}if(yiliaConfig&&yiliaConfig.toc_hide_index){document.querySelectorAll(".toc-number").forEach(function(t){t.style.display="none"})}var n=document.querySelector("#js-aboutme");n&&0!==n.length&&(n.innerHTML=n.innerText)}t.exports={init:r}},function(t,n,r){"use strict";function e(t){return t&&t.__esModule?t:{default:t}}function i(t,n){var r=/\/|index.html/g;return t.replace(r,"")===n.replace(r,"")}function o(){for(var t=document.querySelectorAll(".js-header-menu li a"),n=window.location.pathname,r=0,e=t.length;r<e;r++){var o=t[r];i(n,o.getAttribute("href"))&&(0,h.default)(o,"active")}}function u(t){for(var n=t.offsetLeft,r=t.offsetParent;null!==r;)n+=r.offsetLeft,r=r.offsetParent;return n}function c(t){for(var n=t.offsetTop,r=t.offsetParent;null!==r;)n+=r.offsetTop,r=r.offsetParent;return n}function f(t,n,r,e,i){var o=u(t),f=c(t)-n;if(f-r<=i){var a=t.$newDom;a||(a=t.cloneNode(!0),(0,d.default)(t,a),t.$newDom=a,a.style.position="fixed",a.style.top=(r||f)+"px",a.style.left=o+"px",a.style.zIndex=e||2,a.style.width="100%",a.style.color="#fff"),a.style.visibility="visible",t.style.visibility="hidden"}else{t.style.visibility="visible";var s=t.$newDom;s&&(s.style.visibility="hidden")}}function a(){var t=document.querySelector(".js-overlay"),n=document.querySelector(".js-header-menu");f(t,document.body.scrollTop,-63,2,0),f(n,document.body.scrollTop,1,3,0)}function s(){document.querySelector("#container").addEventListener("scroll",function(t){a()}),window.addEventListener("scroll",function(t){a()}),a()}var l=r(156),h=e(l),v=r(157),p=(e(v),r(382)),d=e(p),y=r(128),g=e(y),b=r(190),m=e(b),x=r(129);(function(){g.default.versions.mobile&&window.screen.width<800&&(o(),s())})(),(0,x.addLoadEvent)(function(){m.default.init()}),t.exports={}},,,,function(t,n,r){(function(t){"use strict";function n(t,n,r){t[n]||Object[e](t,n,{writable:!0,configurable:!0,value:r})}if(r(381),r(391),r(198),t._babelPolyfill)throw new Error("only one instance of babel-polyfill is allowed");t._babelPolyfill=!0;var e="defineProperty";n(String.prototype,"padLeft","".padStart),n(String.prototype,"padRight","".padEnd),"pop,reverse,shift,keys,values,entries,indexOf,every,some,forEach,map,filter,find,findIndex,includes,join,slice,concat,push,splice,unshift,sort,lastIndexOf,reduce,reduceRight,copyWithin,fill".split(",").forEach(function(t){[][t]&&n(Array,t,Function.call.bind([][t]))})}).call(n,function(){return this}())},,,function(t,n,r){r(210),t.exports=r(52).RegExp.escape},,,,function(t,n,r){var e=r(6),i=r(138),o=r(7)("species");t.exports=function(t){var n;return i(t)&&(n=t.constructor,"function"!=typeof n||n!==Array&&!i(n.prototype)||(n=void 0),e(n)&&null===(n=n[o])&&(n=void 0)),void 0===n?Array:n}},function(t,n,r){var e=r(202);t.exports=function(t,n){return new(e(t))(n)}},function(t,n,r){"use strict";var e=r(2),i=r(50),o="number";t.exports=function(t){if("string"!==t&&t!==o&&"default"!==t)throw TypeError("Incorrect hint");return i(e(this),t!=o)}},function(t,n,r){var e=r(72),i=r(125),o=r(116);t.exports=function(t){var n=e(t),r=i.f;if(r)for(var u,c=r(t),f=o.f,a=0;c.length>a;)f.call(t,u=c[a++])&&n.push(u);return n}},function(t,n,r){var e=r(72),i=r(30);t.exports=function(t,n){for(var r,o=i(t),u=e(o),c=u.length,f=0;c>f;)if(o[r=u[f++]]===n)return r}},function(t,n,r){"use strict";var e=r(208),i=r(121),o=r(26);t.exports=function(){for(var t=o(this),n=arguments.length,r=Array(n),u=0,c=e._,f=!1;n>u;)(r[u]=arguments[u++])===c&&(f=!0);return function(){var e,o=this,u=arguments.length,a=0,s=0;if(!f&&!u)return i(t,r,o);if(e=r.slice(),f)for(;n>a;a++)e[a]===c&&(e[a]=arguments[s++]);for(;u>s;)e.push(arguments[s++]);return i(t,e,o)}}},function(t,n,r){t.exports=r(3)},function(t,n){t.exports=function(t,n){var r=n===Object(n)?function(t){return n[t]}:n;return function(n){return String(n).replace(t,r)}}},function(t,n,r){var e=r(1),i=r(209)(/[\\^$*+?.()|[\]{}]/g,"\\$&");e(e.S,"RegExp",{escape:function(t){return i(t)}})},function(t,n,r){var e=r(1);e(e.P,"Array",{copyWithin:r(160)}),r(78)("copyWithin")},function(t,n,r){"use strict";var e=r(1),i=r(48)(4);e(e.P+e.F*!r(47)([].every,!0),"Array",{every:function(t){return i(this,t,arguments[1])}})},function(t,n,r){var e=r(1);e(e.P,"Array",{fill:r(130)}),r(78)("fill")},function(t,n,r){"use strict";var e=r(1),i=r(48)(2);e(e.P+e.F*!r(47)([].filter,!0),"Array",{filter:function(t){return i(this,t,arguments[1])}})},function(t,n,r){"use strict";var e=r(1),i=r(48)(6),o="findIndex",u=!0;o in[]&&Array(1)[o](function(){u=!1}),e(e.P+e.F*u,"Array",{findIndex:function(t){return i(this,t,arguments.length>1?arguments[1]:void 0)}}),r(78)(o)},function(t,n,r){"use strict";var e=r(1),i=r(48)(5),o="find",u=!0;o in[]&&Array(1)[o](function(){u=!1}),e(e.P+e.F*u,"Array",{find:function(t){return i(this,t,arguments.length>1?arguments[1]:void 0)}}),r(78)(o)},function(t,n,r){"use strict";var e=r(1),i=r(48)(0),o=r(47)([].forEach,!0);e(e.P+e.F*!o,"Array",{forEach:function(t){return i(this,t,arguments[1])}})},function(t,n,r){"use strict";var e=r(53),i=r(1),o=r(17),u=r(169),c=r(137),f=r(16),a=r(131),s=r(154);i(i.S+i.F*!r(123)(function(t){Array.from(t)}),"Array",{from:function(t){var n,r,i,l,h=o(t),v="function"==typeof this?this:Array,p=arguments.length,d=p>1?arguments[1]:void 0,y=void 0!==d,g=0,b=s(h);if(y&&(d=e(d,p>2?arguments[2]:void 0,2)),void 0==b||v==Array&&c(b))for(n=f(h.length),r=new v(n);n>g;g++)a(r,g,y?d(h[g],g):h[g]);else for(l=b.call(h),r=new v;!(i=l.next()).done;g++)a(r,g,y?u(l,d,[i.value,g],!0):i.value);return r.length=g,r}})},function(t,n,r){"use strict";var e=r(1),i=r(117)(!1),o=[].indexOf,u=!!o&&1/[1].indexOf(1,-0)<0;e(e.P+e.F*(u||!r(47)(o)),"Array",{indexOf:function(t){return u?o.apply(this,arguments)||0:i(this,t,arguments[1])}})},function(t,n,r){var e=r(1);e(e.S,"Array",{isArray:r(138)})},function(t,n,r){"use strict";var e=r(1),i=r(30),o=[].join;e(e.P+e.F*(r(115)!=Object||!r(47)(o)),"Array",{join:function(t){return o.call(i(this),void 0===t?",":t)}})},function(t,n,r){"use strict";var e=r(1),i=r(30),o=r(67),u=r(16),c=[].lastIndexOf,f=!!c&&1/[1].lastIndexOf(1,-0)<0;e(e.P+e.F*(f||!r(47)(c)),"Array",{lastIndexOf:function(t){if(f)return c.apply(this,arguments)||0;var n=i(this),r=u(n.length),e=r-1;for(arguments.length>1&&(e=Math.min(e,o(arguments[1]))),e<0&&(e=r+e);e>=0;e--)if(e in n&&n[e]===t)return e||0;return-1}})},function(t,n,r){"use strict";var e=r(1),i=r(48)(1);e(e.P+e.F*!r(47)([].map,!0),"Array",{map:function(t){return i(this,t,arguments[1])}})},function(t,n,r){"use strict";var e=r(1),i=r(131);e(e.S+e.F*r(4)(function(){function t(){}return!(Array.of.call(t)instanceof t)}),"Array",{of:function(){for(var t=0,n=arguments.length,r=new("function"==typeof this?this:Array)(n);n>t;)i(r,t,arguments[t++]);return r.length=n,r}})},function(t,n,r){"use strict";var e=r(1),i=r(162);e(e.P+e.F*!r(47)([].reduceRight,!0),"Array",{reduceRight:function(t){return i(this,t,arguments.length,arguments[1],!0)}})},function(t,n,r){"use strict";var e=r(1),i=r(162);e(e.P+e.F*!r(47)([].reduce,!0),"Array",{reduce:function(t){return i(this,t,arguments.length,arguments[1],!1)}})},function(t,n,r){"use strict";var e=r(1),i=r(135),o=r(45),u=r(75),c=r(16),f=[].slice;e(e.P+e.F*r(4)(function(){i&&f.call(i)}),"Array",{slice:function(t,n){var r=c(this.length),e=o(this);if(n=void 0===n?r:n,"Array"==e)return f.call(this,t,n);for(var i=u(t,r),a=u(n,r),s=c(a-i),l=Array(s),h=0;h<s;h++)l[h]="String"==e?this.charAt(i+h):this[i+h];return l}})},function(t,n,r){"use strict";var e=r(1),i=r(48)(3);e(e.P+e.F*!r(47)([].some,!0),"Array",{some:function(t){return i(this,t,arguments[1])}})},function(t,n,r){"use strict";var e=r(1),i=r(26),o=r(17),u=r(4),c=[].sort,f=[1,2,3];e(e.P+e.F*(u(function(){f.sort(void 0)})||!u(function(){f.sort(null)})||!r(47)(c)),"Array",{sort:function(t){return void 0===t?c.call(o(this)):c.call(o(this),i(t))}})},function(t,n,r){r(74)("Array")},function(t,n,r){var e=r(1);e(e.S,"Date",{now:function(){return(new Date).getTime()}})},function(t,n,r){"use strict";var e=r(1),i=r(4),o=Date.prototype.getTime,u=function(t){return t>9?t:"0"+t};e(e.P+e.F*(i(function(){return"0385-07-25T07:06:39.999Z"!=new Date(-5e13-1).toISOString()})||!i(function(){new Date(NaN).toISOString()})),"Date",{toISOString:function(){
if(!isFinite(o.call(this)))throw RangeError("Invalid time value");var t=this,n=t.getUTCFullYear(),r=t.getUTCMilliseconds(),e=n<0?"-":n>9999?"+":"";return e+("00000"+Math.abs(n)).slice(e?-6:-4)+"-"+u(t.getUTCMonth()+1)+"-"+u(t.getUTCDate())+"T"+u(t.getUTCHours())+":"+u(t.getUTCMinutes())+":"+u(t.getUTCSeconds())+"."+(r>99?r:"0"+u(r))+"Z"}})},function(t,n,r){"use strict";var e=r(1),i=r(17),o=r(50);e(e.P+e.F*r(4)(function(){return null!==new Date(NaN).toJSON()||1!==Date.prototype.toJSON.call({toISOString:function(){return 1}})}),"Date",{toJSON:function(t){var n=i(this),r=o(n);return"number"!=typeof r||isFinite(r)?n.toISOString():null}})},function(t,n,r){var e=r(7)("toPrimitive"),i=Date.prototype;e in i||r(27)(i,e,r(204))},function(t,n,r){var e=Date.prototype,i="Invalid Date",o="toString",u=e[o],c=e.getTime;new Date(NaN)+""!=i&&r(28)(e,o,function(){var t=c.call(this);return t===t?u.call(this):i})},function(t,n,r){var e=r(1);e(e.P,"Function",{bind:r(163)})},function(t,n,r){"use strict";var e=r(6),i=r(32),o=r(7)("hasInstance"),u=Function.prototype;o in u||r(11).f(u,o,{value:function(t){if("function"!=typeof this||!e(t))return!1;if(!e(this.prototype))return t instanceof this;for(;t=i(t);)if(this.prototype===t)return!0;return!1}})},function(t,n,r){var e=r(11).f,i=r(66),o=r(24),u=Function.prototype,c="name",f=Object.isExtensible||function(){return!0};c in u||r(10)&&e(u,c,{configurable:!0,get:function(){try{var t=this,n=(""+t).match(/^\s*function ([^ (]*)/)[1];return o(t,c)||!f(t)||e(t,c,i(5,n)),n}catch(t){return""}}})},function(t,n,r){var e=r(1),i=r(171),o=Math.sqrt,u=Math.acosh;e(e.S+e.F*!(u&&710==Math.floor(u(Number.MAX_VALUE))&&u(1/0)==1/0),"Math",{acosh:function(t){return(t=+t)<1?NaN:t>94906265.62425156?Math.log(t)+Math.LN2:i(t-1+o(t-1)*o(t+1))}})},function(t,n,r){function e(t){return isFinite(t=+t)&&0!=t?t<0?-e(-t):Math.log(t+Math.sqrt(t*t+1)):t}var i=r(1),o=Math.asinh;i(i.S+i.F*!(o&&1/o(0)>0),"Math",{asinh:e})},function(t,n,r){var e=r(1),i=Math.atanh;e(e.S+e.F*!(i&&1/i(-0)<0),"Math",{atanh:function(t){return 0==(t=+t)?t:Math.log((1+t)/(1-t))/2}})},function(t,n,r){var e=r(1),i=r(142);e(e.S,"Math",{cbrt:function(t){return i(t=+t)*Math.pow(Math.abs(t),1/3)}})},function(t,n,r){var e=r(1);e(e.S,"Math",{clz32:function(t){return(t>>>=0)?31-Math.floor(Math.log(t+.5)*Math.LOG2E):32}})},function(t,n,r){var e=r(1),i=Math.exp;e(e.S,"Math",{cosh:function(t){return(i(t=+t)+i(-t))/2}})},function(t,n,r){var e=r(1),i=r(141);e(e.S+e.F*(i!=Math.expm1),"Math",{expm1:i})},function(t,n,r){var e=r(1),i=r(142),o=Math.pow,u=o(2,-52),c=o(2,-23),f=o(2,127)*(2-c),a=o(2,-126),s=function(t){return t+1/u-1/u};e(e.S,"Math",{fround:function(t){var n,r,e=Math.abs(t),o=i(t);return e<a?o*s(e/a/c)*a*c:(n=(1+c/u)*e,r=n-(n-e),r>f||r!=r?o*(1/0):o*r)}})},function(t,n,r){var e=r(1),i=Math.abs;e(e.S,"Math",{hypot:function(t,n){for(var r,e,o=0,u=0,c=arguments.length,f=0;u<c;)r=i(arguments[u++]),f<r?(e=f/r,o=o*e*e+1,f=r):r>0?(e=r/f,o+=e*e):o+=r;return f===1/0?1/0:f*Math.sqrt(o)}})},function(t,n,r){var e=r(1),i=Math.imul;e(e.S+e.F*r(4)(function(){return-5!=i(4294967295,5)||2!=i.length}),"Math",{imul:function(t,n){var r=65535,e=+t,i=+n,o=r&e,u=r&i;return 0|o*u+((r&e>>>16)*u+o*(r&i>>>16)<<16>>>0)}})},function(t,n,r){var e=r(1);e(e.S,"Math",{log10:function(t){return Math.log(t)/Math.LN10}})},function(t,n,r){var e=r(1);e(e.S,"Math",{log1p:r(171)})},function(t,n,r){var e=r(1);e(e.S,"Math",{log2:function(t){return Math.log(t)/Math.LN2}})},function(t,n,r){var e=r(1);e(e.S,"Math",{sign:r(142)})},function(t,n,r){var e=r(1),i=r(141),o=Math.exp;e(e.S+e.F*r(4)(function(){return-2e-17!=!Math.sinh(-2e-17)}),"Math",{sinh:function(t){return Math.abs(t=+t)<1?(i(t)-i(-t))/2:(o(t-1)-o(-t-1))*(Math.E/2)}})},function(t,n,r){var e=r(1),i=r(141),o=Math.exp;e(e.S,"Math",{tanh:function(t){var n=i(t=+t),r=i(-t);return n==1/0?1:r==1/0?-1:(n-r)/(o(t)+o(-t))}})},function(t,n,r){var e=r(1);e(e.S,"Math",{trunc:function(t){return(t>0?Math.floor:Math.ceil)(t)}})},function(t,n,r){"use strict";var e=r(3),i=r(24),o=r(45),u=r(136),c=r(50),f=r(4),a=r(71).f,s=r(31).f,l=r(11).f,h=r(82).trim,v="Number",p=e[v],d=p,y=p.prototype,g=o(r(70)(y))==v,b="trim"in String.prototype,m=function(t){var n=c(t,!1);if("string"==typeof n&&n.length>2){n=b?n.trim():h(n,3);var r,e,i,o=n.charCodeAt(0);if(43===o||45===o){if(88===(r=n.charCodeAt(2))||120===r)return NaN}else if(48===o){switch(n.charCodeAt(1)){case 66:case 98:e=2,i=49;break;case 79:case 111:e=8,i=55;break;default:return+n}for(var u,f=n.slice(2),a=0,s=f.length;a<s;a++)if((u=f.charCodeAt(a))<48||u>i)return NaN;return parseInt(f,e)}}return+n};if(!p(" 0o1")||!p("0b1")||p("+0x1")){p=function(t){var n=arguments.length<1?0:t,r=this;return r instanceof p&&(g?f(function(){y.valueOf.call(r)}):o(r)!=v)?u(new d(m(n)),r,p):m(n)};for(var x,w=r(10)?a(d):"MAX_VALUE,MIN_VALUE,NaN,NEGATIVE_INFINITY,POSITIVE_INFINITY,EPSILON,isFinite,isInteger,isNaN,isSafeInteger,MAX_SAFE_INTEGER,MIN_SAFE_INTEGER,parseFloat,parseInt,isInteger".split(","),S=0;w.length>S;S++)i(d,x=w[S])&&!i(p,x)&&l(p,x,s(d,x));p.prototype=y,y.constructor=p,r(28)(e,v,p)}},function(t,n,r){var e=r(1);e(e.S,"Number",{EPSILON:Math.pow(2,-52)})},function(t,n,r){var e=r(1),i=r(3).isFinite;e(e.S,"Number",{isFinite:function(t){return"number"==typeof t&&i(t)}})},function(t,n,r){var e=r(1);e(e.S,"Number",{isInteger:r(168)})},function(t,n,r){var e=r(1);e(e.S,"Number",{isNaN:function(t){return t!=t}})},function(t,n,r){var e=r(1),i=r(168),o=Math.abs;e(e.S,"Number",{isSafeInteger:function(t){return i(t)&&o(t)<=9007199254740991}})},function(t,n,r){var e=r(1);e(e.S,"Number",{MAX_SAFE_INTEGER:9007199254740991})},function(t,n,r){var e=r(1);e(e.S,"Number",{MIN_SAFE_INTEGER:-9007199254740991})},function(t,n,r){var e=r(1),i=r(178);e(e.S+e.F*(Number.parseFloat!=i),"Number",{parseFloat:i})},function(t,n,r){var e=r(1),i=r(179);e(e.S+e.F*(Number.parseInt!=i),"Number",{parseInt:i})},function(t,n,r){"use strict";var e=r(1),i=r(67),o=r(159),u=r(149),c=1..toFixed,f=Math.floor,a=[0,0,0,0,0,0],s="Number.toFixed: incorrect invocation!",l="0",h=function(t,n){for(var r=-1,e=n;++r<6;)e+=t*a[r],a[r]=e%1e7,e=f(e/1e7)},v=function(t){for(var n=6,r=0;--n>=0;)r+=a[n],a[n]=f(r/t),r=r%t*1e7},p=function(){for(var t=6,n="";--t>=0;)if(""!==n||0===t||0!==a[t]){var r=String(a[t]);n=""===n?r:n+u.call(l,7-r.length)+r}return n},d=function(t,n,r){return 0===n?r:n%2==1?d(t,n-1,r*t):d(t*t,n/2,r)},y=function(t){for(var n=0,r=t;r>=4096;)n+=12,r/=4096;for(;r>=2;)n+=1,r/=2;return n};e(e.P+e.F*(!!c&&("0.000"!==8e-5.toFixed(3)||"1"!==.9.toFixed(0)||"1.25"!==1.255.toFixed(2)||"1000000000000000128"!==(0xde0b6b3a7640080).toFixed(0))||!r(4)(function(){c.call({})})),"Number",{toFixed:function(t){var n,r,e,c,f=o(this,s),a=i(t),g="",b=l;if(a<0||a>20)throw RangeError(s);if(f!=f)return"NaN";if(f<=-1e21||f>=1e21)return String(f);if(f<0&&(g="-",f=-f),f>1e-21)if(n=y(f*d(2,69,1))-69,r=n<0?f*d(2,-n,1):f/d(2,n,1),r*=4503599627370496,(n=52-n)>0){for(h(0,r),e=a;e>=7;)h(1e7,0),e-=7;for(h(d(10,e,1),0),e=n-1;e>=23;)v(1<<23),e-=23;v(1<<e),h(1,1),v(2),b=p()}else h(0,r),h(1<<-n,0),b=p()+u.call(l,a);return a>0?(c=b.length,b=g+(c<=a?"0."+u.call(l,a-c)+b:b.slice(0,c-a)+"."+b.slice(c-a))):b=g+b,b}})},function(t,n,r){"use strict";var e=r(1),i=r(4),o=r(159),u=1..toPrecision;e(e.P+e.F*(i(function(){return"1"!==u.call(1,void 0)})||!i(function(){u.call({})})),"Number",{toPrecision:function(t){var n=o(this,"Number#toPrecision: incorrect invocation!");return void 0===t?u.call(n):u.call(n,t)}})},function(t,n,r){var e=r(1);e(e.S+e.F,"Object",{assign:r(172)})},function(t,n,r){var e=r(1);e(e.S,"Object",{create:r(70)})},function(t,n,r){var e=r(1);e(e.S+e.F*!r(10),"Object",{defineProperties:r(173)})},function(t,n,r){var e=r(1);e(e.S+e.F*!r(10),"Object",{defineProperty:r(11).f})},function(t,n,r){var e=r(6),i=r(65).onFreeze;r(49)("freeze",function(t){return function(n){return t&&e(n)?t(i(n)):n}})},function(t,n,r){var e=r(30),i=r(31).f;r(49)("getOwnPropertyDescriptor",function(){return function(t,n){return i(e(t),n)}})},function(t,n,r){r(49)("getOwnPropertyNames",function(){return r(174).f})},function(t,n,r){var e=r(17),i=r(32);r(49)("getPrototypeOf",function(){return function(t){return i(e(t))}})},function(t,n,r){var e=r(6);r(49)("isExtensible",function(t){return function(n){return!!e(n)&&(!t||t(n))}})},function(t,n,r){var e=r(6);r(49)("isFrozen",function(t){return function(n){return!e(n)||!!t&&t(n)}})},function(t,n,r){var e=r(6);r(49)("isSealed",function(t){return function(n){return!e(n)||!!t&&t(n)}})},function(t,n,r){var e=r(1);e(e.S,"Object",{is:r(180)})},function(t,n,r){var e=r(17),i=r(72);r(49)("keys",function(){return function(t){return i(e(t))}})},function(t,n,r){var e=r(6),i=r(65).onFreeze;r(49)("preventExtensions",function(t){return function(n){return t&&e(n)?t(i(n)):n}})},function(t,n,r){var e=r(6),i=r(65).onFreeze;r(49)("seal",function(t){return function(n){return t&&e(n)?t(i(n)):n}})},function(t,n,r){var e=r(1);e(e.S,"Object",{setPrototypeOf:r(144).set})},function(t,n,r){"use strict";var e=r(114),i={};i[r(7)("toStringTag")]="z",i+""!="[object z]"&&r(28)(Object.prototype,"toString",function(){return"[object "+e(this)+"]"},!0)},function(t,n,r){var e=r(1),i=r(178);e(e.G+e.F*(parseFloat!=i),{parseFloat:i})},function(t,n,r){var e=r(1),i=r(179);e(e.G+e.F*(parseInt!=i),{parseInt:i})},function(t,n,r){"use strict";var e,i,o,u=r(69),c=r(3),f=r(53),a=r(114),s=r(1),l=r(6),h=r(26),v=r(68),p=r(79),d=r(146),y=r(151).set,g=r(143)(),b="Promise",m=c.TypeError,x=c.process,w=c[b],x=c.process,S="process"==a(x),_=function(){},O=!!function(){try{var t=w.resolve(1),n=(t.constructor={})[r(7)("species")]=function(t){t(_,_)};return(S||"function"==typeof PromiseRejectionEvent)&&t.then(_)instanceof n}catch(t){}}(),E=function(t,n){return t===n||t===w&&n===o},P=function(t){var n;return!(!l(t)||"function"!=typeof(n=t.then))&&n},j=function(t){return E(w,t)?new F(t):new i(t)},F=i=function(t){var n,r;this.promise=new t(function(t,e){if(void 0!==n||void 0!==r)throw m("Bad Promise constructor");n=t,r=e}),this.resolve=h(n),this.reject=h(r)},M=function(t){try{t()}catch(t){return{error:t}}},A=function(t,n){if(!t._n){t._n=!0;var r=t._c;g(function(){for(var e=t._v,i=1==t._s,o=0;r.length>o;)!function(n){var r,o,u=i?n.ok:n.fail,c=n.resolve,f=n.reject,a=n.domain;try{u?(i||(2==t._h&&I(t),t._h=1),!0===u?r=e:(a&&a.enter(),r=u(e),a&&a.exit()),r===n.promise?f(m("Promise-chain cycle")):(o=P(r))?o.call(r,c,f):c(r)):f(e)}catch(t){f(t)}}(r[o++]);t._c=[],t._n=!1,n&&!t._h&&N(t)})}},N=function(t){y.call(c,function(){var n,r,e,i=t._v;if(T(t)&&(n=M(function(){S?x.emit("unhandledRejection",i,t):(r=c.onunhandledrejection)?r({promise:t,reason:i}):(e=c.console)&&e.error&&e.error("Unhandled promise rejection",i)}),t._h=S||T(t)?2:1),t._a=void 0,n)throw n.error})},T=function(t){if(1==t._h)return!1;for(var n,r=t._a||t._c,e=0;r.length>e;)if(n=r[e++],n.fail||!T(n.promise))return!1;return!0},I=function(t){y.call(c,function(){var n;S?x.emit("rejectionHandled",t):(n=c.onrejectionhandled)&&n({promise:t,reason:t._v})})},k=function(t){var n=this;n._d||(n._d=!0,n=n._w||n,n._v=t,n._s=2,n._a||(n._a=n._c.slice()),A(n,!0))},L=function(t){var n,r=this;if(!r._d){r._d=!0,r=r._w||r;try{if(r===t)throw m("Promise can't be resolved itself");(n=P(t))?g(function(){var e={_w:r,_d:!1};try{n.call(t,f(L,e,1),f(k,e,1))}catch(t){k.call(e,t)}}):(r._v=t,r._s=1,A(r,!1))}catch(t){k.call({_w:r,_d:!1},t)}}};O||(w=function(t){v(this,w,b,"_h"),h(t),e.call(this);try{t(f(L,this,1),f(k,this,1))}catch(t){k.call(this,t)}},e=function(t){this._c=[],this._a=void 0,this._s=0,this._d=!1,this._v=void 0,this._h=0,this._n=!1},e.prototype=r(73)(w.prototype,{then:function(t,n){var r=j(d(this,w));return r.ok="function"!=typeof t||t,r.fail="function"==typeof n&&n,r.domain=S?x.domain:void 0,this._c.push(r),this._a&&this._a.push(r),this._s&&A(this,!1),r.promise},catch:function(t){return this.then(void 0,t)}}),F=function(){var t=new e;this.promise=t,this.resolve=f(L,t,1),this.reject=f(k,t,1)}),s(s.G+s.W+s.F*!O,{Promise:w}),r(81)(w,b),r(74)(b),o=r(52)[b],s(s.S+s.F*!O,b,{reject:function(t){var n=j(this);return(0,n.reject)(t),n.promise}}),s(s.S+s.F*(u||!O),b,{resolve:function(t){if(t instanceof w&&E(t.constructor,this))return t;var n=j(this);return(0,n.resolve)(t),n.promise}}),s(s.S+s.F*!(O&&r(123)(function(t){w.all(t).catch(_)})),b,{all:function(t){var n=this,r=j(n),e=r.resolve,i=r.reject,o=M(function(){var r=[],o=0,u=1;p(t,!1,function(t){var c=o++,f=!1;r.push(void 0),u++,n.resolve(t).then(function(t){f||(f=!0,r[c]=t,--u||e(r))},i)}),--u||e(r)});return o&&i(o.error),r.promise},race:function(t){var n=this,r=j(n),e=r.reject,i=M(function(){p(t,!1,function(t){n.resolve(t).then(r.resolve,e)})});return i&&e(i.error),r.promise}})},function(t,n,r){var e=r(1),i=r(26),o=r(2),u=(r(3).Reflect||{}).apply,c=Function.apply;e(e.S+e.F*!r(4)(function(){u(function(){})}),"Reflect",{apply:function(t,n,r){var e=i(t),f=o(r);return u?u(e,n,f):c.call(e,n,f)}})},function(t,n,r){var e=r(1),i=r(70),o=r(26),u=r(2),c=r(6),f=r(4),a=r(163),s=(r(3).Reflect||{}).construct,l=f(function(){function t(){}return!(s(function(){},[],t)instanceof t)}),h=!f(function(){s(function(){})});e(e.S+e.F*(l||h),"Reflect",{construct:function(t,n){o(t),u(n);var r=arguments.length<3?t:o(arguments[2]);if(h&&!l)return s(t,n,r);if(t==r){switch(n.length){case 0:return new t;case 1:return new t(n[0]);case 2:return new t(n[0],n[1]);case 3:return new t(n[0],n[1],n[2]);case 4:return new t(n[0],n[1],n[2],n[3])}var e=[null];return e.push.apply(e,n),new(a.apply(t,e))}var f=r.prototype,v=i(c(f)?f:Object.prototype),p=Function.apply.call(t,v,n);return c(p)?p:v}})},function(t,n,r){var e=r(11),i=r(1),o=r(2),u=r(50);i(i.S+i.F*r(4)(function(){Reflect.defineProperty(e.f({},1,{value:1}),1,{value:2})}),"Reflect",{defineProperty:function(t,n,r){o(t),n=u(n,!0),o(r);try{return e.f(t,n,r),!0}catch(t){return!1}}})},function(t,n,r){var e=r(1),i=r(31).f,o=r(2);e(e.S,"Reflect",{deleteProperty:function(t,n){var r=i(o(t),n);return!(r&&!r.configurable)&&delete t[n]}})},function(t,n,r){"use strict";var e=r(1),i=r(2),o=function(t){this._t=i(t),this._i=0;var n,r=this._k=[];for(n in t)r.push(n)};r(139)(o,"Object",function(){var t,n=this,r=n._k;do{if(n._i>=r.length)return{value:void 0,done:!0}}while(!((t=r[n._i++])in n._t));return{value:t,done:!1}}),e(e.S,"Reflect",{enumerate:function(t){return new o(t)}})},function(t,n,r){var e=r(31),i=r(1),o=r(2);i(i.S,"Reflect",{getOwnPropertyDescriptor:function(t,n){return e.f(o(t),n)}})},function(t,n,r){var e=r(1),i=r(32),o=r(2);e(e.S,"Reflect",{getPrototypeOf:function(t){return i(o(t))}})},function(t,n,r){function e(t,n){var r,c,s=arguments.length<3?t:arguments[2];return a(t)===s?t[n]:(r=i.f(t,n))?u(r,"value")?r.value:void 0!==r.get?r.get.call(s):void 0:f(c=o(t))?e(c,n,s):void 0}var i=r(31),o=r(32),u=r(24),c=r(1),f=r(6),a=r(2);c(c.S,"Reflect",{get:e})},function(t,n,r){var e=r(1);e(e.S,"Reflect",{has:function(t,n){return n in t}})},function(t,n,r){var e=r(1),i=r(2),o=Object.isExtensible;e(e.S,"Reflect",{isExtensible:function(t){return i(t),!o||o(t)}})},function(t,n,r){var e=r(1);e(e.S,"Reflect",{ownKeys:r(177)})},function(t,n,r){var e=r(1),i=r(2),o=Object.preventExtensions;e(e.S,"Reflect",{preventExtensions:function(t){i(t);try{return o&&o(t),!0}catch(t){return!1}}})},function(t,n,r){var e=r(1),i=r(144);i&&e(e.S,"Reflect",{setPrototypeOf:function(t,n){i.check(t,n);try{return i.set(t,n),!0}catch(t){return!1}}})},function(t,n,r){function e(t,n,r){var f,h,v=arguments.length<4?t:arguments[3],p=o.f(s(t),n);if(!p){if(l(h=u(t)))return e(h,n,r,v);p=a(0)}return c(p,"value")?!(!1===p.writable||!l(v)||(f=o.f(v,n)||a(0),f.value=r,i.f(v,n,f),0)):void 0!==p.set&&(p.set.call(v,r),!0)}var i=r(11),o=r(31),u=r(32),c=r(24),f=r(1),a=r(66),s=r(2),l=r(6);f(f.S,"Reflect",{set:e})},function(t,n,r){var e=r(3),i=r(136),o=r(11).f,u=r(71).f,c=r(122),f=r(120),a=e.RegExp,s=a,l=a.prototype,h=/a/g,v=/a/g,p=new a(h)!==h;if(r(10)&&(!p||r(4)(function(){return v[r(7)("match")]=!1,a(h)!=h||a(v)==v||"/a/i"!=a(h,"i")}))){a=function(t,n){var r=this instanceof a,e=c(t),o=void 0===n;return!r&&e&&t.constructor===a&&o?t:i(p?new s(e&&!o?t.source:t,n):s((e=t instanceof a)?t.source:t,e&&o?f.call(t):n),r?this:l,a)};for(var d=u(s),y=0;d.length>y;)!function(t){t in a||o(a,t,{configurable:!0,get:function(){return s[t]},set:function(n){s[t]=n}})}(d[y++]);l.constructor=a,a.prototype=l,r(28)(e,"RegExp",a)}r(74)("RegExp")},function(t,n,r){r(119)("match",1,function(t,n,r){return[function(r){"use strict";var e=t(this),i=void 0==r?void 0:r[n];return void 0!==i?i.call(r,e):new RegExp(r)[n](String(e))},r]})},function(t,n,r){r(119)("replace",2,function(t,n,r){return[function(e,i){"use strict";var o=t(this),u=void 0==e?void 0:e[n];return void 0!==u?u.call(e,o,i):r.call(String(o),e,i)},r]})},function(t,n,r){r(119)("search",1,function(t,n,r){return[function(r){"use strict";var e=t(this),i=void 0==r?void 0:r[n];return void 0!==i?i.call(r,e):new RegExp(r)[n](String(e))},r]})},function(t,n,r){r(119)("split",2,function(t,n,e){"use strict";var i=r(122),o=e,u=[].push,c="split",f="length",a="lastIndex";if("c"=="abbc"[c](/(b)*/)[1]||4!="test"[c](/(?:)/,-1)[f]||2!="ab"[c](/(?:ab)*/)[f]||4!="."[c](/(.?)(.?)/)[f]||"."[c](/()()/)[f]>1||""[c](/.?/)[f]){var s=void 0===/()??/.exec("")[1];e=function(t,n){var r=String(this);if(void 0===t&&0===n)return[];if(!i(t))return o.call(r,t,n);var e,c,l,h,v,p=[],d=(t.ignoreCase?"i":"")+(t.multiline?"m":"")+(t.unicode?"u":"")+(t.sticky?"y":""),y=0,g=void 0===n?4294967295:n>>>0,b=new RegExp(t.source,d+"g");for(s||(e=new RegExp("^"+b.source+"$(?!\\s)",d));(c=b.exec(r))&&!((l=c.index+c[0][f])>y&&(p.push(r.slice(y,c.index)),!s&&c[f]>1&&c[0].replace(e,function(){for(v=1;v<arguments[f]-2;v++)void 0===arguments[v]&&(c[v]=void 0)}),c[f]>1&&c.index<r[f]&&u.apply(p,c.slice(1)),h=c[0][f],y=l,p[f]>=g));)b[a]===c.index&&b[a]++;return y===r[f]?!h&&b.test("")||p.push(""):p.push(r.slice(y)),p[f]>g?p.slice(0,g):p}}else"0"[c](void 0,0)[f]&&(e=function(t,n){return void 0===t&&0===n?[]:o.call(this,t,n)});return[function(r,i){var o=t(this),u=void 0==r?void 0:r[n];return void 0!==u?u.call(r,o,i):e.call(String(o),r,i)},e]})},function(t,n,r){"use strict";r(184);var e=r(2),i=r(120),o=r(10),u="toString",c=/./[u],f=function(t){r(28)(RegExp.prototype,u,t,!0)};r(4)(function(){return"/a/b"!=c.call({source:"a",flags:"b"})})?f(function(){var t=e(this);return"/".concat(t.source,"/","flags"in t?t.flags:!o&&t instanceof RegExp?i.call(t):void 0)}):c.name!=u&&f(function(){return c.call(this)})},function(t,n,r){"use strict";r(29)("anchor",function(t){return function(n){return t(this,"a","name",n)}})},function(t,n,r){"use strict";r(29)("big",function(t){return function(){return t(this,"big","","")}})},function(t,n,r){"use strict";r(29)("blink",function(t){return function(){return t(this,"blink","","")}})},function(t,n,r){"use strict";r(29)("bold",function(t){return function(){return t(this,"b","","")}})},function(t,n,r){"use strict";var e=r(1),i=r(147)(!1);e(e.P,"String",{codePointAt:function(t){return i(this,t)}})},function(t,n,r){"use strict";var e=r(1),i=r(16),o=r(148),u="endsWith",c=""[u];e(e.P+e.F*r(134)(u),"String",{endsWith:function(t){var n=o(this,t,u),r=arguments.length>1?arguments[1]:void 0,e=i(n.length),f=void 0===r?e:Math.min(i(r),e),a=String(t);return c?c.call(n,a,f):n.slice(f-a.length,f)===a}})},function(t,n,r){"use strict";r(29)("fixed",function(t){return function(){return t(this,"tt","","")}})},function(t,n,r){"use strict";r(29)("fontcolor",function(t){return function(n){return t(this,"font","color",n)}})},function(t,n,r){"use strict";r(29)("fontsize",function(t){return function(n){return t(this,"font","size",n)}})},function(t,n,r){var e=r(1),i=r(75),o=String.fromCharCode,u=String.fromCodePoint;e(e.S+e.F*(!!u&&1!=u.length),"String",{fromCodePoint:function(t){for(var n,r=[],e=arguments.length,u=0;e>u;){if(n=+arguments[u++],i(n,1114111)!==n)throw RangeError(n+" is not a valid code point");r.push(n<65536?o(n):o(55296+((n-=65536)>>10),n%1024+56320))}return r.join("")}})},function(t,n,r){"use strict";var e=r(1),i=r(148),o="includes";e(e.P+e.F*r(134)(o),"String",{includes:function(t){return!!~i(this,t,o).indexOf(t,arguments.length>1?arguments[1]:void 0)}})},function(t,n,r){"use strict";r(29)("italics",function(t){return function(){return t(this,"i","","")}})},function(t,n,r){"use strict";var e=r(147)(!0);r(140)(String,"String",function(t){this._t=String(t),this._i=0},function(){var t,n=this._t,r=this._i;return r>=n.length?{value:void 0,done:!0}:(t=e(n,r),this._i+=t.length,{value:t,done:!1})})},function(t,n,r){"use strict";r(29)("link",function(t){return function(n){return t(this,"a","href",n)}})},function(t,n,r){var e=r(1),i=r(30),o=r(16);e(e.S,"String",{raw:function(t){for(var n=i(t.raw),r=o(n.length),e=arguments.length,u=[],c=0;r>c;)u.push(String(n[c++])),c<e&&u.push(String(arguments[c]));return u.join("")}})},function(t,n,r){var e=r(1);e(e.P,"String",{repeat:r(149)})},function(t,n,r){"use strict";r(29)("small",function(t){return function(){return t(this,"small","","")}})},function(t,n,r){"use strict";var e=r(1),i=r(16),o=r(148),u="startsWith",c=""[u];e(e.P+e.F*r(134)(u),"String",{startsWith:function(t){var n=o(this,t,u),r=i(Math.min(arguments.length>1?arguments[1]:void 0,n.length)),e=String(t);return c?c.call(n,e,r):n.slice(r,r+e.length)===e}})},function(t,n,r){"use strict";r(29)("strike",function(t){return function(){return t(this,"strike","","")}})},function(t,n,r){"use strict";r(29)("sub",function(t){return function(){return t(this,"sub","","")}})},function(t,n,r){"use strict";r(29)("sup",function(t){return function(){return t(this,"sup","","")}})},function(t,n,r){"use strict";r(82)("trim",function(t){return function(){return t(this,3)}})},function(t,n,r){"use strict";var e=r(3),i=r(24),o=r(10),u=r(1),c=r(28),f=r(65).KEY,a=r(4),s=r(126),l=r(81),h=r(76),v=r(7),p=r(182),d=r(153),y=r(206),g=r(205),b=r(138),m=r(2),x=r(30),w=r(50),S=r(66),_=r(70),O=r(174),E=r(31),P=r(11),j=r(72),F=E.f,M=P.f,A=O.f,N=e.Symbol,T=e.JSON,I=T&&T.stringify,k="prototype",L=v("_hidden"),R=v("toPrimitive"),C={}.propertyIsEnumerable,D=s("symbol-registry"),U=s("symbols"),W=s("op-symbols"),G=Object[k],B="function"==typeof N,V=e.QObject,z=!V||!V[k]||!V[k].findChild,q=o&&a(function(){return 7!=_(M({},"a",{get:function(){return M(this,"a",{value:7}).a}})).a})?function(t,n,r){var e=F(G,n);e&&delete G[n],M(t,n,r),e&&t!==G&&M(G,n,e)}:M,K=function(t){var n=U[t]=_(N[k]);return n._k=t,n},J=B&&"symbol"==typeof N.iterator?function(t){return"symbol"==typeof t}:function(t){return t instanceof N},Y=function(t,n,r){return t===G&&Y(W,n,r),m(t),n=w(n,!0),m(r),i(U,n)?(r.enumerable?(i(t,L)&&t[L][n]&&(t[L][n]=!1),r=_(r,{enumerable:S(0,!1)})):(i(t,L)||M(t,L,S(1,{})),t[L][n]=!0),q(t,n,r)):M(t,n,r)},H=function(t,n){m(t);for(var r,e=g(n=x(n)),i=0,o=e.length;o>i;)Y(t,r=e[i++],n[r]);return t},$=function(t,n){return void 0===n?_(t):H(_(t),n)},X=function(t){var n=C.call(this,t=w(t,!0));return!(this===G&&i(U,t)&&!i(W,t))&&(!(n||!i(this,t)||!i(U,t)||i(this,L)&&this[L][t])||n)},Q=function(t,n){if(t=x(t),n=w(n,!0),t!==G||!i(U,n)||i(W,n)){var r=F(t,n);return!r||!i(U,n)||i(t,L)&&t[L][n]||(r.enumerable=!0),r}},Z=function(t){for(var n,r=A(x(t)),e=[],o=0;r.length>o;)i(U,n=r[o++])||n==L||n==f||e.push(n);return e},tt=function(t){for(var n,r=t===G,e=A(r?W:x(t)),o=[],u=0;e.length>u;)!i(U,n=e[u++])||r&&!i(G,n)||o.push(U[n]);return o};B||(N=function(){if(this instanceof N)throw TypeError("Symbol is not a constructor!");var t=h(arguments.length>0?arguments[0]:void 0),n=function(r){this===G&&n.call(W,r),i(this,L)&&i(this[L],t)&&(this[L][t]=!1),q(this,t,S(1,r))};return o&&z&&q(G,t,{configurable:!0,set:n}),K(t)},c(N[k],"toString",function(){return this._k}),E.f=Q,P.f=Y,r(71).f=O.f=Z,r(116).f=X,r(125).f=tt,o&&!r(69)&&c(G,"propertyIsEnumerable",X,!0),p.f=function(t){return K(v(t))}),u(u.G+u.W+u.F*!B,{Symbol:N});for(var nt="hasInstance,isConcatSpreadable,iterator,match,replace,search,species,split,toPrimitive,toStringTag,unscopables".split(","),rt=0;nt.length>rt;)v(nt[rt++]);for(var nt=j(v.store),rt=0;nt.length>rt;)d(nt[rt++]);u(u.S+u.F*!B,"Symbol",{for:function(t){return i(D,t+="")?D[t]:D[t]=N(t)},keyFor:function(t){if(J(t))return y(D,t);throw TypeError(t+" is not a symbol!")},useSetter:function(){z=!0},useSimple:function(){z=!1}}),u(u.S+u.F*!B,"Object",{create:$,defineProperty:Y,defineProperties:H,getOwnPropertyDescriptor:Q,getOwnPropertyNames:Z,getOwnPropertySymbols:tt}),T&&u(u.S+u.F*(!B||a(function(){var t=N();return"[null]"!=I([t])||"{}"!=I({a:t})||"{}"!=I(Object(t))})),"JSON",{stringify:function(t){if(void 0!==t&&!J(t)){for(var n,r,e=[t],i=1;arguments.length>i;)e.push(arguments[i++]);return n=e[1],"function"==typeof n&&(r=n),!r&&b(n)||(n=function(t,n){if(r&&(n=r.call(this,t,n)),!J(n))return n}),e[1]=n,I.apply(T,e)}}}),N[k][R]||r(27)(N[k],R,N[k].valueOf),l(N,"Symbol"),l(Math,"Math",!0),l(e.JSON,"JSON",!0)},function(t,n,r){"use strict";var e=r(1),i=r(127),o=r(152),u=r(2),c=r(75),f=r(16),a=r(6),s=r(3).ArrayBuffer,l=r(146),h=o.ArrayBuffer,v=o.DataView,p=i.ABV&&s.isView,d=h.prototype.slice,y=i.VIEW,g="ArrayBuffer";e(e.G+e.W+e.F*(s!==h),{ArrayBuffer:h}),e(e.S+e.F*!i.CONSTR,g,{isView:function(t){return p&&p(t)||a(t)&&y in t}}),e(e.P+e.U+e.F*r(4)(function(){return!new h(2).slice(1,void 0).byteLength}),g,{slice:function(t,n){if(void 0!==d&&void 0===n)return d.call(u(this),t);for(var r=u(this).byteLength,e=c(t,r),i=c(void 0===n?r:n,r),o=new(l(this,h))(f(i-e)),a=new v(this),s=new v(o),p=0;e<i;)s.setUint8(p++,a.getUint8(e++));return o}}),r(74)(g)},function(t,n,r){var e=r(1);e(e.G+e.W+e.F*!r(127).ABV,{DataView:r(152).DataView})},function(t,n,r){r(55)("Float32",4,function(t){return function(n,r,e){return t(this,n,r,e)}})},function(t,n,r){r(55)("Float64",8,function(t){return function(n,r,e){return t(this,n,r,e)}})},function(t,n,r){r(55)("Int16",2,function(t){return function(n,r,e){return t(this,n,r,e)}})},function(t,n,r){r(55)("Int32",4,function(t){return function(n,r,e){return t(this,n,r,e)}})},function(t,n,r){r(55)("Int8",1,function(t){return function(n,r,e){return t(this,n,r,e)}})},function(t,n,r){r(55)("Uint16",2,function(t){return function(n,r,e){return t(this,n,r,e)}})},function(t,n,r){r(55)("Uint32",4,function(t){return function(n,r,e){return t(this,n,r,e)}})},function(t,n,r){r(55)("Uint8",1,function(t){return function(n,r,e){return t(this,n,r,e)}})},function(t,n,r){r(55)("Uint8",1,function(t){return function(n,r,e){return t(this,n,r,e)}},!0)},function(t,n,r){"use strict";var e=r(166);r(118)("WeakSet",function(t){return function(){return t(this,arguments.length>0?arguments[0]:void 0)}},{add:function(t){return e.def(this,t,!0)}},e,!1,!0)},function(t,n,r){"use strict";var e=r(1),i=r(117)(!0);e(e.P,"Array",{includes:function(t){return i(this,t,arguments.length>1?arguments[1]:void 0)}}),r(78)("includes")},function(t,n,r){var e=r(1),i=r(143)(),o=r(3).process,u="process"==r(45)(o);e(e.G,{asap:function(t){var n=u&&o.domain;i(n?n.bind(t):t)}})},function(t,n,r){var e=r(1),i=r(45);e(e.S,"Error",{isError:function(t){return"Error"===i(t)}})},function(t,n,r){var e=r(1);e(e.P+e.R,"Map",{toJSON:r(165)("Map")})},function(t,n,r){var e=r(1);e(e.S,"Math",{iaddh:function(t,n,r,e){var i=t>>>0,o=n>>>0,u=r>>>0;return o+(e>>>0)+((i&u|(i|u)&~(i+u>>>0))>>>31)|0}})},function(t,n,r){var e=r(1);e(e.S,"Math",{imulh:function(t,n){var r=65535,e=+t,i=+n,o=e&r,u=i&r,c=e>>16,f=i>>16,a=(c*u>>>0)+(o*u>>>16);return c*f+(a>>16)+((o*f>>>0)+(a&r)>>16)}})},function(t,n,r){var e=r(1);e(e.S,"Math",{isubh:function(t,n,r,e){var i=t>>>0,o=n>>>0,u=r>>>0;return o-(e>>>0)-((~i&u|~(i^u)&i-u>>>0)>>>31)|0}})},function(t,n,r){var e=r(1);e(e.S,"Math",{umulh:function(t,n){var r=65535,e=+t,i=+n,o=e&r,u=i&r,c=e>>>16,f=i>>>16,a=(c*u>>>0)+(o*u>>>16);return c*f+(a>>>16)+((o*f>>>0)+(a&r)>>>16)}})},function(t,n,r){"use strict";var e=r(1),i=r(17),o=r(26),u=r(11);r(10)&&e(e.P+r(124),"Object",{__defineGetter__:function(t,n){u.f(i(this),t,{get:o(n),enumerable:!0,configurable:!0})}})},function(t,n,r){"use strict";var e=r(1),i=r(17),o=r(26),u=r(11);r(10)&&e(e.P+r(124),"Object",{__defineSetter__:function(t,n){u.f(i(this),t,{set:o(n),enumerable:!0,configurable:!0})}})},function(t,n,r){var e=r(1),i=r(176)(!0);e(e.S,"Object",{entries:function(t){return i(t)}})},function(t,n,r){var e=r(1),i=r(177),o=r(30),u=r(31),c=r(131);e(e.S,"Object",{getOwnPropertyDescriptors:function(t){for(var n,r=o(t),e=u.f,f=i(r),a={},s=0;f.length>s;)c(a,n=f[s++],e(r,n));return a}})},function(t,n,r){"use strict";var e=r(1),i=r(17),o=r(50),u=r(32),c=r(31).f;r(10)&&e(e.P+r(124),"Object",{__lookupGetter__:function(t){var n,r=i(this),e=o(t,!0);do{if(n=c(r,e))return n.get}while(r=u(r))}})},function(t,n,r){"use strict";var e=r(1),i=r(17),o=r(50),u=r(32),c=r(31).f;r(10)&&e(e.P+r(124),"Object",{__lookupSetter__:function(t){var n,r=i(this),e=o(t,!0);do{if(n=c(r,e))return n.set}while(r=u(r))}})},function(t,n,r){var e=r(1),i=r(176)(!1);e(e.S,"Object",{values:function(t){return i(t)}})},function(t,n,r){"use strict";var e=r(1),i=r(3),o=r(52),u=r(143)(),c=r(7)("observable"),f=r(26),a=r(2),s=r(68),l=r(73),h=r(27),v=r(79),p=v.RETURN,d=function(t){return null==t?void 0:f(t)},y=function(t){var n=t._c;n&&(t._c=void 0,n())},g=function(t){return void 0===t._o},b=function(t){g(t)||(t._o=void 0,y(t))},m=function(t,n){a(t),this._c=void 0,this._o=t,t=new x(this);try{var r=n(t),e=r;null!=r&&("function"==typeof r.unsubscribe?r=function(){e.unsubscribe()}:f(r),this._c=r)}catch(n){return void t.error(n)}g(this)&&y(this)};m.prototype=l({},{unsubscribe:function(){b(this)}});var x=function(t){this._s=t};x.prototype=l({},{next:function(t){var n=this._s;if(!g(n)){var r=n._o;try{var e=d(r.next);if(e)return e.call(r,t)}catch(t){try{b(n)}finally{throw t}}}},error:function(t){var n=this._s;if(g(n))throw t;var r=n._o;n._o=void 0;try{var e=d(r.error);if(!e)throw t;t=e.call(r,t)}catch(t){try{y(n)}finally{throw t}}return y(n),t},complete:function(t){var n=this._s;if(!g(n)){var r=n._o;n._o=void 0;try{var e=d(r.complete);t=e?e.call(r,t):void 0}catch(t){try{y(n)}finally{throw t}}return y(n),t}}});var w=function(t){s(this,w,"Observable","_f")._f=f(t)};l(w.prototype,{subscribe:function(t){return new m(t,this._f)},forEach:function(t){var n=this;return new(o.Promise||i.Promise)(function(r,e){f(t);var i=n.subscribe({next:function(n){try{return t(n)}catch(t){e(t),i.unsubscribe()}},error:e,complete:r})})}}),l(w,{from:function(t){var n="function"==typeof this?this:w,r=d(a(t)[c]);if(r){var e=a(r.call(t));return e.constructor===n?e:new n(function(t){return e.subscribe(t)})}return new n(function(n){var r=!1;return u(function(){if(!r){try{if(v(t,!1,function(t){if(n.next(t),r)return p})===p)return}catch(t){if(r)throw t;return void n.error(t)}n.complete()}}),function(){r=!0}})},of:function(){for(var t=0,n=arguments.length,r=Array(n);t<n;)r[t]=arguments[t++];return new("function"==typeof this?this:w)(function(t){var n=!1;return u(function(){if(!n){for(var e=0;e<r.length;++e)if(t.next(r[e]),n)return;t.complete()}}),function(){n=!0}})}}),h(w.prototype,c,function(){return this}),e(e.G,{Observable:w}),r(74)("Observable")},function(t,n,r){var e=r(54),i=r(2),o=e.key,u=e.set;e.exp({defineMetadata:function(t,n,r,e){u(t,n,i(r),o(e))}})},function(t,n,r){var e=r(54),i=r(2),o=e.key,u=e.map,c=e.store;e.exp({deleteMetadata:function(t,n){var r=arguments.length<3?void 0:o(arguments[2]),e=u(i(n),r,!1);if(void 0===e||!e.delete(t))return!1;if(e.size)return!0;var f=c.get(n);return f.delete(r),!!f.size||c.delete(n)}})},function(t,n,r){var e=r(185),i=r(161),o=r(54),u=r(2),c=r(32),f=o.keys,a=o.key,s=function(t,n){var r=f(t,n),o=c(t);if(null===o)return r;var u=s(o,n);return u.length?r.length?i(new e(r.concat(u))):u:r};o.exp({getMetadataKeys:function(t){return s(u(t),arguments.length<2?void 0:a(arguments[1]))}})},function(t,n,r){var e=r(54),i=r(2),o=r(32),u=e.has,c=e.get,f=e.key,a=function(t,n,r){if(u(t,n,r))return c(t,n,r);var e=o(n);return null!==e?a(t,e,r):void 0};e.exp({getMetadata:function(t,n){return a(t,i(n),arguments.length<3?void 0:f(arguments[2]))}})},function(t,n,r){var e=r(54),i=r(2),o=e.keys,u=e.key;e.exp({getOwnMetadataKeys:function(t){
return o(i(t),arguments.length<2?void 0:u(arguments[1]))}})},function(t,n,r){var e=r(54),i=r(2),o=e.get,u=e.key;e.exp({getOwnMetadata:function(t,n){return o(t,i(n),arguments.length<3?void 0:u(arguments[2]))}})},function(t,n,r){var e=r(54),i=r(2),o=r(32),u=e.has,c=e.key,f=function(t,n,r){if(u(t,n,r))return!0;var e=o(n);return null!==e&&f(t,e,r)};e.exp({hasMetadata:function(t,n){return f(t,i(n),arguments.length<3?void 0:c(arguments[2]))}})},function(t,n,r){var e=r(54),i=r(2),o=e.has,u=e.key;e.exp({hasOwnMetadata:function(t,n){return o(t,i(n),arguments.length<3?void 0:u(arguments[2]))}})},function(t,n,r){var e=r(54),i=r(2),o=r(26),u=e.key,c=e.set;e.exp({metadata:function(t,n){return function(r,e){c(t,n,(void 0!==e?i:o)(r),u(e))}}})},function(t,n,r){var e=r(1);e(e.P+e.R,"Set",{toJSON:r(165)("Set")})},function(t,n,r){"use strict";var e=r(1),i=r(147)(!0);e(e.P,"String",{at:function(t){return i(this,t)}})},function(t,n,r){"use strict";var e=r(1),i=r(46),o=r(16),u=r(122),c=r(120),f=RegExp.prototype,a=function(t,n){this._r=t,this._s=n};r(139)(a,"RegExp String",function(){var t=this._r.exec(this._s);return{value:t,done:null===t}}),e(e.P,"String",{matchAll:function(t){if(i(this),!u(t))throw TypeError(t+" is not a regexp!");var n=String(this),r="flags"in f?String(t.flags):c.call(t),e=new RegExp(t.source,~r.indexOf("g")?r:"g"+r);return e.lastIndex=o(t.lastIndex),new a(e,n)}})},function(t,n,r){"use strict";var e=r(1),i=r(181);e(e.P,"String",{padEnd:function(t){return i(this,t,arguments.length>1?arguments[1]:void 0,!1)}})},function(t,n,r){"use strict";var e=r(1),i=r(181);e(e.P,"String",{padStart:function(t){return i(this,t,arguments.length>1?arguments[1]:void 0,!0)}})},function(t,n,r){"use strict";r(82)("trimLeft",function(t){return function(){return t(this,1)}},"trimStart")},function(t,n,r){"use strict";r(82)("trimRight",function(t){return function(){return t(this,2)}},"trimEnd")},function(t,n,r){r(153)("asyncIterator")},function(t,n,r){r(153)("observable")},function(t,n,r){var e=r(1);e(e.S,"System",{global:r(3)})},function(t,n,r){for(var e=r(155),i=r(28),o=r(3),u=r(27),c=r(80),f=r(7),a=f("iterator"),s=f("toStringTag"),l=c.Array,h=["NodeList","DOMTokenList","MediaList","StyleSheetList","CSSRuleList"],v=0;v<5;v++){var p,d=h[v],y=o[d],g=y&&y.prototype;if(g){g[a]||u(g,a,l),g[s]||u(g,s,d),c[d]=l;for(p in e)g[p]||i(g,p,e[p],!0)}}},function(t,n,r){var e=r(1),i=r(151);e(e.G+e.B,{setImmediate:i.set,clearImmediate:i.clear})},function(t,n,r){var e=r(3),i=r(1),o=r(121),u=r(207),c=e.navigator,f=!!c&&/MSIE .\./.test(c.userAgent),a=function(t){return f?function(n,r){return t(o(u,[].slice.call(arguments,2),"function"==typeof n?n:Function(n)),r)}:t};i(i.G+i.B+i.F*f,{setTimeout:a(e.setTimeout),setInterval:a(e.setInterval)})},function(t,n,r){r(330),r(269),r(271),r(270),r(273),r(275),r(280),r(274),r(272),r(282),r(281),r(277),r(278),r(276),r(268),r(279),r(283),r(284),r(236),r(238),r(237),r(286),r(285),r(256),r(266),r(267),r(257),r(258),r(259),r(260),r(261),r(262),r(263),r(264),r(265),r(239),r(240),r(241),r(242),r(243),r(244),r(245),r(246),r(247),r(248),r(249),r(250),r(251),r(252),r(253),r(254),r(255),r(317),r(322),r(329),r(320),r(312),r(313),r(318),r(323),r(325),r(308),r(309),r(310),r(311),r(314),r(315),r(316),r(319),r(321),r(324),r(326),r(327),r(328),r(231),r(233),r(232),r(235),r(234),r(220),r(218),r(224),r(221),r(227),r(229),r(217),r(223),r(214),r(228),r(212),r(226),r(225),r(219),r(222),r(211),r(213),r(216),r(215),r(230),r(155),r(302),r(307),r(184),r(303),r(304),r(305),r(306),r(287),r(183),r(185),r(186),r(342),r(331),r(332),r(337),r(340),r(341),r(335),r(338),r(336),r(339),r(333),r(334),r(288),r(289),r(290),r(291),r(292),r(295),r(293),r(294),r(296),r(297),r(298),r(299),r(301),r(300),r(343),r(369),r(372),r(371),r(373),r(374),r(370),r(375),r(376),r(354),r(357),r(353),r(351),r(352),r(355),r(356),r(346),r(368),r(377),r(345),r(347),r(349),r(348),r(350),r(359),r(360),r(362),r(361),r(364),r(363),r(365),r(366),r(367),r(344),r(358),r(380),r(379),r(378),t.exports=r(52)},function(t,n){function r(t,n){if("string"==typeof n)return t.insertAdjacentHTML("afterend",n);var r=t.nextSibling;return r?t.parentNode.insertBefore(n,r):t.parentNode.appendChild(n)}t.exports=r},,,,,,,,,function(t,n,r){(function(n,r){!function(n){"use strict";function e(t,n,r,e){var i=n&&n.prototype instanceof o?n:o,u=Object.create(i.prototype),c=new p(e||[]);return u._invoke=s(t,r,c),u}function i(t,n,r){try{return{type:"normal",arg:t.call(n,r)}}catch(t){return{type:"throw",arg:t}}}function o(){}function u(){}function c(){}function f(t){["next","throw","return"].forEach(function(n){t[n]=function(t){return this._invoke(n,t)}})}function a(t){function n(r,e,o,u){var c=i(t[r],t,e);if("throw"!==c.type){var f=c.arg,a=f.value;return a&&"object"==typeof a&&m.call(a,"__await")?Promise.resolve(a.__await).then(function(t){n("next",t,o,u)},function(t){n("throw",t,o,u)}):Promise.resolve(a).then(function(t){f.value=t,o(f)},u)}u(c.arg)}function e(t,r){function e(){return new Promise(function(e,i){n(t,r,e,i)})}return o=o?o.then(e,e):e()}"object"==typeof r&&r.domain&&(n=r.domain.bind(n));var o;this._invoke=e}function s(t,n,r){var e=P;return function(o,u){if(e===F)throw new Error("Generator is already running");if(e===M){if("throw"===o)throw u;return y()}for(r.method=o,r.arg=u;;){var c=r.delegate;if(c){var f=l(c,r);if(f){if(f===A)continue;return f}}if("next"===r.method)r.sent=r._sent=r.arg;else if("throw"===r.method){if(e===P)throw e=M,r.arg;r.dispatchException(r.arg)}else"return"===r.method&&r.abrupt("return",r.arg);e=F;var a=i(t,n,r);if("normal"===a.type){if(e=r.done?M:j,a.arg===A)continue;return{value:a.arg,done:r.done}}"throw"===a.type&&(e=M,r.method="throw",r.arg=a.arg)}}}function l(t,n){var r=t.iterator[n.method];if(r===g){if(n.delegate=null,"throw"===n.method){if(t.iterator.return&&(n.method="return",n.arg=g,l(t,n),"throw"===n.method))return A;n.method="throw",n.arg=new TypeError("The iterator does not provide a 'throw' method")}return A}var e=i(r,t.iterator,n.arg);if("throw"===e.type)return n.method="throw",n.arg=e.arg,n.delegate=null,A;var o=e.arg;return o?o.done?(n[t.resultName]=o.value,n.next=t.nextLoc,"return"!==n.method&&(n.method="next",n.arg=g),n.delegate=null,A):o:(n.method="throw",n.arg=new TypeError("iterator result is not an object"),n.delegate=null,A)}function h(t){var n={tryLoc:t[0]};1 in t&&(n.catchLoc=t[1]),2 in t&&(n.finallyLoc=t[2],n.afterLoc=t[3]),this.tryEntries.push(n)}function v(t){var n=t.completion||{};n.type="normal",delete n.arg,t.completion=n}function p(t){this.tryEntries=[{tryLoc:"root"}],t.forEach(h,this),this.reset(!0)}function d(t){if(t){var n=t[w];if(n)return n.call(t);if("function"==typeof t.next)return t;if(!isNaN(t.length)){var r=-1,e=function n(){for(;++r<t.length;)if(m.call(t,r))return n.value=t[r],n.done=!1,n;return n.value=g,n.done=!0,n};return e.next=e}}return{next:y}}function y(){return{value:g,done:!0}}var g,b=Object.prototype,m=b.hasOwnProperty,x="function"==typeof Symbol?Symbol:{},w=x.iterator||"@@iterator",S=x.asyncIterator||"@@asyncIterator",_=x.toStringTag||"@@toStringTag",O="object"==typeof t,E=n.regeneratorRuntime;if(E)return void(O&&(t.exports=E));E=n.regeneratorRuntime=O?t.exports:{},E.wrap=e;var P="suspendedStart",j="suspendedYield",F="executing",M="completed",A={},N={};N[w]=function(){return this};var T=Object.getPrototypeOf,I=T&&T(T(d([])));I&&I!==b&&m.call(I,w)&&(N=I);var k=c.prototype=o.prototype=Object.create(N);u.prototype=k.constructor=c,c.constructor=u,c[_]=u.displayName="GeneratorFunction",E.isGeneratorFunction=function(t){var n="function"==typeof t&&t.constructor;return!!n&&(n===u||"GeneratorFunction"===(n.displayName||n.name))},E.mark=function(t){return Object.setPrototypeOf?Object.setPrototypeOf(t,c):(t.__proto__=c,_ in t||(t[_]="GeneratorFunction")),t.prototype=Object.create(k),t},E.awrap=function(t){return{__await:t}},f(a.prototype),a.prototype[S]=function(){return this},E.AsyncIterator=a,E.async=function(t,n,r,i){var o=new a(e(t,n,r,i));return E.isGeneratorFunction(n)?o:o.next().then(function(t){return t.done?t.value:o.next()})},f(k),k[_]="Generator",k.toString=function(){return"[object Generator]"},E.keys=function(t){var n=[];for(var r in t)n.push(r);return n.reverse(),function r(){for(;n.length;){var e=n.pop();if(e in t)return r.value=e,r.done=!1,r}return r.done=!0,r}},E.values=d,p.prototype={constructor:p,reset:function(t){if(this.prev=0,this.next=0,this.sent=this._sent=g,this.done=!1,this.delegate=null,this.method="next",this.arg=g,this.tryEntries.forEach(v),!t)for(var n in this)"t"===n.charAt(0)&&m.call(this,n)&&!isNaN(+n.slice(1))&&(this[n]=g)},stop:function(){this.done=!0;var t=this.tryEntries[0],n=t.completion;if("throw"===n.type)throw n.arg;return this.rval},dispatchException:function(t){function n(n,e){return o.type="throw",o.arg=t,r.next=n,e&&(r.method="next",r.arg=g),!!e}if(this.done)throw t;for(var r=this,e=this.tryEntries.length-1;e>=0;--e){var i=this.tryEntries[e],o=i.completion;if("root"===i.tryLoc)return n("end");if(i.tryLoc<=this.prev){var u=m.call(i,"catchLoc"),c=m.call(i,"finallyLoc");if(u&&c){if(this.prev<i.catchLoc)return n(i.catchLoc,!0);if(this.prev<i.finallyLoc)return n(i.finallyLoc)}else if(u){if(this.prev<i.catchLoc)return n(i.catchLoc,!0)}else{if(!c)throw new Error("try statement without catch or finally");if(this.prev<i.finallyLoc)return n(i.finallyLoc)}}}},abrupt:function(t,n){for(var r=this.tryEntries.length-1;r>=0;--r){var e=this.tryEntries[r];if(e.tryLoc<=this.prev&&m.call(e,"finallyLoc")&&this.prev<e.finallyLoc){var i=e;break}}i&&("break"===t||"continue"===t)&&i.tryLoc<=n&&n<=i.finallyLoc&&(i=null);var o=i?i.completion:{};return o.type=t,o.arg=n,i?(this.method="next",this.next=i.finallyLoc,A):this.complete(o)},complete:function(t,n){if("throw"===t.type)throw t.arg;return"break"===t.type||"continue"===t.type?this.next=t.arg:"return"===t.type?(this.rval=this.arg=t.arg,this.method="return",this.next="end"):"normal"===t.type&&n&&(this.next=n),A},finish:function(t){for(var n=this.tryEntries.length-1;n>=0;--n){var r=this.tryEntries[n];if(r.finallyLoc===t)return this.complete(r.completion,r.afterLoc),v(r),A}},catch:function(t){for(var n=this.tryEntries.length-1;n>=0;--n){var r=this.tryEntries[n];if(r.tryLoc===t){var e=r.completion;if("throw"===e.type){var i=e.arg;v(r)}return i}}throw new Error("illegal catch attempt")},delegateYield:function(t,n,r){return this.delegate={iterator:d(t),resultName:n,nextLoc:r},"next"===this.method&&(this.arg=g),A}}}("object"==typeof n?n:"object"==typeof window?window:"object"==typeof self?self:this)}).call(n,function(){return this}(),r(158))}])</script><script src="/./main.0cf68a.js"></script><script>!function(){!function(e){var t=document.createElement("script");document.getElementsByTagName("body")[0].appendChild(t),t.setAttribute("src",e)}("/slider.e37972.js")}()</script>


<script type="text/x-mathjax-config">
MathJax.Hub.Config({
    tex2jax: {
        inlineMath: [ ['$','$'], ["\\(","\\)"]  ],
        processEscapes: true,
        skipTags: ['script', 'noscript', 'style', 'textarea', 'pre', 'code']
    }
});

MathJax.Hub.Queue(function() {
    var all = MathJax.Hub.getAllJax(), i;
    for(i=0; i < all.length; i += 1) {
        all[i].SourceElement().parentNode.className += ' has-jax';                 
    }       
});
</script>

<script src="//cdn.mathjax.org/mathjax/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML">
</script>


    
<div class="tools-col" q-class="show:isShow,hide:isShow|isFalse" q-on="click:stop(e)">
  <div class="tools-nav header-menu">
    
    
      
      
      
    
      
      
      
    
    

    <ul style="width: 70%">
    
    
      
      <li style="width: 50%" q-on="click: openSlider(e, 'innerArchive')"><a href="javascript:void(0)" q-class="active:innerArchive">所有文章</a></li>
      
        
      
      <li style="width: 50%" q-on="click: openSlider(e, 'aboutme')"><a href="javascript:void(0)" q-class="active:aboutme">关于我</a></li>
      
        
    </ul>
  </div>
  <div class="tools-wrap">
    
    	<section class="tools-section tools-section-all" q-show="innerArchive">
        <div class="search-wrap">
          <input class="search-ipt" q-model="search" type="text" placeholder="find something…">
          <i class="icon-search icon" q-show="search|isEmptyStr"></i>
          <i class="icon-close icon" q-show="search|isNotEmptyStr" q-on="click:clearChose(e)"></i>
        </div>
        <div class="widget tagcloud search-tag">
          <p class="search-tag-wording">tag:</p>
          <label class="search-switch">
            <input type="checkbox" q-on="click:toggleTag(e)" q-attr="checked:showTags">
          </label>
          <ul class="article-tag-list" q-show="showTags">
             
              <li class="article-tag-list-item">
                <a href="javascript:void(0)" class="js-tag color2">mathematics</a>
              </li>
             
              <li class="article-tag-list-item">
                <a href="javascript:void(0)" class="js-tag color4">碎碎念</a>
              </li>
             
              <li class="article-tag-list-item">
                <a href="javascript:void(0)" class="js-tag color4">ADC</a>
              </li>
             
              <li class="article-tag-list-item">
                <a href="javascript:void(0)" class="js-tag color5">基础医学</a>
              </li>
             
              <li class="article-tag-list-item">
                <a href="javascript:void(0)" class="js-tag color4">mRNA Vaccines</a>
              </li>
             
              <li class="article-tag-list-item">
                <a href="javascript:void(0)" class="js-tag color3">笔记</a>
              </li>
             
              <li class="article-tag-list-item">
                <a href="javascript:void(0)" class="js-tag color5">Blog</a>
              </li>
             
              <li class="article-tag-list-item">
                <a href="javascript:void(0)" class="js-tag color5">bsAb</a>
              </li>
             
              <li class="article-tag-list-item">
                <a href="javascript:void(0)" class="js-tag color1">CAR-T</a>
              </li>
             
              <li class="article-tag-list-item">
                <a href="javascript:void(0)" class="js-tag color2">CAR-NK</a>
              </li>
             
              <li class="article-tag-list-item">
                <a href="javascript:void(0)" class="js-tag color1">LaTeX</a>
              </li>
             
              <li class="article-tag-list-item">
                <a href="javascript:void(0)" class="js-tag color3">mRNA Vaccine</a>
              </li>
             
              <li class="article-tag-list-item">
                <a href="javascript:void(0)" class="js-tag color1">WIN10</a>
              </li>
             
              <li class="article-tag-list-item">
                <a href="javascript:void(0)" class="js-tag color3">mRNA vaccine</a>
              </li>
             
              <li class="article-tag-list-item">
                <a href="javascript:void(0)" class="js-tag color4">HistCite</a>
              </li>
             
              <li class="article-tag-list-item">
                <a href="javascript:void(0)" class="js-tag color5">生信分析</a>
              </li>
             
              <li class="article-tag-list-item">
                <a href="javascript:void(0)" class="js-tag color5">诊断检验</a>
              </li>
             
              <li class="article-tag-list-item">
                <a href="javascript:void(0)" class="js-tag color4">R语言</a>
              </li>
             
              <li class="article-tag-list-item">
                <a href="javascript:void(0)" class="js-tag color5">love</a>
              </li>
            
            <div class="clearfix"></div>
          </ul>
        </div>
        <ul class="search-ul">
          <p q-show="jsonFail" style="padding: 20px; font-size: 12px;">
            缺失模块。<br/>1、请确保node版本大于6.2<br/>2、在博客根目录（注意不是yilia根目录）执行以下命令：<br/> npm i hexo-generator-json-content --save<br/><br/>
            3、在根目录_config.yml里添加配置：
<pre style="font-size: 12px;" q-show="jsonFail">
  jsonContent:
    meta: false
    pages: false
    posts:
      title: true
      date: true
      path: true
      text: false
      raw: false
      content: false
      slug: false
      updated: false
      comments: false
      link: false
      permalink: false
      excerpt: false
      categories: false
      tags: true
</pre>
          </p>
          <li class="search-li" q-repeat="items" q-show="isShow">
            <a q-attr="href:path|urlformat" class="search-title"><i class="icon-quo-left icon"></i><span q-text="title"></span></a>
            <p class="search-time">
              <i class="icon-calendar icon"></i>
              <span q-text="date|dateformat"></span>
            </p>
            <p class="search-tag">
              <i class="icon-price-tags icon"></i>
              <span q-repeat="tags" q-on="click:choseTag(e, name)" q-text="name|tagformat"></span>
            </p>
          </li>
        </ul>
    	</section>
    

    

    
    	<section class="tools-section tools-section-me" q-show="aboutme">
  	  	
  	  		<div class="aboutme-wrap" id="js-aboutme">想成为大白的小白&lt;br&gt;&lt;br&gt;认真苟活的小白</div>
  	  	
    	</section>
    
  </div>
  
</div>
    <!-- Root element of PhotoSwipe. Must have class pswp. -->
<div class="pswp" tabindex="-1" role="dialog" aria-hidden="true">

    <!-- Background of PhotoSwipe. 
         It's a separate element as animating opacity is faster than rgba(). -->
    <div class="pswp__bg"></div>

    <!-- Slides wrapper with overflow:hidden. -->
    <div class="pswp__scroll-wrap">

        <!-- Container that holds slides. 
            PhotoSwipe keeps only 3 of them in the DOM to save memory.
            Don't modify these 3 pswp__item elements, data is added later on. -->
        <div class="pswp__container">
            <div class="pswp__item"></div>
            <div class="pswp__item"></div>
            <div class="pswp__item"></div>
        </div>

        <!-- Default (PhotoSwipeUI_Default) interface on top of sliding area. Can be changed. -->
        <div class="pswp__ui pswp__ui--hidden">

            <div class="pswp__top-bar">

                <!--  Controls are self-explanatory. Order can be changed. -->

                <div class="pswp__counter"></div>

                <button class="pswp__button pswp__button--close" title="Close (Esc)"></button>

                <button class="pswp__button pswp__button--share" style="display:none" title="Share"></button>

                <button class="pswp__button pswp__button--fs" title="Toggle fullscreen"></button>

                <button class="pswp__button pswp__button--zoom" title="Zoom in/out"></button>

                <!-- Preloader demo http://codepen.io/dimsemenov/pen/yyBWoR -->
                <!-- element will get class pswp__preloader--active when preloader is running -->
                <div class="pswp__preloader">
                    <div class="pswp__preloader__icn">
                      <div class="pswp__preloader__cut">
                        <div class="pswp__preloader__donut"></div>
                      </div>
                    </div>
                </div>
            </div>

            <div class="pswp__share-modal pswp__share-modal--hidden pswp__single-tap">
                <div class="pswp__share-tooltip"></div> 
            </div>

            <button class="pswp__button pswp__button--arrow--left" title="Previous (arrow left)">
            </button>

            <button class="pswp__button pswp__button--arrow--right" title="Next (arrow right)">
            </button>

            <div class="pswp__caption">
                <div class="pswp__caption__center"></div>
            </div>

        </div>

    </div>

</div>
  </div>
<script type="text/x-mathjax-config">
    MathJax.Hub.Config({
        tex2jax: {
            inlineMath: [ ["$","$"], ["\\(","\\)"] ],
            skipTags: ['script', 'noscript', 'style', 'textarea', 'pre', 'code'],
            processEscapes: true
        }
    });
    MathJax.Hub.Queue(function() {
        var all = MathJax.Hub.getAllJax();
        for (var i = 0; i < all.length; ++i)
            all[i].SourceElement().parentNode.className += ' has-jax';
    });
</script>
<script src="http://cdn.mathjax.org/mathjax/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
</body>
</html>